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Abstract 
 
The molecular processes by which information is incorporated and distributed 
within a cell are termed signal transduction.  These pathways allow cells to interact with 
each other and with their environments and are critical to the proper cellular function in a 
variety of contexts.  Previously developed methods for analyzing signaling networks have 
been largely ignored, most likely due to their mathematical complexity and difficulty in 
application.  A novel analysis framework was developed to assist in the examination of 
signaling networks, both to facilitate the reconstruction of previously undetermined 
pathways as well as to quantitatively characterize interactions between components.   
This approach, termed activation ratio analysis, involves the ratio between active 
and inactive forms of signaling intermediates at steady state.  The activation ratio of an 
intermediate is shown to depend linearly upon the concentration of the activating 
enzyme.  The slope of the line is defined as the activation factor, and is determined by the 
kinetic parameters of activation and inactivation.  The mathematical functionality of the 
activation ratio changes for other signaling network arrangements.  It is therefore possible 
to extract the original network structure from a set of measured activation ratios, with 
activation factors yielding a measure of activation potential between intermediates.  
 3
This framework was tested using computational simulations of a small-scale 
interconnected network, cascades with feedback, and in the presence of experimental 
noise.  In the process, additional tools were developed to automate and evaluate the 
analysis.  The theoretical concepts were also applied to examine the modification cycles 
of the protein Erk2 by the kinase Mek1 and phosphatases PTP1B and PP2A in vitro.  
Limitations in the accuracy of measurements and experimental setup resulted in high 
uncertainty in the calculated distribution of Erk states, preventing a quantitative analysis 
of this system.  Nevertheless, qualitative predictions from activation ratio analysis were 
verified, in particular, the influence of component concentrations on the Erk distribution 
at steady state.  While these issues indicate considerations for future experimental studies, 
they do not override the ability of activation ratio analysis to investigate signaling 
networks, where description of interactions in the whole system is more important than 
detailed examination of the individual steps. 
 
Thesis Supervisor: Gregory Stephanopoulos 
Title: Professor of Chemical Engineering
 4
 
 
 
 
 
 
 
 
 
 
 
For Dan and Lia 
 
In loving memory 
 
 
 
 5
 6
Acknowledgements 
 
The process of the Ph. D. is a long one, but fortunately, not a lonely one.  
Although the work described here was performed independently, I never would have 
been able to complete it if not for the support of many wonderful people.  I owe a great 
many my sincere gratitude: 
My advisor, Gregory Stephanopoulos, without which this work could never have 
been done.  Thanks for providing a fantastic work environment, and for support, pressure, 
and patience when I needed them.  My thesis committee members, Doug Lauffenburger, 
Peter Sorger, and (for a time) Martin Yarmush, for open ears, lively discussions, and 
advice to help me along my way. 
My dear friend, colleague, former group- and office-mate, “academic sister” and 
perennial mentor, Maria Klapa, who has been teaching me since my first day at MIT and 
continues even now.  I have strived to live up to her standard and example, as an 
exemplary scientist and a wonderful individual.  I simply can’t imagine graduate school 
without her presence or guidance. 
My current and former colleagues of the Stephanopoulos group, for providing 
advice, intellectual debate, a sympathetic ear, or a few laughs over years of coffee, lunch 
and bad pizza.  Special thanks to Saliya Silva, Matt Wong, Bill Schmitt, Jatin Misra, Jose 
Aleman, Stelios Kouvroukoglou, Gary Jung, and Stefan Wildt. 
Brett Roth, Ilda Moura, Janet Fisher, Elaine Aufiero, Suzanne Easterly, Anne 
Fowler, Jenn Shedd, Mary Keith, and Susan Lanza, for helping with so many little 
administrative things along the way (I’m sure, many I don’t even know about) that made 
life at MIT move much more smoothly.  Joanne Sorrento and Frances Meale, for helping 
me juggle the schedules and keep track of three very busy professors. 
The National Science Foundation (Graduate Research Fellowship) and Singapore-
MIT Alliance for financial support, helping to give me the academic freedom to pursue a 
project a bit outside the normal realm of my advisor.   
 7
Tom Wang, Brian Bucher, Arvind Mallik, Wendy Prud’homme, Gwang-Soo 
Kim, and Sarah Spurgeon, for being roommates, friends, and family, all rolled up 
together.  You helped make homes exactly that—homes, not mere apartments where I 
kept my things and slept.  We didn’t just share a place to stay, but shared lives.   
Friends from both coasts, so many that I dare not forget any, for standing by me 
and supporting me when I needed it, for giving me refuge when I needed that, and 
accepting my help when I could give it.  Folks I knew before coming here: Vineet 
Gossain, Stacy Mar, Mike Lu, Khanh Ngo, Colleen Yeh, Khang Dao, George Tsao, Betty 
Chan, Brett Kurtin, Nizar Abdalla, Binita Bhattacharjee, Jimmy Lin, and Gopal Sridhar.  
And those I met and befriended along the way: Lily Koo, Connie Sun, Carmen Patrick, 
Hang Lu, Yonathan Thio, Casim Sarkar, Betty Yu, Inn Yuk, Klaudyne Hong, Lacey 
Southerland, and Lisa Wang.  Others I may have missed in name, but you’re always in 
my heart.  Without you, I never would have had the strength to get through the dark days 
or felt the joy celebrating the bright ones.   
Poh Lim, Stan Hunter, Helena Chia, AJ Liuba, and other members past and 
present of the MIT Korean Karate Club, for great exercise and better friendship.  Tae 
Kwon Do was not just a way to exercise in the cold winters, or to work out some 
frustrations, or clear my head from a long day—it was all of that, and so much more. 
Last, but never least, my dear family, for bringing me up, nurturing me along the 
way, and supporting me through the years even without understanding just what I was up 
to.  My father, whose love of science and engineering led me to where I am.  My mother, 
whose compassion and determination helped me become who I am.  My sister, whose 
consideration, intelligence, and courage have always showed me who I wanted to be.  My 
“Uncle” Dan Larson, whose friendship with my father over decades gave me a perfect 
example of how friends should be.  My Uncle Carlos and Aunt Lia, for showing me what 
family should be, too.  And my Grandma Tota, for stories, for laughs, for that optimism 
that gave me a glimmer of hope when all was dark.    
Thank you all, because without you, I never would have made it to and through 
MIT, never learned so much along the journey, and never gotten to my own “Ithaca”. 
 8
Table of Contents 
Abstract ........................................................................................................................... 3 
Acknowledgements.......................................................................................................... 7 
Table of Contents ............................................................................................................ 9 
Table of Figures............................................................................................................ 11 
Table of Tables.............................................................................................................. 14 
 
1. INTRODUCTION....................................................................................................... 15 
1.1 Motivation ............................................................................................................... 17 
1.2. Background............................................................................................................ 19 
1.2.1. Construction and application of models ......................................................... 19 
1.2.2. Mathematical analysis techniques................................................................... 22 
1.2.3. Measurement techniques and experimental considerations............................ 25 
1.3. Objectives............................................................................................................... 27 
1.4. Thesis overview...................................................................................................... 29 
1.5. References .............................................................................................................. 30 
 
2. ACTIVATION RATIO ANALYSIS ......................................................................... 35 
2.1. Methods.................................................................................................................. 35 
2.2. Isolated interconverting cycle................................................................................ 36 
2.3. Extension to simple network arrangements ........................................................... 43 
2.3.1. Linear Cascade................................................................................................ 44 
2.3.2. Converging Pathways ..................................................................................... 48 
2.3.3. Diverging Pathways ........................................................................................ 51 
2.3.4. Dual activation steps ....................................................................................... 52 
2.3.5. Cascades with feedback .................................................................................. 53 
2.4. Saturating conditions and influence of enzyme-substrate complexes.................... 57 
2.5. Conclusions............................................................................................................ 63 
2.6. References .............................................................................................................. 65 
 
3. NETWORK RECONSTRUCTION USING ACTIVATION RATIOS................. 67 
3.1. Concepts and Algorithm ........................................................................................ 67 
3.1.1. Structural and numerical observability ........................................................... 67 
3.1.2. Stepwise analysis of networks ........................................................................ 69 
3.1.3. Consistency..................................................................................................... 71 
3.2. Analysis of a Model Network ................................................................................. 73 
3.2.1. Network structure and features ....................................................................... 73 
3.2.2. Network analysis using free concentrations ................................................... 74 
3.2.3. Network analysis using total activation ratios ................................................ 79 
3.3 Automated regression of data and pattern assignment........................................... 84 
3.3.1. Methodology................................................................................................... 84 
3.3.2. Model selection and evaluation ...................................................................... 87 
3.3.3. Example:  cascade analysis in the presence of experimental noise ................ 89 
3.4. Conclusions............................................................................................................ 97 
3.5. References .............................................................................................................. 98 
 
 9
4. ACTIVATION RATIO ANALYSIS OF ERK PHOSPHORYLATION............... 99 
4.1. Experimental system selection and design........................................................... 100 
4.2. Development and Operation ................................................................................ 103 
4.2.1. Materials and Methods.................................................................................. 103 
4.2.2. Reaction operating conditions....................................................................... 105 
4.2.3. Enzyme immobilization ................................................................................ 109 
4.3. Model for Interpreting ELISA Data..................................................................... 114 
4.3.1. Motivation and concepts ............................................................................... 114 
4.3.2. Selection of data............................................................................................ 121 
4.3.2. Error analysis and model validation ............................................................. 123 
4.4. Activation Ratios in Erk Phosphorylation Cycles................................................ 129 
4.4.1. Comparison of liquid-phase and immobilized reactions .............................. 129 
4.4.2. Variation of total Erk concentration ............................................................. 135 
4.4.3. Modulation of phosphatases ......................................................................... 137 
4.5. Conclusions.......................................................................................................... 140 
4.6. References ............................................................................................................ 141 
 
5. CONCLUSIONS – FUTURE WORK..................................................................... 145 
5.1. References ............................................................................................................ 147 
 
6. APPENDICES........................................................................................................... 149 
Appendix 1. Single cycle model .................................................................................. 149 
A1.1. Simulation details.......................................................................................... 149 
A1.2. MATLAB files.............................................................................................. 150 
Appendix 2. Parameter values for simple signaling models....................................... 154 
A2.1. Linear Cascade.............................................................................................. 154 
A2.2. Converging Cycles........................................................................................ 154 
A2.3. Diverging Pathways ...................................................................................... 154 
A2.4. Cascades with Feedback ............................................................................... 154 
Appendix 3. Model signaling network ........................................................................ 155 
Appendix 4. Extended cascade with noise .................................................................. 156 
Appendix 5. Sensitivity matrix for ELISA measurement model .................................. 157 
 
 10
Table of Figures 
Figure 2.1. Single cycle diagrams and reaction scheme. ................................................. 36 
Figure 2.2. Simulation results for simple binding under saturating conditions.  A) 
Fraction of A complexed ([A·B]/AT) or B) activation ratio ([A·B]/A) plotted against free 
B (circles) or BT (squares). ............................................................................................... 39 
Figure 2.3. Simulation results for an individual covalent-modification cycle as shown in 
Figure 2.1.  A) Fraction of A activated (A*/AT) and B) Activation ratios ARA (A*/A) for 
the simple cycle, plotted against free activating enzyme E1.  Parameter values:  k1 = 10, 
k2 = 10, Km2 = 1, E2T = 1, AT = 10, Km1 = 20 (diamonds), 10 (squares), 4 (triangles), 2 
(x’s), 1 (stars), 0.4 (circles), 0.2 (+’s). .............................................................................. 43 
Figure 2.4. Diagrams of extended signaling structures. A) linear cascade, B) converging 
pathways, C) diverging pathways, D) dual activation steps, E) cascade with feedback 
(single-step activation as in A). ........................................................................................ 44 
Figure 2.5. Activation ratios for the linear cascade of Figure 2.4A, plotted against free 
concentrations of E1 (A), A* (B), B* (C), or C* (D).  Ratios for A: diamonds, B: squares, 
C: triangles. ....................................................................................................................... 47 
Figure 2.6. Fractional activation and activation ratios for the converging cycle as shown 
in Figure 1C. A) and B), fractional activation (A*/AT), C) and D), activation ratio (A*/A) 
plotted against free activating enzyme E1 (A) and (C) or E2 (B) and (D). ....................... 50 
Figure 2.7. Results for diverging branches in Figure 2.4C.  A) Activation ratios for A 
(diamonds) and B (squares) plotted against free activating enzyme E1, B) Activation 
ratios for A and B plotted against each other, i.e. ARA against B* and ARB against A*. . 52 
Figure 2.8. Activation ratios for cascade with positive feedback, unsaturated in feedback 
step (KFB >> AT), plotted against free E1 (A), A* (B), B* (C), C* (D). D* (E), or E* (F).  
For clarity, markers were omitted for activation ratios of A in pt. A. .............................. 55 
Figure 2.9. Activation ratios for cascade with negative feedback, unsaturated in feedback 
step (KFB >> AT), plotted against free E1 (A), A* (B), B* (C), C* (D). D* (E), or E* (F).  
For clarity, markers were omitted for activation ratios of A in pt. A. .............................. 56 
Figure 2.10. Total activation ratios for the isolated covalent modification cycle (using 
total active A*T and total inactive AT) plotted against free E1, with enzyme conditions A) 
Saturated: parameters as shown in Figure 2.3.  B) Unsaturated:  with EiT/Kmi < 0.1. ...... 59 
Figure 3.1. Network with parallel pathways. ................................................................... 68 
Figure 3.2. Diagram of sample model network, showing activation reaction numbering.  
Model details and parameter values are included in Appendix 3. .................................... 73 
Figure 3.3. Activation ratios for intermediates in model network of Figure 3.2, calculated 
using free species only, plotted against A) E1, B) A*, C) C*, D) E*, E) G*, and F) H*.  In 
each case E2 = 0. ............................................................................................................... 75 
Figure 3.4. Activation ratios for intermediates in model network of Figure 3.2, calculated 
using free species only, plotted against A) E2, B) B*, C) C*, D) D*, E) E*, and F) F*. In 
each case E1 = 0. ............................................................................................................... 76 
 11
Figure 3.5. Activation ratios for E (A and B) or F (C and D), plotted as contours against 
C* (constant D*, A and C) or D* (constant C*, B and D). ................................................. 77 
Figure 3.6. Total activation ratios for intermediates in model network of Figure 3.2, 
plotted against A) E1, B) A*, C) C*, D) E*, E) G*, and F) H*. In each case E2 = 0........... 81 
Figure 3.7. Total activation ratios for intermediates in model network of Figure 3.2, 
plotted against A) E2, B) B*, C) C*, D) D*, E) E*, and F) F*. In each case E1 = 0............ 82 
Figure 3.8.  Total activation ratios for E (A and B) or F (C and D), plotted as contours 
against C* (constant D*, A and C) or D* (constant C*, B and D)...................................... 83 
Figure 3.9. Models used automated regression of activation ratio data, with graphical 
significance of parameters and half-saturation points shown. .......................................... 85 
Figure 3.10. A) Cascade structure and color scheme and B) Expected (and observed) 
output matrix Rji following automated regression analysis. ............................................. 89 
Figure 3.11. Activation ratios (symbols) and best-fit model curves (solid lines) for 
cascade of Figure 3.10A following automated regression.  Activation ratios for A: 
squares, B: circles, C: triangles, D: diamonds, E: x’s....................................................... 90 
Figure 3.12. Activation ratios (symbols) and best-fit model curves (solid lines) for 
cascade with noise added to activation ratios.  The noise has a standard deviation of 40% 
of the true value.   Symbols as in Figure 3.11................................................................... 93 
Figure 3.13. Activation ratios (symbols) and best-fit model curves (lines) for cascade 
with noise added in active and inactive species.  The noise has a standard deviation of 
20% of the true value.  Symbols as in Figure 3.11. .......................................................... 94 
Figure 4.1. Immobilization of enzymes enables separation of free species from enzyme-
substrate complexes. ....................................................................................................... 101 
Figure 4.2. Erk covalent modification cycles under action of Mek, PTP1B and PP2A. 103 
Figure 4.3. Sample results for in vitro reactions using Erk as a substrate.  A) 
Phosphorylation by N4-Mek (5-10µL) or US-Mek (2µL) in different buffers (see text for 
composition).  For N4-Mek in EB, numbers signify µL Mek added (5+5 is 5µL N4-
Mek+5µL EB).  B) ErkPP dephosphorylation by 1µL phosphatases in RB with or without 
addition of inhibitors. OA: 100 nM Okadaic Acid, NaVO4: 1 mM sodium vanadate. .. 107 
Figure 4.4. Phosphorylation of Erk in presence of N4-Mek, PTP1B, and PP2A.  A) 
Dynamic time course of Erk phosphorylation using 0.1 µL of each enzyme. B) 
Distribution of Erk forms after reaction for 2 hr............................................................. 108 
Figure 4.5. Enzymatic activities following direct adsorption to polystyrene.  A) 
Phosphorylation of Erk using N4-Mek. B) Dephosphorylation of ErkPP using PTP1B 
(closed symbols) or PP2A (open symbols).  Diamonds represent immobilized reaction 
conditions, while squares represent data taken for liquid-phase reactions. .................... 110 
Figure 4.6. Enzymatic activities following immobilization on Protein G-coated plates 
using capture antibodies without (A, C, E) or with (B, D, F) an extra blocking step.  A 
and B) Phosphorylation of Erk by N4-Mek.  C and D) Dephosphorylation of 
 12
phosphotyrosine- (PTP1B) or phosphoserine-containing (PP2A) peptides.  E and F) 
Dephosphorylation of ErkPP by phosphatases. .............................................................. 111 
Figure 4.7. Enzymatic activities following immobilization using capture antibodies 
directly adsorbed to plates.  A) Phosphorylation of Erk by N4-Mek.  B) 
Dephosphorylation of ErkPP by phosphatases.  C) Saturation of immobilization of PP2A.  
D) Phosphate release from phosphopeptides. Diamonds: immobilized enzymes, Squares: 
liquid-phase reactions, Triangles: enzymes remaining in supernatant liquid following 
immobilization. ............................................................................................................... 113 
Figure 4.8. Expectations for ELISA results with potential issues. A) Cross-reactivity of 
anti-Erk antibodies (taken from Yao et al [12]), B) Sigmoidal overall response containing 
an intermediate linear region. ......................................................................................... 114 
Figure 4.9. ELISA data modeling and regression as two steps: first, rescaling of data 
using composition parameters, second, linear fit of resulting rescaled data.  Circles: “D” 
(original ErkPP), squares: “T” (ErkPP + PTP1B), diamonds: “Y” (ErkPP + PP2A), 
triangles: “N” (ErkPP + both phosphatases)................................................................... 118 
Figure 4.10. Sample results from ELISA standards regression.  Symbols as in Figure 4.9.  
Solid lines represent model predictions using best-fit parameters.................................. 119 
Figure 4.11. Collection of data points from different samples and best-fit regression 
results.  Data is the same as used in generation of Figure 4.10, with xT rescaled using 
model parameters. ........................................................................................................... 120 
Figure 4.12. Sample ELISA data, showing dependence of experimental variance on 
absolute signal.  Diamonds: average signal (triplicate measurements).  Squares: ratio of 
standard deviation to average value at each point. ......................................................... 122 
Figure 4.13. A) Activation profiles and B) Activation Ratios for Erk cycles vs. 
normalized volume of N4-Mek added, in liquid phase (closed symbols) or immobilized 
using capture antibodies (open symbols).  “Low” (circles) signifies a maximum of 0.1 µL 
N4-Mek added, “Norm” (squares): 1 µL, “High” (triangles): 10 µL Mek..................... 131 
Figure 4.14. A) Activation profiles (fraction Erk in each form) and B) Activation Ratios 
vs. volume Mek added, for Erk cycles in liquid phase, varying total concentration of Erk.
......................................................................................................................................... 136 
Figure 4.15. A) Activation profiles and B) Activation Ratios vs. volume Mek added, for 
Erk cycles in liquid phase, varying total amounts of both phosphatases........................ 138 
Figure 4.16. A) Activation profiles and B) Activation Ratios vs. volume Mek added, for 
Erk cycles in liquid phase, varying total amounts of each phosphatase independently. 139 
 
 13
Table of Tables 
Table 2.1.  Regression results for converging pathway, using parameter values from 
Figure 2.6. ......................................................................................................................... 49 
Table 2.2.  Summary of results for simple signaling systems: expressions for activation 
ratios.................................................................................................................................. 63 
Table 3.1. Expectations for activation ratios when inverting the relationship between 
species I and J. .................................................................................................................. 72 
Table 3.2. Activation ratio combinations for three-species structures............................. 72 
Table 3.3.  Regression results for simple network, using free activation ratios............... 78 
Table 3.4. Models and parameter bounds for automated regression of activation ratio 
data.  Here ∆y = ymax–ymin, ∆x = xmax–xmin, yavg=(ymax+ymin)/2, and xavg=(xmax+ xmax)/2. 
x(y=yavg) signifies the value of x nearest to where y equals yavg, and vice versa for 
y(x=xavg)............................................................................................................................ 86 
Table 3.5. Results of automated regression/decision analysis for extended cascade in 
Figure 3.9A.  Results shown are mean value from 10 replicate calculations in selecting an 
optimal model.  0 represents linear fit, 1 is hyperbolic fit, and –1 is inverse hyperbolic fit. 
See Figures 3.12-13 for example data............................................................................... 91 
Table 3.6.  Worst-case results of automated regression/decision analysis for extended 
cascade in Figure 3.10A, where activation ratios have an added noise term of 40% of true 
value.  Data is shown in Figure 3.12.  Tables represent model with lowest AIC and 
weights for each model. .................................................................................................... 95 
Table 3.7.  Worst-case results of automated regression/decision analysis for extended 
cascade in Figure 3.10A, where active and inactive concentrations have an added noise 
term of 20% of true value.  Data is shown in Figure 3.13.  Tables represent model with 
lowest AIC and weights for each model. .......................................................................... 95 
Table 4.1. Buffers used in experimental studies (final values). ..................................... 105 
Table 4.2. Conditions tested during optimization of enzyme immobilization, and details 
of final procedure............................................................................................................ 113 
Table 4.3. Parameter values from ELISA standards regression (data shown in Figures 
4.9-4.11).......................................................................................................................... 126 
Table 4.4. Comparison of predicted (from standards composition) and observed 
(estimated from measurements) Erk amounts using mixtures of standards (D, T, Y, N) 
samples. 10 ng of each standard (20 ng total) was added to wells, and ELISA 
measurements used with Equation 4.20 to calculate x.  Predictions were calculated 
according to Equation 4.2.  All entries are shown in ng Erk of each form..................... 128 
 
 
 14
1 INTRODUCTION 
The normal operation of any cell can be imagined to consist of three interacting 
systems.  The metabolism is comprised of the enzymes and intermediates involved in 
production of energy and synthesis, processing, and recycling of essential building blocks 
like amino acids, lipids and nucleotides from any materials available to the cell.  The 
genetic system contains the DNA and RNA as well as the polymerases, splicing 
apparatus, ribosomes, and posttranslational machinery that together act to produce 
structural proteins and enzymes for all cellular reactions.  The signaling system acts to 
recognize extracellular cues, relay them across the membrane, and transmit the 
information accordingly to help direct both the metabolic network, through changes in 
enzymatic or transporter activities, and the genetic network, though regulation of 
transcription factors.  Of course, this simplified perspective neglects to explicitly consider 
physical components of the cell like the cytoskeleton or some of the systems involved in 
cell division such as DNA replication and chromosomal separation.   But these aspects of 
cellular behavior also depend upon and interact with the systems described above, and 
contain components that in some cases can also be considered members of the metabolic, 
signaling or genetic networks.   
Traditional efforts to discover and characterize individual components of each 
system have recently begun to give way to more encompassing “systems biology” 
initiatives.  This is in part due to the level of detail to which many of the relevant 
pathways have already been described.  Perhaps more importantly, it is a reflection of the 
desire to study molecules not in isolation but rather within the contexts of the cellular 
networks in which they interact.  Detailed investigations of specific components provide 
much important information about the physical and chemical interactions of these 
molecules, but they cannot address the question of what the actual in vivo activity is in a 
particular cell type or set of environmental conditions.   Instead, a set of measurements 
about the system must be combined with an analytical framework capable of processing 
the data. 
 15
  There are already a variety of methods in place to reconstruct and characterize 
metabolic and genetic networks.   In the case of metabolism, analysis of the flux, or 
throughput, between metabolic intermediates is used to provide a measure for the relative 
engagement of particular reactions as matter is transferred through pathways in the 
network, based on a set of steady-state mass balances around each intermediate [1].  This 
methodology has been extended to provide additional insight, such as identification of 
reversible reactions and cycles, by utilizing substrates labeled with radioactive or 
uncommon stable isotopes (e.g. 13C), measurement by nuclear magnetic resonance 
(NMR) or mass spectrometry (MS), and adding the appropriate isotopomer balances to 
the analysis [2].   The correlation between expression patterns for different genes, 
measured using DNA microarrays, across many sample types or over time has been used 
to identify connectivity between the genes and assign parameters reflecting the strength 
of interaction [3, 4].  More recently, analysis of time-lagged correlations has been used to 
order genes in sequence and therefore add directional information, which may be used to 
suggest causality [5].    
At this time, no analogous method exists to translate measurements of the 
activation of particular signaling intermediates directly into putative network structures.  
The connectivity of signaling networks has been predicted by examination of databases 
describing protein-protein interactions based on two-hybrid experiments or by searching 
protein sequences for potentially interacting domains [6-8].  However, such approaches 
are not designed to incorporate information regarding activation of intermediates, and 
therefore cannot be applied to evaluate the activation of different signaling pathways 
under a particular set of experimental conditions.  Structural identification of the 
signaling network is separated from a quantitative description, whereas ideally both can 
be accomplished with the same technique simultaneously. 
The methods described above for study of metabolic or genetic systems 
unfortunately cannot be applied to examine signaling.  Metabolic analysis methods 
depend upon mass flow between intermediates, which does not occur in signal 
transduction pathways.  Genetic analysis depends in general upon the separation in time 
between activation of each intermediate:  production of the corresponding protein is 
required to activate the next gene in sequence.  In signaling, however, activation of one 
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step can begin before completion of the previous step.  While some groups have 
previously attempted to modify existing tools for the study of signaling networks, in 
general their results have been mathematically intractable or experimentally infeasible 
and thus applied only sparingly.  Therefore, it was apparent that a novel analysis 
framework was necessary for the study of signaling systems. 
1.1 Motivation 
Signal transduction processes allow cells to interact with each other and with their 
environments and are critical to the proper function of both unicellular eukaryotes and 
cells in a multicellular organism.  Bacteria and yeasts utilize signaling pathways to sense 
and respond to environmental cues including food, osmotic pressure, or mating factors [9, 
10].  In higher-order species including worms, fruit flies, mice and humans, signaling is 
used to direct proliferation and differentiation of embryonic stem cells into neural, 
muscle, bone and other tissues, to activate the immune response in macrophages and B 
and T lymphocytes, and to coordinate organs together, such as the action of insulin to 
simultaneously regulate liver, pancreatic, fat and muscle tissue following a meal [11-13].  
These pathways are therefore centrally involved in the regulation of cellular behavior, 
from induction of growth and division, death (by apoptosis), movement and shape to 
even changes in phenotype, either in the metabolic state or patterns of gene expression 
[14].  Defects in signaling processes have been linked to a variety of diseases, most 
notably diabetes and cancer [15, 16]. 
Developing a more thorough understanding of signal transduction phenomena 
depends on the ability to analyze the simultaneous action of the elements involved.  Thus, 
the same reasons that prompt research in signal transduction in the first place are also 
pertinent to developing analytical methods. A framework for analysis of signal 
transduction would give researchers a tool for experimental design, interpretation of 
results, and a way to visualize the breadth of effects that a signal can have.  Together with 
improved methods in making measurements, this framework would enable the creation 
and evaluation of models of signal transduction.  These could be used in understanding 
the processes of cellular development, stem cell differentiation, and progression of 
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disease.  Furthermore, methods for analysis of signaling systems could be used for 
selection of drug targets, evaluation of efficacy, and observation of side effects. 
Signal transduction pathways are, by nature, involved in the transfer of 
information; in many cases this takes the form of intermediates cycling between two or 
more states; the “information” is contained within the relative amounts of these states and 
how they influence the states of other intermediates.  Individual steps typically involve a 
translocation of proteins to specific regions of the cell, activation of enzymes, covalent 
modification of proteins (particularly by phosphorylation), or production and 
translocation of small “second messenger” molecules, such as Ca2+, IP3, and cAMP [17, 
18].  In each case, the state of one species will regulate the activity of an enzyme, either 
directly or indirectly.  This enzyme then acts to modify a new target, and thus the state of 
one species can be used to direct a change in the state of one (or more) other species.  A 
set of cascades and branching networks is created that ultimately ends at the level of 
transcription factors or metabolic enzymes.  Depending on the specifics of each step, the 
cascades offer a method for both signal amplification and attenuation [19-23]. 
The past few decades have witnessed an explosion of research in biology, with a 
large amount of energy devoted towards the discovery and description of signal 
transduction phenomena.  Completion of sequencing projects for genomes for a variety of 
organisms, from bacteria to humans, has yielded databases full of putative genes with 
unknown function, many of which may be involved in signal transduction.  
Technological advances in sequencing and identification of proteins, characterization and 
detection of posttranslational modifications, observation of protein-protein complexes, 
and subcellular microscopy have offered new tools for studying these processes.  
Powerful new computational techniques for protein and gene sequence alignment and 
homology identification have been used to classify newly discovered genes, suggest 
potential interaction partners, and predict catalytic activities.   This has combined to give 
researchers a great number of possible signaling components, but not the ability to 
quickly identify where these molecules actually reside in the overall signaling network.   
Frequently, signal transduction research attempts to investigate in detail particular 
molecules or short pathways.  This approach has proven valuable in learning about 
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mechanisms of signaling, identification of characteristic domains, and provided 
information critical for prediction of putative signaling components from genomic and 
proteomic databases.  However, the variety of cellular and effector systems used to study 
one molecule have yielded results that are sometimes contradictory, and often confusing, 
when combined with data for other molecules.  Exogenous expression, use of knockout 
or constitutively active forms of intermediates, and investigation in a variety of cell types 
are all examples of cases where the study of one component, and how it affects other 
species, may not be reflective of its behavior in the unperturbed system.  It is partly for 
this reason that signaling research is beginning to focus more on the response of 
networks, not individual components.  Without methods in place to analyze data for 
entire signaling networks, however, it is difficult to integrate data from multiple sources, 
or more importantly, direct and interpret these systemic studies.   
One of the most confusing areas in signaling research so far has been that of 
signaling specificity.  An astounding number of different ligands, receptors, and 
intracellular signaling intermediates have been discovered and described.  However, any 
particular cell type may respond very differently to the same ligand than another cell 
type, and the same cell type may respond differently to different ligands [24, 25].  
Nevertheless many of the same pathways appear to be activated under a variety of 
different situations, although perhaps by different upstream mechanisms [26].  
Understanding signaling specificity depends upon the ability to accurately describe how 
different cellular and environmental conditions influence the activation of the entire 
network. 
1.2. Background 
1.2.1. Construction and application of models 
Models for signaling networks have been used as a tool to help investigate 
properties of these systems for nearly as long as research in signal transduction has been 
performed.  In the lack of experiments that are easy to develop or without appropriate 
measurements, models can provide researchers a way to test theories on potential 
mechanisms.  The level of detail can vary from quite abstract to highly detailed, 
depending upon the amount of information that is available and the particular focus of the 
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investigation.  And while models have an inherent capacity to predict system behavior, it 
should be noted that they are always constructed so as to fit some sort of training data set.  
Therefore, models are typically limited in their ability to check their own consistency—
i.e., they may not be able to identify inaccuracies in the presumed structure of the 
network, which would be hidden by the flexibility in values for adjustable parameters. 
One way to avoid this problem is to utilize a relatively abstract model, which 
focuses on representing the network structure rather than mechanistic details.  In that case 
the interaction between system nodes (signaling molecules or modules) is described as 
probabilities of signal transfer.  The resulting models may be constructed in the form of 
Boolean, logical, neural, or stochastic Petri networks [27].  Structure identification is 
possible by first enumerating all possible connections between nodes, and nonzero 
probabilities after fitting to data indicate a structural connection, although an extremely 
large amount of data is required for this process [28].  On the other hand, models with 
predefined structure can be used to explore qualitative features of the system, including 
requirements for different modes of operation (as in T-cell activation vs. relaxation, or 
metabolic vs. mitogenic signaling by insulin) [29-31].    
However, it is difficult to place a physical interpretation on the probabilities or 
connect them to a particular mechanism.  Furthermore, it has been questioned whether 
signaling can even be thought of as a digital process [32].  To more accurately represent 
the signal-response characteristics of individual steps, Omholt used “switchlike” sigmoid 
functions to describe signal transfer during iron homeostasis, although at the expense of 
requiring additional parameters to describe each reaction [33].  As further modifications 
to the model are added, to incorporate additional detail regarding the mechanism of each 
step, the distinction from kinetic models is lost.  It is likely that for this reason, such 
abstract approaches have only been sparingly used in examining signaling systems. 
Detailed kinetic models have been used extensively to describe a variety of 
signaling systems [34-37].   Several groups focused on analyzing the behavior of a single 
intermediate cycling between two forms [38-40].   It was thus shown that such a signaling 
intermediate could show a sharp, “ultrasensitive” response to the amount of activating 
enzyme, reminiscent of the cooperativity seen in the binding of oxygen by hemoglobin 
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[38].  This behavior was dependent upon saturation of one or both enzymes operating to 
drive the cycle (zero-order ultrasensitivity), and was observed experimentally for 
activation of isocitrate dehyrogenase and glycogen phosphorylase [41-44].  Examination 
of models for short cascades showed that sequences of signaling steps could also yield 
sharp overall responses (multistep ultrasensitivity) [21, 23, 45-47].  Additional system 
features, including oscillations or bistability resulting from different feedback modes, 
interplay with scaffolding proteins, and the effects of multiple activation steps or 
limitation of diffusion of components across spatial gradients have also been considered 
[48-51].   Combination with models for receptor-ligand interactions and trafficking has 
yielded expansive descriptions of signaling induced by growth factors such as EGF [52-
55].   
Such approaches allow researchers to test theories about details of different 
mechanisms.  However the analysis of model results is essentially qualitative; kinetic 
parameters could be varied over several orders of magnitude without significantly 
altering the overall behavior [49, 52, 55].  As the model complexity increases, so does the 
number of parameters and concentrations of intermediates that need to be included.  
Some are taken from independent experiments using enzymes purified in vitro, which 
calls into question the validity of the values for in vivo, as well as limiting model 
definition to only a few experimental systems.  Others are fit to coincide with data but are 
rarely validated by additional experiments later, and again can be varied significantly 
without influencing the fit to experimental data, suggesting that the models may not be 
completely describing the experimental system.   
While increasingly complex systems can be successfully simulated, detailed 
models nevertheless possess some serious limitations.  The model complexity means that 
results become almost as difficult to interpret as the experimental results that they are 
trying to emulate.  In general, errors in the structure (missing or incorrectly placed 
reactions or components) cannot be recognized.  So models provide little insight on how 
newly discovered components or entire pathways could be incorporated into the analysis.  
Furthermore, they provide no easy method by which to gain a general perspective on 
what components play key roles in the signaling process. With the uncertainty present in 
the kinetic parameters, little can be said about the relative importance of different 
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pathways to yield the overall observed behavior.   Such characterization generally 
requires the application of mathematical manipulations to define and extract descriptive 
parameters. 
1.2.2. Mathematical analysis techniques  
The basic concept behind an analysis framework is that structural and quantitative 
information about a system can be somehow inferred directly from the data, without 
having to construct a model (of any level of detail) ahead of time.  A model may be used 
as a starting point to help develop insight into the behavior of the system, but the 
technique is developed by determining what the proper transformation of data should be, 
based on some sort of mathematical analysis.  The final form of the analysis is 
independent of the original model, and thus truly describes an alternate method of 
examining the system. 
Perhaps unsurprisingly, the majority of attempts to develop such a technique for 
the examination of signaling pathways have been based in extending methods originally 
developed for the analysis of regulation in linear metabolic pathways.  Metabolic control 
analysis (MCA) was created to quantify the effects of changes in the enzyme activities 
(E) upon the steady-state flux (J) of mass through metabolic networks or the 
concentrations (X) of intermediates [56, 57].  These effects can be described in terms of 
the flux control coefficient (FCC) CEJ and concentration control coefficient (CCC) CEX: 
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MCA therefore amounts essentially to a sensitivity analysis, using control 
coefficients to describe the distribution of regulation that particular enzymes (and 
therefore particular steps in a pathway) have upon the overall flux.  Similar expressions 
can be written in terms of changes to other system parameters, such as allosteric 
regulators or concentrations of other metabolites; these are usually called response 
coefficients (RPJ and RPX) to accentuate that these molecules act indirectly on the system.  
It should be noted that these coefficients are determined as total differentials, therefore 
arise from both the direct effects (upon a particular reaction) as well as indirect effects 
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(by altering concentrations of intermediates that regulate other reactions in the network).  
This can be seen by application of the so-called summation and connectivity theorems: 
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The second equality in Equation 1.7 is based on the fact that the rate of a particular 
reaction is in general directly proportional to the enzymatic activity.  If the kinetics of a 
particular reaction is known, then the elasticities can be obtained by differentiation of the 
rate expression.  The elasticities and control coefficients can also be determined 
experimentally, using perturbations to each reaction step, by what is known as the 
double-modulation method and its extensions [58].   
This approach was originally developed for the study of linear metabolic 
pathways, but through a series of steps has been extended to include cycles and pathways 
without mass transfer between intermediates [59-63].  Nevertheless, the basis of analysis 
was focused on measurement of changes in fluxes following changes to enzymatic 
activities.  In signal transduction, the fluxes in question would correspond to the rate of 
interconversion between forms of each intermediate at steady state—to date, impossible 
to measure.  Furthermore, each reaction step for each interconverting cycle must be 
included, leading to a prohibitively large number of different permutations required to 
fully examine the system.   Thus these extensions of MCA have only rarely been applied 
directly to examine signaling systems [64-66].  
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A novel approach has been recently proposed that is instead based on examining 
changes to the steady-state concentrations of the intermediates themselves, and also 
reduces the complexity by separating the system into interacting modules, and focusing 
attention only on representative molecules each module [67, 68].  This method, called 
modular response analysis (MRA), utilizes connectivity theorems to translate how the 
intermodular response coefficients (describing the effect of a molecule from one module 
onto another module) will result in overall response coefficients for the system.  This 
process can be inverted to determine the intermodular coefficients, which indicate 
structural connectivity as well as give a quantitative value for module interactions.   
However, the method suffers from the major limitation that to determine the coefficients, 
a perturbation must be applied that is specific to each module.  For known signaling 
components, perturbations of the form of enzymatic inhibitors may be available, but that 
may not be the case for newfound species.  And indirect connections arising from 
missing components (not measured or perturbed directly) will not be recognized with this 
methodology.  Within the species that are being measured, the approach is able to 
reconstruct the network, but unable to determine exactly where missing steps might be.  
Another analytical technique for studying reaction pathways was developed by 
using time-lagged correlations to infer connectivity between components [69].  The 
premise here is that the time-dependent behavior of two species will be most similar if 
they are connected in a reaction network.  The correlations can be translated into a matrix 
of Euclidian distances, and through a series of steps designed to reduce the dimension of 
the data, a projection into 2D space that ultimately reflects the original structure of the 
system.  Unfortunately, the algorithm does not always obtain the correct structure at the 
end of analysis; as the method is based on correlations in time then two subsystems with 
different timescales of operation may not be recognized as being connected.  Also, this 
procedure requires a large number of dynamic data points, where input signals are 
modulated at a frequency on the same timescale as the remainder of reactions in the 
network, which for signal transduction would be seconds to minutes.  It may be for this 
reason that this method has not been applied to examine signaling systems, although it 
has been tested on a segment of glycolysis constructed in vitro with purified enzymes 
[70]. 
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1.2.3. Measurement techniques and experimental considerations 
Any analysis of signaling pathways depends upon the ability to make quantitative 
measurements of how an external signal is influencing intracellular components.  The 
complexity inherent in the analytical techniques described above may partially explain 
the relative lack of experimental applications thus far.  But other complications either in 
design of experiments or methods of sampling may be playing a role.  It is therefore 
worthwhile to consider the various techniques available for measuring signaling 
intermediates, and the limitations currently placed on conducting experiments. 
Signal transduction proceeds through a wide range of different mechanisms, and 
therefore the ability to measure the amount of “active” intermediate depends on the 
characteristics of the signaling step.  Molecules that are transported to different regions of 
the cell might be observed through microscopy or by sampling specifically from that 
region (membrane, cytosol, nucleus, vesicle, etc.).  Some intermediates undergo covalent 
modification, typically by phosphorylation, and thus the modified form must be separated 
or detected specifically from its original unmodified form.  Formation or dissolution of 
stable noncovalent complexes could be determined by coimmunoprecipitation.  As these 
changes may coincide with induction of enzymatic activity, functional assays are often 
utilized if a substrate is readily available.  Obviously, handling issues related to 
maintaining the active state become important, whether through appropriate composition 
of buffers (for example to include inactivating enzyme inhibitors) or sampling conditions 
(time, temperature, physical separations, etc.) 
Furthermore, the type of molecule should be considered.  Most signaling 
intermediates are proteins, therefore are relatively large (10-200 kDa), potentially 
membrane-bound, and containing complicated surface charges and chemistries.  The 
physical properties of proteins are generally changed only slightly by covalent 
modification of a few residues.  Therefore many protein detection methods involve the 
use of specific binding reagents such as antibodies, which can preferentially recognize 
the modified form of the protein.  The Western blot is by far the most common method 
used to detect and quantify signaling proteins, but requires several tedious handling steps 
and can handle few samples at a time. The multiwell plate version of the assay (ELISA) 
is gaining popularity, because of the ability to handle more samples, be automated, and is 
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more readily quantified.  Antibodies tagged with fluorophores can be used to track 
protein localization via microscopy, or protein presence by flow cytometry.  In either 
case, the primary limitation in measurements is the availability of antibodies specific for 
each protein.   
Mass spectrometry (MS) has increasingly been applied for the quantitation and 
characterization of signaling proteins [71].  One or more separation steps using 
electrophoresis (gel or capillary) or chromatography are combined with a digestion 
reaction with specific proteases such as trypsin before the peptides are then applied to the 
MS.  Covalent modifications can be observed as a shift in the mass for a particular 
peptide in the protein.  Quantitation is possible by mixing the test material with a control 
sample, where one of the two is labeled with a stable isotope to shift the mass slightly 
[72-74].  While MS-based techniques thus far have primarily been used to identify targets 
of input stimuli (profiling), it may soon become a dominant technique for protein 
quantification [74-77]. 
Unlike proteins, small molecule second messengers often may be measured 
directly.  Phospholipids and their breakdown products can be separated by thin-layer 
chromatography (TLC) or HPLC and visualized if previously labeled with a fluorophore 
or radioactivity (32P, 3H or 14C) [78, 79].  Cyclic nucleotides (cAMP or cGMP) can also 
be separated from their native forms by TLC or alumina-based chromatography [80, 81].  
On the other hand, Ca2+ concentrations in various regions of the cell are typically 
measured using secondary reagents, such as fluorescent dyes or enzymes like aeqorin and 
adenyl cyclase, that show altered activity in the presence of the ion [82-84]. 
Regardless of the type of molecule or analytical method used, the time and effort 
involved in preparing samples generally limits the reproducible sampling frequency to 
the order of minutes, similar in magnitude to the dynamics of most signaling reactions.  
Cost and time constraints may also reduce the number of measurements. Since most 
techniques are limited in capacity of measurements at one time, usually less than ten 
observations are made for any one molecule in an experiment.  This is in stark contrast to 
the capacity of DNA microarrays to measure the expression thousands of genes at one 
time, and where the timescale of gene expression changes is in the tens of minutes.  Thus 
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analysis of signaling systems must be performed with relatively small numbers of 
samples and under significant experimental uncertainty.  Significant efforts are underway 
to develop various high-throughput techniques to measure proteins, which will help 
address the limitation of capacity, but not of sample handling [85-88].  Thus more 
signaling intermediates may be measured at one time, but for each protein there may still 
be only a few observations.  Analysis techniques such as time-lagged correlations 
described in Section 1.2.2 would still be infeasible, and thus a new approach appears to 
be necessary. 
1.3. Objectives 
In general, when examining signaling networks two questions will arise: 
1.  What are the pathways involved in response to a particular stimulus? 
2.  How much are these pathways utilized? 
 It is by answering these questions that signaling under different conditions can be 
compared.  The first question is essentially qualitative, and is solved by determining the 
structure of the signaling network downstream of a particular input.  This requires not 
only knowledge of which components are activated, but also how their activation leads to 
that of other species—in other words, the connectivity of the signaling network.  
Quantitative descriptions of signaling, which specifically answer the second question, 
may also be necessary in structural identification.  This is because multiple factors may 
activate some of the same pathways to saturation, and thus the response due to one factor 
may be concealed by another.  With these questions in mind, it is possible to describe the 
important properties of signaling analysis methods. 
First, a method capable of systemic, network analysis is needed, rather than an 
examination of individual pathways or components.  No one pathway operates in 
isolation.  It is likely that several unseen factors are simultaneously contributing to 
activate several pathways to produce the observed effect.  Signaling networks are 
complex, with many possible interactions, and many different sets of external conditions 
must be compared [25, 26, 36].  Only by examining the full signaling network can 
interactions between different pathways be seen, and only then can the considerable 
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complexity of signaling interactions be deconvoluted.  Therefore the method must be 
capable of examining the entire network, and not be dependent upon detailed descriptions 
of any one step.   
Second, a quantitative approach is necessary.  Although qualitative descriptions 
of signaling are important to know which pathways are involved in the response, it is 
only by measuring quantitatively the differences in signaling under different conditions 
that comparisons can truly be made [89].  Through a quantitative approach, values can be 
defined to represent signaling under different conditions and relative contributions of 
different pathways to the response.  These values can then be compared between 
experiments to suggest which factors influence signaling.  This necessarily requires that 
large-scale quantitative measurements of signaling must be available to decipher signal 
specificity.  Furthermore, the measurement methods must be able to provide as much 
detail as possible about individual states of each component.   
Finally, a practical method is required that allows visualization of in vivo activity 
under specific sets of conditions.  It is of little use to develop analytical methods for study 
of signaling networks that are mathematically sound but cannot be applied to 
experimental data for signaling reactions within cells.  Previous efforts to analyze 
signaling networks have been largely ignored, in some cases because of a dependence on 
unmeasurable values (such as the interconversion rate for a particular intermediate).  On 
the other hand, it may be impossible to characterize signaling networks with 
measurements that are currently available.  In that case, an analytical framework may be 
useful in directing what types of measurements are necessary for systems analysis.    
The objective of this work therefore was to develop a novel analytical approach 
for the examination of signal transduction networks, with the specific understanding of 
limitations of experimental methods and lack of in vivo kinetic data.  Of primary concern 
was that the framework could be readily applied for the structural analysis of a signaling 
network yet would still contain quantitative descriptions for the interactions between 
intermediates.  This approach is also useful in experimental design, since it can be used to 
indicate the types, quantity, and quality of data that will be necessary.  The framework 
should yield simple relationships for simple forms of interactions, and change 
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appropriately when more complicated interactions are considered, thus enabling the 
detection of these complicated interactions.   
1.4. Thesis overview 
Equations representing the time-dependent behavior of species in signaling 
systems were combined with simulations written in MATLAB 5.2 (Mathworks, Inc) to 
investigate how the activation of one component may be described in terms of the other 
species.  The behavior of a single component cycling between two states was studied in 
detail as a model of the most fundamental unit in signal transduction.  This led to the 
definition of activation ratios as an informative measure of the interaction between target 
and activator, where all kinetic constants for the reaction system are collapsed into one 
single factor.  Extension to simplified network substructures, such as linear cascades, 
convergence and divergence points resulted in a set of observations for how the 
activation ratio for an individual intermediate reflects its position in a larger network. 
Details for the derivation of activation ratios and sample simulation results for these 
systems are discussed in Chapter 2.   
These observations, however, represent how activation ratios are predicted to 
behave given a presupposed network structure.  In order to invert this process, and 
thereby reconstruct a network from measurements, the addition of constraints based on 
self-consistency was required.  The resulting algorithm is discussed in Chapter 3, along 
with an example of application to a small model network, where simulation results from a 
more detailed model were utilized as theoretical measurements.  This process was 
partially automated using a MATLAB script to regress data against linear and nonlinear 
models and evaluate fit based on the Akaike Information Criteria.  This enabled an 
examination of how issues with data quality could influence the analysis results. 
Activation ratio analysis was applied to a real experimental system by studying 
the phosphorylation of protein kinase Erk2 in vitro, as described in Chapter 4.  The 
experimental setup and tools for processing raw data were developed so as to provide the 
correct types of measurements needed to calculate activation ratios.  Details for 
development of the system, optimization of reaction conditions, and tools for filtering 
data are also discussed.  Variation of system parameters enabled verification of some 
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predictions for activation ratios, while highlighting the importance of improvements in 
measurement capabilities. 
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2 ACTIVATION RATIO ANALYSIS  
Any investigation into the description and analysis of a system requires decisions 
to be made regarding the scope and complexity that will be considered.  The scale (in 
time, space, and concentration) must be selected to sufficiently describe the features of 
the system while maintaining feasible bounds on intellectual, conceptual and 
experimental requirements.  As the primary objective of this work was to develop 
methods to characterize and describe the structure of signaling networks, the scope 
therefore was on examination of interactions between signaling components.  This 
proceeded in two stages: first, the construction and examination of models for several 
network modules, to determine mathematical expressions based on potentially 
measurable quantities that reflect the relationship between intermediates while reducing 
the system complexity; and second, development of an algorithm to reconstruct the 
modular arrangement based upon those measurements.   
In this chapter the first stage is described, where examination of the rate equations 
describing reactions occurring in signal transduction is combined with practical 
understanding of measurement limitations to suggest a measurable quantity for a 
signaling intermediate that reflects its connection to other components in the network.  
The activation ratio, defined as the ratio between active and inactive forms of an 
interconverting intermediate, depends quantitatively and qualitatively upon the structural 
relationship of that intermediate with other network species.  This is shown below for a 
variety of simplified network substructures that can be combined to describe realistic 
signaling networks.   
2.1. Methods 
Deterministic, kinetic models were used as simulators of simple signaling 
arrangements as have been described previously [1-6].  These types of models have been 
used extensively to examine qualitative features in signaling pathways, which have been 
later observed experimentally. Enzyme-catalyzed reactions were assumed to follow 
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simple Michaelis-Menten kinetics, and parameters were varied to explore the patterns of 
behavior for each network arrangement. Concentrations of non-protein reactants (such as 
Mg2+, ATP, and water) were assumed to remain constant.  Models were developed as a 
set of coupled ordinary differential equations in MATLAB 5.2 (Mathworks, Inc) and 
integrated until steady state using the “ode15s” algorithm.  Steady-state concentrations of 
active and inactive fractions of components at various input stimulus levels were used as 
“data” in the analytical approach presented here.  Further details, parameter values, and 
sample MATLAB files are included in the Appendices 1 and 2. 
2.2. Isolated interconverting cycle  
The most basic signaling unit can be imagined to consist of a source driving the 
conversion of a target from one state to another.  The input signal is the activity of the 
source, while the state of the target is the output.  Relaxation of the system to its original 
state requires a competing force to counteract the effect of the source.  In biological 
signaling, this type of interaction is often realized by simple binding between two 
molecules, such as a ligand to its receptor, or through chemical modification of the target, 
for example via phosphorylation or acetylation of proteins or cyclization of ATP to 
cAMP [7].  These cases are shown in Figure 2.1, along with the resulting reaction 
schemes assuming simple association kinetics for binding or Michaelis-Menten kinetics 
for an enzymatic modification cycle. 
E1
A A*
E2
Reaction scheme
A + E1 A* + E1[E1·A]
a1
d1
k1
A* + E2 A + E2[E2·A*]
a2
d2
k2
Interaction Diagram
Covalent 
modification
A + B [A·B]
a
d
Binding
B
A A·B
 
Figure 2.1. Single cycle diagrams and reaction scheme. 
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It may appear peculiar at first to consider binding as an example of an 
interconverting cycle, but several key features of signaling cycles can be examined very 
simply in this system.  Here, the state (concentration) of molecule B determines the state 
of the target A, namely, in its free form or bound in the noncovalent complex [A·B].  This 
interaction can be quantified by the association and dissociation rate constants, a and d.  
Although we can write expressions for the dynamic interaction between these molecules, 
it is more common to consider the situation at equilibrium, where the rates of the 
association and dissociation reactions are equal: 
  (2.1) [ BAdBAa ⋅= ]
Or, by rearranging: 
 [ ] BKB
d
a
A
BAAR aA ==⋅≡  (2.2) 
According to Equation 2.2, at equilibrium the ratio between the amounts of A 
complexed with B (“active”) and that of free A (“inactive”) is directly proportional to the 
amount of free “activator” B.  The association constant Ka, which is the natural parameter 
used to describe the binding interaction, appears as the coefficient of the activator B.   
Thus the activation ratio ARA, defined as the ratio between active and inactive forms of a 
signaling intermediate A, is linearly dependent upon the concentration of its activator, 
and the two are related by an activation factor, which quantitatively measures the 
interaction between the source and target.  In this case, the activation factor αBA = Ka. 
Since the total amount of A, AT = A + [A·B], we can also write: 
 [ ] [ ][ ]
[ ]
[ ] BKA/BA1
A/BA
BAA
BA
A
BA
a
T
T
T
=⋅−
⋅=⋅−
⋅=⋅  (2.3) 
 [ ]
BK1
BK
A
BA
a
a
T +
=⋅  (2.4) 
We can estimate Ka from a set of measurements for the fraction of A in its 
“active”, complexed form through either of Equations 2.3-2.4.  Normally Equation 2.4 is 
used and Ka found via a nonlinear regression procedure, but by rescaling the problem as 
in Equation 2.3 a simple linear regression approach can be used.   
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Note that each expression in written in terms of the amount of free activator B, 
not the total amount BT (= B + [A·B]).  For most binding studies it is assumed that B ≈ 
BT, i.e. that the complexes do not significantly deplete the amount of B available to bind 
A.  More explicitly, this requires that KaAT << 1.  Although this assumption can be 
realized during in vitro binding experiments, under in vivo conditions it is likely to be 
invalid, since most relevant protein interactions occur with high specificity.  
Nevertheless, Equations 2.1-2.2 will still hold, and combining them with conservation 
relationships for A and B we find that: 
 [ ] [ ] [ ]


 ⋅−


 ⋅−=⋅
TT
T
T
Ta
T A
BA
A
B
A
BA1AK
A
BA  (2.5) 
This equation can be solved to yield: 
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Under saturating conditions, where KaAT is significant, the expressions for the 
fraction of A complexed to B (Equation 2.6) as well as the ratio to free A (Equation 2.7) 
both become significantly more complicated, as well as being much more difficult to 
extract the relevant quantitative parameter, Ka.  Using a mathematical package such as 
MATLAB, Equations 2.3-2.4 and 2.6-2.7 can be plotted, as shown in Figure 2.2.  The 
system is saturated (Ka = 2, AT = 1), but we can readily observe that the activation ratio 
shows a generally linear dependence upon BT. On the other hand, the fraction of A 
complexed ([A·B]/AT) appears to be approximately hyperbolic in shape, with some 
curvature seen for low values of BT. 
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Figure 2.2. Simulation results for simple binding under saturating conditions.  A) Fraction of A complexed 
([A·B]/AT) or B) activation ratio ([A·B]/A) plotted against free B (circles) or BT (squares).   
If we assume for the moment that there are other compounds which may also 
interact with either A or B, then Equations 2.1-2.2 will still be valid, but new 
conservation relationships will apply, as will additional binding expressions.   The 
resulting coupled system of equations will have to be solved simultaneously, preventing a 
closed-form solution for any single component.  The concentrations of these other species 
will play a role in the expressions for the fraction active and thus decoupling the 
interactions becomes difficult.  By focusing only on the free species, the interaction 
between A and B can be isolated via Equations 2.1-2.2.   
Next, consider the case of a covalent modification cycle shown in Figure 2.1, 
where the target converts between two states A and A* by the competing action of 
enzymes E1 and E2. In protein kinase cascades, E1 and E2 are a kinase and phosphatase, 
respectively, and A and A* represent the nonphosphorylated and phosphorylated forms of 
the intermediate A.  Here [E1·A] and [E2·A*] represent the enzyme-substrate complexes, 
while E1 and E2 are the free concentrations of enzymes, and ai, di, and ki are the 
association, dissociation, and catalytic rate constants for reaction i.  There are a total of 
six species in this system, and their time-dependent behavior can be described by the 
following rate equations: 
 
[ ] [ ]*221111 AEkAEdEAadtdA ⋅+⋅+−=  (2.8) 
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[ ] [ ]AEkAEdEAa
dt
dA
11
*
222
*
2
*
⋅+⋅+−=
 (2.9) 
 
[ ] [ ]AE)kd(EAa
dt
AEd
11111
1 ⋅+−=⋅
 (2.10) 
 
[ ] [ ]*2222*2*2 AE)kd(EAadt AEd ⋅+−=⋅  (2.11) 
 [ AE)kd(EAa
dt
dE
11111
1 ⋅++−= ]  (2.12) 
 [ ] (2.13) *2222*22 AE)kd(EAadtdE ⋅++−=
These species are further coupled by conservation equations: 
  (2.14) [ AEEE 11T1 ⋅+= ]
 [ ]*22T2 AEEE ⋅+=  (2.15) 
 [ ] [ ]*21*T AEAEAAA ⋅+⋅++=  (2.16) 
If it is possible to measure the time-dependent concentrations of three of the 
species, for example A, [E1·A], and [E2·A*], along with the total concentrations for each 
component (AT, E1T, E2T), then Equations 2.8-2.16 can be used to estimate the values of 
the parameters of the system, namely the rate constants a, d, and k for both reactions.  It 
is these rate constants that collectively are quantitative measures of the interaction 
between the components A, E1, and E2 in this simple system.  This is a difficult task for 
even an isolated in vitro system, and totally infeasible for a signaling intermediate within 
a cell.  In protein kinase cascades it may be possible to determine the identity and 
concentration of kinase E1, but often the phosphatase E2 is undefined and may be one of 
several nonspecific enzymes.  Thus, it may be unrealistic to consider E2 or [E2·A*] as 
measurable quantities, and it becomes impossible to solve Equations 2.8-2.16.  
Furthermore, estimation of the individual rate constants may not be informative, 
particularly if the behavior of a network of intermediates is being investigated, where a 
single quantitative parameter describing the interaction between E1 and A is preferable. 
Instead of considering the dynamic behavior of this system, we concentrate on the 
relationship between intermediates at steady state, analogous to equilibrium for the 
binding system.  In this case Equations 2.8-2.13 are equal to zero.  Equations 2.10-2.11 
can then be rearranged to yield: 
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Where Km1 and Km2 are the Michaelis constants for enzymes E1 and E2, respectively.  
Also, at steady state the two net reaction rates must be equal: 
 [ ] [ ]*2211 AEkAEk ⋅=⋅  (2.19) 
Substituting Equations 2.17-2.18 into Equation 2.19 and rearranging: 
 1
A
1
2m22
1m11
*
A EK/Ek
K/Ek
A
AAR α≡=≡  (2.20) 
From Equation 2.20, it is apparent that the activation ratio ARA is once again 
linearly proportional to the concentration of free activating enzyme E1 (that is, unbound 
by substrate A).  The unknown kinetic parameters for the enzymes, as well as (most likely 
unmeasurable) E2, are collected together in the activation factor α1A.  The activation 
factor represents the sensitivity of the activation ratio for A with respect to E1, and is 
therefore a quantitative measure of the potential for E1 to activate A.  As k1 increases or 
Km1 decreases, E1 becomes a more powerful activator of A, and α1A increases.  Similarly, 
as k2 increases or Km2 decreases, E2 is a more powerful inactivator, and therefore E1 is a 
relatively weaker activator of A.  
An explicit closed-form solution for A* in terms of the other parameters is 
possible for a few special cases.  If the enzyme-substrate complexes can be considered 
negligible in the conservation relationship for the substrate A (Equation 2.16), such that 
A* + A ≈ AT, it can be shown that [8]: 
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V
V , V1 = k1E1T, V2 = k2E2T, K1 = Km1/AT, and 
K2 = Km2/AT.  To satisfy this assumption, E1T/Km1 and E2T/Km2 must both be much less 
than one.  In signaling networks involving enzymatic cascades, the substrate of one step 
is the activating enzyme of another step, and concentrations of all species may be 
significant relative to saturation constants [9].   Thus this may be a poor assumption, but 
even by making it the expression in Equation 2.21 shows significant complexity as well 
as the lack of a single quantifiable parameter.  Is K1, K2, their ratio, or some other 
parameter a significant representation of this system?  Comparing Equations 2.20 and 
2.21, it is easy to observe the simplicity of activation ratios and activation factors for 
describing the interaction between source E1 and target A.   
In the event that enzyme-substrate complexes constitute a negligible fraction of 
the total enzyme concentrations as well as substrate, which would occur when both 
enzymes are far from saturation, E1 ≈ E1T, E2 ≈ E2T and:  
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A
2mT221mT11
1mT11
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A
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1
1
α+
α
=+=  (2.22) 
where 
2mT22
1m1A
K/Ek
K/k
1
=α .  In this very idealized situation, the obvious 
quantitative measure describing this system is again α1A, the same activation factor from 
Equation 2.20.  While Equation 2.22 yields a hyperbolic relationship between A* and E1T, 
the activation ratio (Equation 2.20) is still linear.  In the event that enzyme-substrate 
complexes cannot be neglected, the fraction active cannot be determined explicitly but is 
the solution of a third-order equation, and thus mathematical simulation is necessary to 
determine the steady-state behavior of the system.   
Simulation results for the individual cycle are shown in Figure 2.3.  The 
association constant for activation of A (a1) was varied so as to adjust Km1 50-fold 
without affecting k1, with other parameters set such that enzyme-substrate complexes are 
significant for balances on substrate as well as enzymes.  The fraction of A in the active 
form, A*/AT, is shown in Figure 2.3A, while activation ratios ARA are plotted in Figure 
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2.3B.  The curvature seen for the fraction active in Figure 2.3A is replaced by a set of 
lines for the activation ratios in Figure 2.3B.  The activation factor α1A as defined in 
Equation 2.20 is not necessarily constant, because the concentration of E2 is not 
necessarily constant and may be indirectly influenced by E1.  Nevertheless, α1A does 
approach a limiting value and the curves in Figure 2.3B are well approximated by straight 
lines, and α1A can be calculated easily as the slope.   
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Figure 2.3. Simulation results for an individual covalent-modification cycle as shown in Figure 2.1.  A) 
Fraction of A activated (A*/AT) and B) Activation ratios ARA (A*/A) for the simple cycle, plotted against 
free activating enzyme E1.  Parameter values:  k1 = 10, k2 = 10, Km2 = 1, E2T = 1, AT = 10, Km1 = 20 
(diamonds), 10 (squares), 4 (triangles), 2 (x’s), 1 (stars), 0.4 (circles), 0.2 (+’s). 
2.3. Extension to simple network arrangements 
In the relatively simple case of an isolated cycle, use of activation ratios yields a 
simple linear relationship between an activator and its target, even under saturating 
conditions for enzymes and substrates.  The power of this approach becomes more 
apparent as increasingly complicated signaling systems are considered.  This is because 
Equations 2.2 and 2.20 continue to be valid when the cycle is no longer isolated, but 
rather embedded within a signaling network.  Of particular interest are the cases of 
converging and diverging pathways and linear cascades, as the behavior of these model 
systems can be combined to examine the effects of multiple inputs on a set of 
interconnected intermediates, in the absence of feedback.  Multiple activation steps and 
cascades with feedback are further complications that can also be examined using 
activation ratios.   
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These arrangements are drawn schematically in Figure 2.4.  For each case, 
expressions governing the steady-state ratio between active and inactive forms of each 
component are developed.   As the systems become complicated, closed-form analytical 
solutions for the activated fraction of various species become impossible.  Therefore, 
simulations were developed using time-dependent equations analogous to Equations 2.8-
2.13 and integrated until steady state to demonstrate the behavior of each system. 
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Figure 2.4. Diagrams of extended signaling structures. A) linear cascade, B) converging pathways, C) 
diverging pathways, D) dual activation steps, E) cascade with feedback (single-step activation as in A).   
2.3.1. Linear Cascade  
A common arrangement of signaling intermediates is a linear cascade of enzymes, 
where the activated form of one intermediate catalyzes the activation of the succeeding 
intermediate, as shown in Figure 2.4A.  Following a similar analysis for each cycle in the 
cascade as done previously for the isolated cycle, using expressions analogous to 
Equations 2.17-2.20, the activation ratios for the intermediates are: 
 1
A
1
mIAIAIA
1m11
*
A EK/Ek
K/Ek
A
AAR α==≡  (2.23) 
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 *BA
mIBIBIB
2m
*
2
*
B AK/Ek
K/Ak
B
BAR α==≡  (2.24) 
 *CB
mICICIC
3m
*
3*
C BK/Ek
K/Bk
C
CAR α==≡  (2.25) 
The action of each step upon the next is the same as if the cycle were isolated, as 
discussed above.  However, when considering an indirect effect, for example E1 upon 
ARB, the results take a quite different form.  As described in Section 2.2, the equations 
are written in terms of free species, unbound by enzymes or targets.  If for simplicity 
enzyme-substrate complexes can be considered negligible, then A* + A ≈ AT and B* + B 
≈ BT, and it can be shown that: 
 
1
A
1T
BA
B
E1
EA
AR
1
A1
α+
αα
=  (2.26) 
 ( )TBA1A1 1TT
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B
B
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*B
A
*
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B
B
A
C
A1E1
EAB
A1
AB
AR α+α+
ααα=α+
αα=  (2.27) 
The sensitivity of the overall cascade is a product of the sensitivity at each 
individual level (multistep sensitivity), as has been described previously [9-12].  
However, the expression for the activation ratios changes in form, from linear to 
hyperbolic, depending on which upstream enzyme is being considered.  For example, 
although ARB is linear with respect to A*, it is hyperbolic with respect to E1.  ARC is 
hyperbolic with respect both to A* and E1, but linear with respect to B*.  This radical 
change in form can be readily visualized graphically and realized numerically through a 
linear or hyperbolic regression.  We can thus use this approach to suggest if a step is 
missing between two intermediates of interest.  Note, however, it is not possible to 
distinguish between one or more missing steps.  In this example, it is possible to know 
that C is indirectly downstream of E1 and A, but not by how many steps.  By establishing 
direct links between E1 to A, A to B, and then B to C, however, the cascade structure can 
be realized. 
Equations 2.26-2.27 explicitly arise from the assumption that enzyme-substrate 
complexes can be neglected in the conservation relationships for A and B.  This 
assumption specifically requires that E1T/Km1, EIAT/KmIA, AT/Km2, and EIBT/KmIB are 
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significantly less than one, essentially meaning that Km values for each reaction should be 
large relative to the concentrations of all species.  Prior experience with MAP Kinase 
cascades indicates this to be highly unlikely [9].  Nevertheless, the patterns for activation 
ratios still hold even if these are assumptions are relaxed.  Thus, the plots for activation 
ratios will continue to be linear for direct effects and hyperbolic in shape for indirect 
effects.  Although it is difficult to demonstrate this analytically, it can be readily seen 
using simulation results for signaling cascades under saturating enzyme conditions. 
We have thus far seen that plots of activation ratios of intermediates will be linear 
or hyperbolic when plotted against intermediates directly and indirectly upstream, 
respectively.  What if we now look at downstream intermediates?  In other words, what 
do the plots of activation ratios of intermediates against their direct and indirect targets 
look like?  Again for simplicity, if enzyme-substrate complexes are neglected, then the 
following results can be obtained: 
 ( ) *TCTTC
*
B
CB1CB
CAR
BB
α+−α=  (2.28) 
 
( )
( )[ ] *TCBTBATTTCBBA
*
*
T
B
ATT
B
A
*
A
CB1A1CBA
C
BA1BA
BAR
α+α+−αα=
α+−α=
 (2.29) 
The activation ratios ARA and ARB in Equations 2.28-2.29 take the form of an 
inverse hyperbola (technically, the upper left quadrant of a hyperbolic section).  Thus, the 
activation ratio for an inverted response has a quite distinct functionality from either type 
of forward response.  It should be further noted that the forms of Equations 2.28-2.29 are 
the same, albeit with different parameters.  Therefore it is impossible to distinguish 
between a direct and indirect inverted response from the mathematical structure of the 
relationship; it can only be said that the presumed target and activator are actually in 
reverse order.  As above, Equations 2.28-2.29 hold explicitly only when enzyme-
substrate complexes are negligible, but the same patterns as predicted from those 
equation will still appear if this assumption is relaxed.  
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Plots of activation ratios for the model cascade of Figure 2.4A are shown in 
Figure 2.5.  Each step in the pathway is saturated, with AT, BT, and CT all equal to 10 and 
Km values in the range of 0.50-4.   Thus, enzyme-substrate complexes will not be 
negligible compared to the free species in this case.  In Figure 2.5A, the activation ratios 
for each intermediate are plotted against E1.  As expected from Equations 2.23-2.27, the 
curve for ARA is linear while the curves for ARB and ARC are hyperbolic.  Similarly, in 
Figure 2.5B the plot of ARB against A* is linear and ARC against A* is hyperbolic, and in 
Figure 2.5C, ARC plotted against B* is linear.  The inverse hyperbolae expected for ARA 
and ARB against C* are seen in Figure 2.5D, in accordance with Equations 2.28-2.29.  
Activation ratios for an intermediate plotted against itself, such as ARA against A*, also 
appear inverse hyperbolic, which is readily understandable when ARA ≈ A*/(AT - A*). 
The activation ratio data plotted on the ordinate is the same in each graph, and the figures 
differ only in which component is used for the abscissa. 
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Figure 2.5. Activation ratios for the linear cascade of Figure 2.4A, plotted against free concentrations of E1 
(A), A* (B), B* (C), or C* (D).  Ratios for A: diamonds, B: squares, C: triangles.  
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In summary, comparing Equations 2.24, 2.26, and 2.28 it is possible to see that 
the activation ratio for an intermediate B (ARB) will be linear, hyperbolic, or inverse 
hyperbolic when plotted against its direct activator (A*), indirect upstream activator (E1), 
or downstream target (C*), respectively.  The functional form of the activation ratios 
reflects the relationship between activator and target.  Activation ratios can therefore be a 
powerful tool to arrange intermediates in a cascade based on simultaneous measurements 
of activation for each component.   Furthermore, missing steps can be detected through 
the lack of any direct steps as demonstrated through linear activation ratio plots. 
2.3.2. Converging Pathways 
In converging pathways, two separate enzymes act independently to activate an 
intermediate, as shown in Figure 2.4B.  One example is the activation of Pbs2p by either 
Ssk2p/22p isoforms or Ste11p in the yeast high osmolarity (HOG) pathway[13].  In this 
case, either enzyme E1 or E2 can bind and activate A, although they cannot both bind A 
simultaneously.  The activation of A therefore becomes a combination of the effects from 
the two enzymes, and the expression for the activation ratio is:  
 2
A
21
A
1
mIAIAIA
2m22
mIAIAIA
1m11
A EEK/Ek
K/Ek
K/Ek
K/EkAR α+α=+=  (2.30) 
Equation 2.30 shows that the activation ratio for an intermediate of converging 
pathways is a linear combination of terms arising from (and only dependent upon) each 
activator.  The effects of the two activating enzymes are thus completely separated.   
Moreover, the expression for each enzyme in Equation 2.30 is the same as if E1 and E2 
were acting upon unrelated substrates.   Thus each enzyme is unaffected by the presence 
of the other.  This must be the case since it is conceptually possible to separate one 
enzyme into two identical pools, and we would expect that the total effect of the two 
pools would be indistinguishable from the original state. 
Since the enzyme effects are separated in Equation 2.30, it is possible to calculate 
the activation ratio for each enzyme by varying them independently.  By keeping E2 
constant at any value and varying E1, it is possible to calculate α1A; α2A can be similarly 
determined by keeping E1 constant.  These two can be compared to indicate the relative 
strength of the two branches on the activation of A.  Varying both simultaneously will 
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lead to an additive effect that can be predicted using the parameters calculated for each 
enzyme in isolation, or calculated using multiple linear regression techniques.  Also, the 
presence of a second activating enzyme can be predicted since a plot of ARA against E1, 
for example, will not pass through the origin.  Graphically, the activation ratio plots of an 
intermediate at a convergence point will appear as a set of parallel lines when plotted 
against either enzyme.   
Simulation results for the converging pathway are shown in Figure 2.6.  
Parameter values were chosen such that Km1 = Km2 but k1 = 2 k2, thus we expect that α1A 
= 2α2A.  In Figures 2.6A and 2.6B, the fraction active (A*/AT) is shown, while in Figures 
2.6C and 2.6D the activation ratios are plotted.  From inspection of Figures 2.6A and 
2.6B it is difficult to separate the effects of the two enzymes easily, or describe the 
relative strength of either enzyme in activating A, since the shapes of the curves changes 
as both enzyme concentrations are varied.  On the other hand, plots of activation ratios 
ARA against either enzyme yield the predicted set of parallel lines in Figures 2.6C and 
2.6D. 
Using simultaneous linear regression for both activators E1 and E2, it is possible to 
obtain values for the activation factors α1A and α2A.  The regression results for the data 
presented in Figure 2.6 are shown in Table 2.1.  The activation factors calculated during 
regression are slightly lower than the maximum theoretical value, determined by inserting 
the parameters values into Equation 2.30.  (Note that free EIA = EIAT/(1 + A*/KmIA) ≈ 
0.01/1.1 for near-complete activation.)  This discrepancy is simply due to the fact that 
some of the substrate A is retained bound to enzymes E1, E2, and EIA, so A* < AT.   
Nevertheless, the agreement between theoretical and calculated activation factors is 
excellent, as is the ratio between them (2.002). 
Table 2.1.  Regression results for converging pathway, using parameter values from Figure 2.6.   
Enzyme Average Slope Range (95% CI) Theoretical 
E1 109.63 109.62-109.64 110 
E2 54.76 54.76-54.77 55 
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Figure 2.6. Fractional activation and activation ratios for the converging cycle as shown in Figure 1C. A) 
and B), fractional activation (A*/AT), C) and D), activation ratio (A*/A) plotted against free activating 
enzyme E1 (A) and (C) or E2 (B) and (D).   
Equation 2.30 shows that the activation ratio for an intermediate A is a linear 
combination of the effects from the direct activators E1 and E2.  Furthermore, the 
expression for each term is the same as if there were no second activator.  What if either 
E1 or E2 (or both) are not direct activators of A?  In this case the term for the indirect 
activator changes from linear to hyperbolic in form, just as was seen in Equations 2.26-
2.27 for a linear cascade.  Instead of a set of parallel lines, plots of activation ratios for 
the common target will appear as a set of hyperbolic curves when plotted against the 
indirect activator.  It is still possible to determine that there are two activators for the 
intermediate, but the plots cannot be used to calculate activation factors for the two direct 
activators independently. 
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2.3.3. Diverging Pathways 
One intermediate may have multiple targets, enabling distribution of the signal.  
Typically, receptor-linked enzymes, such as the EGFR, insulin (IR), and PDGFR kinases, 
act on several substrates including other receptor molecules and adapter proteins IRS-1, 
Src, and Shc [14, 15].  In the simple case of branching pathways as shown in Figure 2.4C, 
one enzyme E1 activates two different targets A and B.  Since there is no direct 
interaction between A and B we would not expect one to influence the activation of the 
other.  We can see that this is indeed the case for activation ratios, since:   
 1
A
1
mIAIAIA
1m11
A EK/Ek
K/EkAR α==  (2.31) 
 1
B
1
mIBIBIB
2m12
B EK/Ek
K/EkAR α==  (2.32) 
Once again, the expression for the activation ratio of each intermediate is the 
same as if they were isolated, and the activation factors α1A and α1B are determined only 
from parameters arising from the interaction between E1 and A and B, respectively.   
There is only an indirect interaction between A and B arising from sharing the activating 
enzyme E1.  If A and B were actually different pools of the same enzyme, we would 
rightly expect that Equations 2.31-2.32 have the same form, and the same value for α1A 
and α1B.  Once again by neglecting enzyme-substrate complexes, it can also be shown 
that: 
 *
T
*
B
1
A
1
A
BB
BAR −α
α=  (2.33) 
 *
T
*
A
1
B
1
B
AA
AAR −α
α=  (2.34) 
Therefore for branching pathways, we expect that plots of activation ratios for 
each branch would be linear with respect to their common activator, just as if there were 
no other branch present.  However, plots of activation ratios for the two branch 
intermediates against each other will be inversely hyperbolic, as if they were the same 
molecule.  Recall from Figure 2.5 that activation ratios for a component plotted against 
itself also appeared inverse hyperbolic.  That this same pattern is observed for different 
branches should not be surprising, since again we should be able to conceptually divide a 
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single pool into two identical pools.  The diverging case can therefore be resolved from a 
linear cascade, where one plot would be inversely hyperbolic, and the other would be 
linear or hyperbolic.  These results can be seen readily in Figure 2.7, where ARA and ARB 
are plotted against E1 (Figure 2.7A) or B* or A*, respectively (Figure 2.7B) for a 
simulation of diverging pathway.   
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Figure 2.7. Results for diverging branches in Figure 2.4C.  A) Activation ratios for A (diamonds) and B 
(squares) plotted against free activating enzyme E1, B) Activation ratios for A and B plotted against each 
other, i.e. ARA against B* and ARB against A*. 
2.3.4. Dual activation steps 
The analysis thus far has considered the case of intermediates interconverting by 
single-step mechanisms.  Many important signaling components, however, require 
multiple modification steps; for example, activation of MAPKs by MAPKKs require two 
distinct, nonprocessive phosphorylation events [16, 17].  In such cases complete 
activation can be considered as overlapping cycles, and activation ratio analysis can still 
be performed on each cycle.  (Multiple processive activation and deactivation steps 
would be indistinguishable from single-step activation and therefore result in behavior 
similar to the single-step cycle analyzed in Section 2.2.) 
If two steps are required for complete activation of A as shown in Figure 2.4D, 
each under Michaelis-Menten kinetics, then several activation ratios can be defined:   
 1
A
1
2m22
1m11
*
1A EK/Ek
K/Ek
A
AAR α≡=≡  (2.35) 
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According to Equation 2.37, the “overall” activation ratio ARA3 will be quadratic 
rather than linear with respect to E1.  Nevertheless, each of the individual ratios ARA1 and 
ARA2 will be linear.  Each individual factor α1A and α2 A reflects the parameters for the 
individual steps.  It can therefore be tested if the second step is faster, slower, or the same 
as the first, under in vivo conditions where the substrate is being deactivated as well as 
activated.   
It is important to note that in cases of multiple activation/deactivation steps, it is 
necessary to have measurements of the intermediate form (e.g., A*) as well as the fully 
active and inactive states (A, A**).  Lacking this information may result in incorrect 
conclusions regarding the nature of the relationship between target and activator, since a 
quadratic response may appear similar to an inverse hyperbola, suggesting that target and 
activator are reversed or parallel targets of some upstream component.   Additional 
information arising from other components in the network would assist in resolving this 
issue.  For example, in a cascade where A** activates a target B, then plots of ARB against 
E1 would still be hyperbolic, but linear against A**, suggesting that E1 is upstream of A 
after all.  This type of situation would alert the analyst that further investigation is 
required, and indicates the presence of multiple activation steps if not previously known. 
2.3.5. Cascades with feedback 
The presence of feedback is an important component of signaling pathways, since 
without feedback there is no possibility for attenuation or adaptation.  An increase in the 
level of an activating stimulus would eventually saturate the signaling machinery, 
reducing the overall sensitivity of the system to variations in external conditions.  
Although attenuation is possible simply through downregulation of signaling 
intermediates, a faster mechanism involves modification of an upstream effector that 
ultimately leads to deactivation [2, 18, 19].  Positive feedback allows for further 
sharpening of a signal towards a “step-like” response and has also been observed 
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experimentally [20].  It was therefore critical to investigate whether activation ratio 
analysis would still be valid in feedback systems.   
To this end, two cascade models were developed, with the structure shown in 
Figure 2.4E.  The linear cascade of Figure 2.4A was modified to include two additional 
intermediates (facilitating analysis by extending the number of steps within the feedback 
loop) and add feedback such that E* catalyzes activation of A (positive feedback) or 
inactivation of A* (negative feedback).  At steady state, the balance between rates of 
activation and inactivation of A can be described in one of the following ways:   
Positive feedback:  
mAI
*
AI2
FB
*
FB
1m
11
K
AEk
K
AEk
K
AEk =+  (2.38) 
Negative feedback:  
FB
**
FB
mAI
*
AI2
1m
11
K
AEk
K
AEk
K
AEk +=  (2.39) 
Results for positive and negative feedback models are shown in Figures 2.8 and 
2.9, respectively.  In these models, the parameter values and total concentrations of each 
component were identical to results previously shown for an open cascade; each step is 
saturated such that the total concentrations are greater than the Km values.  Here the 
feedback step is unsaturated (KFB = 100, ET = 10) and the strength of the feedback 
response is varied by adjusting kFB over three orders of magnitude.  The activation ratios 
for each component are plotted against each of the other factors, where the results at each 
value of kFB are overlaid.  It can be readily seen that feedback has no net effect on the 
activation ratios of most of the components, and all feedback cases collapse together.  
Furthermore, the activation ratios continue to show a linear response for one intermediate 
when plotted against its directly upstream activator (e.g. ARA vs. E1, ARB vs. A*, etc.), a 
hyperbolic response for indirectly upstream activators (ARB, ARC, ARD, ARE vs. E1, 
etc.), and an inverse hyperbolic response when plotted against downstream targets (ARB 
vs. C*, D*, E*. etc.).  These results are identical with those observed in the absence of 
feedback.   
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Figure 2.8. Activation ratios for cascade with positive feedback, unsaturated in feedback step (KFB >> AT), 
plotted against free E1 (A), A* (B), B* (C), C* (D). D* (E), or E* (F).  For clarity, markers were omitted for 
activation ratios of A in pt. A. 
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Figure 2.9. Activation ratios for cascade with negative feedback, unsaturated in feedback step (KFB >> AT), 
plotted against free E1 (A), A* (B), B* (C), C* (D). D* (E), or E* (F).  For clarity, markers were omitted for 
activation ratios of A in pt. A. 
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The only readily apparent change in the profiles of activation ratios involves the 
point of feedback, A.  In the presence of positive feedback, the results still appear linear, 
with identical slope but the intercept increasing as kFB is increased.  In the presence of 
negative feedback, the intercept remains at zero but the slope decreases with increasing 
kFB.  This can be understood by rearranging Equations 2.38-2.39: 
Positive feedback: *AE1
A
1
mAIAIAI
FB
*
FB
mAIAIAI
1m11
A EEK/Ek
K/Ek
K/Ek
K/EkAR α+α=+=  (2.40) 
Negative feedback: ( ) 1'A1
FB
*
FBmAIAIAI
1m11
A E
K/EkK/Ek
K/Ek α=+=AR  (2.41) 
In order to interpret these results, it is important to realize that, as the endpoint of 
the cascade, E will become activated quickly, and thus E* will remain relatively constant 
as E1 is varied (certainly, relative to A and A*).  This is a consequence of multistep 
ultrasensitivity, where the activation of a downstream component saturates before 
upstream components, even without feedback [10-12].  Therefore, in the positive 
feedback system, we expect that the activation ratio for A will still be linear with respect 
to E1, with a nonzero intercept that is determined by the feedback parameters kFB and 
KFB.  Increasing kFB therefore increases the intercept by increasing αEA, as seen in Figure 
2.8A.  With negative feedback, increasing kFB would increase the constant factor in the 
denominator of α1A, causing a decreased slope as observed in Figure 2.9A.  In either 
case, analysis of the remainder of the cascade is unaffected by the presence of feedback.  
This is to be expected as activation ratios are determined by performing local balances 
around each intermediate, and therefore look at each step as if isolated.  In the feedback 
system, only the feedback point (here, A) is changed. 
2.4. Saturating conditions and influence of enzyme-substrate 
complexes   
The method of activation ratios can be quite powerful for the reconstruction of 
signaling networks, since it enables an isolated examination of the relationship between 
components regardless of other connections to either species.  There is a key 
consideration, however, which is that the analysis depends on the measurement of free 
(unbound) intermediates.  In other words, it is important to resolve between signaling 
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intermediates in their free active and inactive forms (A* and A) from when they are 
bound to other intermediates, including enzyme-substrate complexes (e.g. [E1·A], 
[E2·A*], [A*·B], etc).  In the simple case of intermolecular binding shown in Figure 2.1, 
there must obviously be a separation possible between free from complexed A to detect 
“activation” as the concentration of [A·B].  Moreover, it was shown previously that 
measurement of free B would greatly simplify the analysis (compare Equations 2.1-2.4 
and 2.5-2.7), although the pattern would be similar (Figure 2.2). 
For covalent-modification cycles either in isolation or connected in networks, this 
issue is even more significant.  As an example, consider the isolated cycle of Figure 2.1.  
In this system there exist six species, i.e. A*, A, (free active and inactive); E1, E2, (free 
enzyme 1 and 2); and [E1·A], [E2·A*] (enzyme-substrate complexes).  At steady state 
Equations 2.17-2.19 hold, and the activation ratio (as defined in Equation 2.20) is linearly 
dependent upon E1.    
If we are unable to resolve the free species from complexes, then we may only be 
able to measure total active and inactive A (A*Tot and ATot, respectively), and total 
concentrations of enzymes E1T and E2T.  These total concentrations are related to the 
components of the system in the following way: 
  (2.42) [ AEAA 1Tot ⋅+= ]
 [ ]*2**Tot AEAA ⋅+=  (2.43) 
Since we probably do not know Km1 and Km2, we cannot use Equations 2.17-2.18 
to help calculate the free species from measurements of the totals ATot, A*Tot, E1T, E2T, 
and Equations 2.14-2.15, 2.42 and 2.43. Note that AT = ATot + A*Tot, so only two of the 
three values need to be measured.  We will have six unknowns and four equations, and 
therefore are unable to calculate or estimate the true activation ratio ARA based on total 
activation measurements.  If instead of free species, the total active A*Tot and total 
inactive ATot concentrations are used to construct ratios, the results are less useful for 
network reconstruction.  This is because:  
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In Equation 2.44 the “total activation ratio” TARA is no longer linear, but rather 
hyperbolic, with respect to free E1.  Thus a direct effect, when examined using total 
active and inactive species, takes the same form as an indirect effect using only free 
species.  This can be seen in Figure 2.10, where TARA is plotted against free E1.  In 
Figure 2.10A, parameter conditions were identical to those used to generate Figure 2.3, 
where enzyme concentrations were similar in magnitude to the Km values.  It is readily 
apparent that the lines of Figure 2.3B have been replaced by hyperbolas in Figure 2.10A.  
Note that this effect arises only when the enzyme concentrations are significant.  If 
enzyme concentrations are negligible, that is, where E1T/Km1 and E2T/Km2 are much less 
than one, the total activation ratios should still be linear.  This case, shown in Figure 
2.10B, was generated by adjusting the parameters to decrease enzyme concentrations 
100-fold and increasing kinetic constants accordingly to maintain the same Km values.  
Indeed, the ratio between total active and total inactive A remains linear.  However, it 
should be remembered that this highly idealized case is unlikely to occur in real signaling 
systems, where enzymes and substrates are proteins often of similar concentrations, and 
the system is saturated with respect to both. 
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Figure 2.10. Total activation ratios for the isolated covalent modification cycle (using total active A*T and 
total inactive AT) plotted against free E1, with enzyme conditions A) Saturated: parameters as shown in 
Figure 2.3.  B) Unsaturated:  with EiT/Kmi < 0.1. 
For an individual cycle under saturating conditions, the total activation ratio for 
the target (substrate) will appear to be hyperbolic with respect to the direct activator.  
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This can cause confounding with a cascade arrangement where the activator acts 
indirectly through one or more other species.  Furthermore, the activation factor, 
measured as the slope for the linear plot of the free activation ratio, can no longer be 
determined nor used as a quantitative description of the kinetic parameters.   
Results for the linear cascade are even more complicated, since A*T will now be 
the sum of free A* and that complexed both to the inactivase EIA and to the target B, and 
similarly B*T includes complexes for [B*·C] and [EIB·B*].  Equations 2.23-2.25 are 
therefore replaced by the following expressions using total forms: 
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The total activation ratios in Equations 2.45-2.47 are hyperbolic with respect to 
the direct upstream activator, and the concentrations of targets (B, C) also appear, which 
may further complicate the functional forms of these expressions, since those will also 
vary as E1 is increased.  The presence of other species in the expressions for total 
activation ratios is a consequence of the fact that multiple components can form 
complexes with each intermediate.  For example, since B can bind A*, increasing the 
amount of free B will increase the amount of complex [A*·B] and therefore total A*T, but 
the balance of activation around A, determined by free A and A*, will remain the same.  
The theoretical isolation that arises using free species to find activation ratios no longer 
applies when total activation ratios are calculated. 
Simple physical arguments can be used to show that the total activation ratio will 
still be hyperbolic for indirect effects.  If it is assumed that A* is approximately a 
hyperbolic function of E1, then substitution into Equation 2.46 would yield an expression 
for TARB that is also a hyperbolic function of E1.  A similar argument can be made for 
TARC as a function of E1 or A*.  This can be verified during simulations of cascades 
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under saturating conditions, where Km values are similar in magnitude to the 
concentrations of all species.  Since total activation ratios will appear hyperbolic for both 
direct and indirect interactions, they can not resolve between these two cases, and thus 
are more limited in their ability to perform reconstruction of cascade structures, as will be 
described in Chapter 3.   
For converging pathways, the use of total activation ratios has two drawbacks.  
Since two enzymes can bind A independently, the total amount of A (AT) will be 
dependent on both enzyme concentrations.  Equation 2.30 is therefore replaced by: 
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The total activation ratio is still a sum of the effects of each input, but each term is 
hyperbolic with respect to both inputs.  This changes the mathematical form of the 
expression, and the effects of the two inputs are no longer separated into different terms.  
Plots of total activation ratios under saturating conditions will appear as sets of 
hyperbolae, but the shape and spacing of plots will change as E1 and E2 are varied.  This 
is in stark contrast to free activation ratios (Equation 2.30), where each term contains the 
effect of only one activator, and thus the activation factors could be determined 
independently. 
It should also be noted that in the analysis thus far the free, not total, amounts of 
the activating enzyme were used, i.e. activation ratios were plotted against E1 and not 
E1T.  The importance of measurement of free species (A and A*) was shown above; the 
importance of using E1 instead of E1T is not so critical.  Equation 2.20 shows that the 
activation ratio for an isolated cycle is linearly dependent upon E1, the free (not total) 
concentration of activating enzyme, by an activation factor α1A.  If the total 
concentrations of enzymes are used then Equation 2.20 becomes: 
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In Equation 2.49 as in Equation 2.20, the activation ratio ARA is still linearly 
proportional to E1T, but by a new activation factor β1A.  The difference in these 
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expressions is the inclusion of A* and A, therefore β1A is more explicitly a function of A* 
and A, and varies more than α1A as E1 is increased.  In fact α1A is also a function of A*, 
since the amount of free E2 is determined by A* according to Equations 2.15 and 2.18, so 
that: 
 ( )2m* T22 K/A1 EE +=  (2.50) 
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It is true that β1A is not constant, but approaches a constant value as the fraction of 
A in the active form (A*/ATot) increases.  Nevertheless, it represents the local sensitivity 
of the activation ratio with respect to E1T and can be a useful measure of the interaction 
between E1 and A.  The presence of A* and A in Equations 2.49 and 2.51 result in a slight 
curvature for plots of activation ratios, in particular at lower values of E1T where A* and 
A are varying significantly.  As E1T increases, A* and A approach limiting values, and 
activation ratio plots appear linear.  The severity of this curvature depends upon the 
degree of saturation of the enzymes; if Km1 and Km2 are much greater than ATot the plots 
will be linear for the full range of E1T. 
A similar result occurs when determining total activation ratios as a function of 
total enzyme concentrations: 
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As before, the total activation ratio is generally hyperbolic with respect to the 
concentration of the activator.  The presence of A* and A in Equation 2.52 once again 
results in a curvature at lower values of E1T, yielding an slightly sigmoidal shape overall.   
Since it is important to determine concentrations of free active forms of 
intermediates, to avoid calculation of total activation ratios, then the issue of free or total 
enzyme is most likely not a major concern.  If the free active and free inactive 
concentrations of each intermediate in the network are measured, then by default the free 
concentrations of enzymes will be measured.  The free activation ratios that will be 
calculated should yield nearly linear results for direct effects.    
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2.5. Conclusions 
A novel method for examination of signaling pathways was developed, based 
simply on an understanding of the nature of the interconverting cycles that are prominent 
in these pathways.  It was shown that by considering the ratio of active to inactive forms 
of the intermediate, it is possible to write expressions that focus on isolated interactions 
between activator and target.  Unknown kinetic constants and enzyme concentrations are 
compressed together into a single quantitative parameter, the activation factor.  This 
approach yields a linear relationship between the activation ratio and the concentration of 
the enzyme that drives the activating reaction.  This simple relationship remains even 
when the activator and target are embedded in more complicated systems, where 
converging and diverging pathways, linear cascades, multiple activation steps, or 
feedback appear.  The properties of activation ratios for different systems are summarized 
in Table 2.2. 
Table 2.2.  Summary of results for simple signaling systems: expressions for activation ratios. 
Arrangement Expression Mathematical Form of ARi 
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Arrangement Expression Mathematical Form of ARi 
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Activation ratios have great potential in network reconstruction, because the 
functional form (or graphical pattern, if plotted) changes along with the nature of 
interaction between two species.  Since the network structure is reflected in the form for 
the activation ratios, then the problem can be inverted; namely, the functionality of 
activation ratios can be used to determine the structure.  This will be discussed in  further 
detail in the next chapter.  The ratios can also be used as a descriptive tool during 
examination of a single step, since the activation factors are reflective of the kinetic 
parameters, and multi-step, nonprocessive activation kinetics can be resolved from 
single-step or processive reactions.   
The analysis described here was developed assuming steady state in the signaling 
system.  This simplification greatly facilitates the overall analysis development, since 
concentrations of enzyme-substrate complexes can be written in terms of free species 
(e.g. E1 and A), as in Equations 2.17-2.18, and individual kinetic parameters (kcat and Km) 
can be collected together as shown in Equation 2.20.  In the absence of a steady-state 
system, such as cells growing in a chemostat, this assumption will not be precisely valid.  
The transient nature of signaling pathways has been well documented; rather than 
achieving a steady state often components will peak in activation and relax more slowly 
[21].  Nevertheless, the method may still be applicable if a pseudo-steady state 
assumption can be made.  A pseudo-steady state approximation is often made in 
examination of enzyme systems, and is based on the assumption that the rate of formation 
of enzyme-substrate complexes is faster than the rate of decomposition.   In this case, the 
assumption would require that dynamics of component activation (within a step) are 
faster than transmission (between steps).  In such a case it may be possible to apply this 
pseudo-steady state assumption to the signaling system at each time point over the more 
global dynamics of the system.  Further work in this area is warranted, to investigate the 
applicability of activation ratios to dynamic signaling systems. 
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3 NETWORK RECONSTRUCTION USING 
ACTIVATION RATIOS 
Reconstruction of networks involves the determination of connectivity between 
components of the network, and can be accomplished through one of two methods.  One 
possibility is to assume a priori a network structure, and then utilize a model based upon 
the assumed structure to predict the behavior of the system.  Discrepancies between 
predictions and experimental observations, after allowing for noise and potential 
variation of parameter values, can be used to indicate any errors in the assumed structure.  
The alternative approach is to determine the network structure directly from experimental 
data, using some sort of inversion method.  In the previous chapter, models of simple 
network structures were used to demonstrate how the structure is reflected in the patterns 
for activation ratios.  This chapter describes an algorithm to deduce the network structure 
from a set of measured activation ratios, as well as tools useful for automating the process 
and for evaluating the confidence in the final assignment.   
3.1. Concepts and Algorithm  
3.1.1. Structural and numerical observability 
A key issue to consider before delving extensively into procedures for analyzing 
networks is that of observability, namely, what information can be determined about the 
network and what features may be invisible.  While of course this will depend upon the 
connectivity of the network, it can also be influenced highly by the type and quality of 
measurements that are available.  Not all measurements may equally contribute 
information about the network.  Furthermore, the numerical sensitivity of some 
parameters to particular measurements may make the system structurally, but not 
numerically, observable.  In other words, while some measurements may be useful “in 
theory” for determination of unknown variables, some values of those measurements may 
lead to numerical singularities whereupon they are rendered essentially meaningless.   
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As an example, consider the small system shown in Figure 3.1.  If this system 
represents a typical chemical reaction sequence, such as found in cellular metabolism, 
then the reactions 1-9 may represent uptake, export and conversion between 
intermediates X0-X8.   In that case the flux v, or throughput, of each reaction step is of 
interest [1].  It is trivial that the fluxes v1, v2, and v9 must be equal at steady state, as well 
as the total flux between the two parallel paths (v3+v4)—so that measurement of any one 
can be used to determine all.  From the standpoint of structural observability, it should be 
noted that fluxes v3 and v4 (and their respective equivalents) cannot be independently 
measured if only the total flux is known [2].   In fact, without some additional 
information about any of the steps in either pathway (such as v3 or a ratio e.g. v7/v8) we 
may as well consider the two paths together as one combined reaction between X2 and 
X7.  In effect, the separation could be ignored since there is no way to independently 
determine either, and we may not even be aware the split exists.  Numerical observability 
issues appear in this case when there is almost no flux in one branch, or if the capacity to 
measure the flux is poor.  In either situation, the additional information does not actually 
provide further resolution on the split, simply because of the numerical value (and error) 
of the measurement.   
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Figure 3.1. Network with parallel pathways. 
If the system above is now considered to be a sequencing of signaling reactions, 
then the physical relationship between intermediates changes drastically. The connections 
represent transfer of information, which need not be conserved around each node. Thus 
measurement of “information flux” v1 (perhaps as an activation factor α01) does not give 
information about v2.  To resolve the network above, activation of all intermediates X0-
X8 must be measured so that all activation factors can be determined.   
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Once again, to correctly identify and quantify the two parallel paths, it is also 
necessary to obtain some additional information.  In this case, measuring the activation of 
X3 and X4 is sufficient to determine the split, since diverging pathways can be observed 
as described in Section 2.3.3.  The convergence at X7 might be identified as a result of 
direct connections from both X5 and X6.  However, to correctly quantify the convergence, 
there must be some way to independently regulate the activities of X5 and X6, through 
additional activation or inhibition with some factor external of X2.  Otherwise the 
activities of X5 and X6 will be interdependent, and it will be impossible to separately 
calculate α57and α67. 
Therefore structural observability limitations in signaling networks arise from the 
need to measure the activation profile of each intermediate, as well as the capacity to 
ensure independence of activators at convergence points.  For the interactions to be 
numerically observable, there must be enough samples, with high enough quality in the 
data, to qualitatively and quantitatively describe lines, hyperbolae and inverse 
hyperbolae.  If too few samples are taken, or only at low activation points, then the 
conclusions drawn about the network will be incorrect.  Hyperbolae will appear as lines, 
the early curvature for direct interactions may make them appear as inverse hyperbolae, 
and inverse hyperbolae will appear as very flat lines (low slope).  It will be important to 
increase the spread of data samples, through variation of activators over orders of 
magnitude, and try to minimize measurement error to reduce scatter that may lead to 
confounding.    
3.1.2. Stepwise analysis of networks  
Once issues regarding observability have been addressed, by selecting the 
appropriate number and quality of measurements for a network system, the next step is to 
combine them an algorithm that utilizes the measurements.  As shown in Chapter 2, and 
summarized in Table 2.2, the arrangement of molecules in simple signaling systems is 
reflected in the patterns for activation ratios.  Reconstruction of signaling networks 
therefore involves inverting a set of activation ratio measurements to yield one (or 
potentially several) possible network structures, which may need to be verified by 
additional experiments.  This proceeds by stepwise examination of the activation ratios 
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for one intermediate I (ARI), plotted against the active concentrations of each other 
intermediate J (J*), which may yield several possibilities: 
1) If the plot is linear, then I is immediately downstream of J (most likely, J directly 
activates I).  The slope of the line is αJI.  Note that there may be some curvature for low 
values of J*, yielding a negative intercept.  A positive intercept suggests the possibility of 
another activator for I.   
2) If the plot is hyperbolic, then I is further downstream of J (one or more steps exist 
between J and I).  Most likely, J indirectly activates I.  The cascade must be determined 
using direct results for other intermediates between J and I, if available.  Also, the 
hyperbola will be steeper (lower saturation constant) as the distance between J and I 
increase.  Note that if total activation ratios are used, then even direct interactions will 
appear hyperbolic.  
3) If the plot is inverse hyperbolic, then either a) I is actually upstream of J by one or 
more steps or b) I and J are on the same level of different branches from an unknown 
third intermediate.  These two possibilities can be resolved by considering plots of ARJ 
against I* as well as ARI and ARJ against other intermediates K*. 
4) If the plot is quadratic (or higher power), then J directly activates I, through multiple 
steps.  Further study into finding and measuring intermediate forms between I and I* may 
be required.   
If there exist multiple inputs to the system, then these studies can be performed 
for each input individually, as well as two or more together.  For intermediates at 
convergence points, sets of curves appear when both inputs are varied.  As described in 
Section 2.3.2, sets of lines are expected for plots of ARI against a direct activator J, while 
sets of hyperbolic curves are expected for an indirect activator.  Regardless, each input 
must be modulated independently to properly determine the interactions. 
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Observations regarding the shapes of curves can be determined visually, and often 
it will be advantageous to examine the activation ratio plots for each intermediate to gain 
confidence in the method and results.  Nevertheless, it is possible to automate this 
algorithm, by performing both linear and nonlinear regression (using hyperbolic and 
inverse hyperbolic models) for each pair of intermediates, as will be described in Section 
3.3.  In either case, the data must be able to allow differentiation between these 
possibilities by extending as far as possible.  Although direct effects can show curvature 
at early points, the plot will approach a limit of a straight line.  An inverse hyperbola will 
approach an infinite slope at its asymptotic limit, whereas a quadratic plot will remain 
curved.  
3.1.3. Consistency 
The algorithm described above is based upon examination of each two-way 
interaction between species, independent of the others in the system.  Although the 
approach seems rather simplistic, its power is expanded by the requirements of 
consistency.  The algorithm can be extended in two ways:  first, by looking at the inverse 
relationship of the two species I and J, and second, by looking at three-way interactions 
with additional species K.  In neither case can the activation ratios take any arbitrary 
pattern, since they must be determined by the physical relationship between the species.  
These requirements can be exploited to help resolve any limitations in the data quality 
(that might lead to misassignment), or point out potential trouble spots where there exists 
less certainty.   
The first approach, looking at inverting two-way interactions, is summarized in 
Table 3.1.  Listed are all the combinations for how activation ratios are expected to 
change as the target I and effector J are switched.  Although ARI may take any of the 
possible patterns when plotted against J*, plots of ARJ against I* is restricted to specific 
possibilities.  At least one of the two must be inverse hyperbolic, and no more than one 
can be linear, hyperbolic or quadratic without violating the rules of consistency.  If 
anything other than these combinations is observed, then there is most likely some 
problem with the data quality, and it may be important to verify the confidence of both 
assignments. 
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Table 3.1. Expectations for activation ratios when inverting the relationship between species I and J. 
Pattern for 
ARI vs. J* 
Relative placement Likely relationship Pattern for ARJ vs. I* 
Linear Direct downstream J I (direct)  
Inverse 
Hyperbolic 
Hyperbolic Indirect downstream J I (indirect)  
Inverse 
Hyperbolic 
Quadratic Direct (multistep) J I (direct)  
Inverse 
Hyperbolic 
Upstream J I  
Linear, 
Hyperbolic, 
Quadratic Inverse 
Hyperbolic 
Parallel K
I
J  
Inverse 
Hyperbolic 
  
Three-way interactions, and further extensions, also can be expected only to have 
particular combinations of patterns for the activation ratios, which can be assembled from 
the individual two-way possibilities.  Here it becomes much more simple to describe the 
combinations based upon the possible arrangements for the three species.  (Four-way 
interactions, and beyond, can be sequentially broken down to three-way interactions and 
so forth.)  The possible network structures involving three species, and activation ratio 
patterns for the three corresponding two-component substructures, are shown in Table 
3.2.  In each case, the two-way inversion rules as described in Table 3.1 also apply.  
Again, departure from these combinations is a signal of problems with data quality or 
pattern assignment. 
Table 3.2. Activation ratio combinations for three-species structures. 
Structure ARI vs. J* ARI vs. K* ARJ vs. K* 
J IK  
Linear (direct) or 
Hyperbolic (indirect) Hyperbolic Linear or Hyperbolic 
I
J
K  
Linear or Hyperbolic Linear or Hyperbolic Inverse Hyperbolic 
K
I
J  
Inverse Hyperbolic Linear or Hyperbolic Linear or Hyperbolic 
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3.2. Analysis of a Model Network  
3.2.1. Network structure and features 
To illustrate this algorithm in a somewhat realistic system, a model for a small, 
interconnected network was constructed, with the structure shown in Figure 3.2.  This 
network contains both distinct and overlapping pathways for the two inputs E1 and E2 and 
cascades with three levels of activation.  Parameter values were selected such that in most 
interactions the Vmax and/or Km values for activation or inactivation reactions differ 
slightly, allowing comparison between the effects of these constants, and using total 
concentrations such that all reactions are saturated.  Further details, including values for 
all kinetic constants, are included in Appendix 3.  Here we will focus on how the 
analytical framework described above can be used to accurately reconstruct the network 
structure from a set of simulated measurements.  For this purpose, we assume that 
although all species A-H are known and measurable, we have no a priori information 
about how either E1 or E2 may activate these species.   
E
C
E2
B
D
F
3
6
2
5
8
4
7
G
9
E1
A
1
H
10
 
Figure 3.2. Diagram of sample model network, showing activation reaction numbering.  Model details and 
parameter values are included in Appendix 3. 
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3.2.2. Network analysis using free concentrations 
Activation ratios for the network components in response to E1 and E2 
individually (i.e., for E2 or E1 = 0, respectively) are shown in Figures 3.3-3.4.  The color 
and marker for each curve corresponds with the species being plotted, in accordance with 
the legends shown in each figure.  These activation ratios were calculated using free 
(unbound) active and inactive concentrations for each component, and are plotted against 
the free active concentration of each other intermediate.  Species that are not included in 
these plots showed no activation with respect to that input, so B, D, and F were 
unaffected by the concentration of E1, whereas A, G, and H were independent of E2.  
Both E1 and E2 activate C and E, indicating an overlap between these two effectors.  For 
the sake of simplicity, first the subnetwork downstream of each input will be examined 
independently. 
Downstream of E1, five species (A, C, E, G, H) are activated, and the line in 
Figure 3.3A indicates that activation of A (blue squares) is direct, whereas the remaining 
components are indirect, most likely through A.  This assumption is strengthened by the 
plot of activation ratios against A* shown in Figure 3.3B, showing lines for C, G, and H 
(green triangles, red circles and magenta diamonds, respectively).  The difference in 
slopes for ARC, ARG and ARH shows a preference for the activation of C.  The parallel 
activation of these three species can also be deduced by the fact that activation ratio for 
each is inverse hyperbolic when plotted against the other two.  The activation ratio for E 
(black x’s) is linear when plotted against C*, but hyperbolic against G* and H*, suggesting 
that E is activated directly by C.  All activation ratios are inverse hyperbolic when plotted 
against E*, consistent with the assumption that E is the endpoint of the cascade.    
The results in Figure 3.4 indicate that B (blue squares) is directly activated by E2, 
with the remaining species further downstream.  Both ARC and ARD are linear when 
plotted against B*, with almost identical slope.  Thus B directly activates C and D, with a 
slight preference for C.  Plots of ARE and ARF appear linear with respect to both C* and 
D*, making it difficult to determine the remaining connections.  The results of activation 
from E1 only might be used to assume that C activates E alone, while D activates F alone.  
However, by simultaneously varying both C* and D* (by varying E1 and E2), it is possible 
to clarify the situation. 
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Figure 3.3. Activation ratios for intermediates in model network of Figure 3.2, calculated using free 
species only, plotted against A) E1, B) A*, C) C*, D) E*, E) G*, and F) H*.  In each case E2 = 0.   
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Figure 3.4. Activation ratios for intermediates in model network of Figure 3.2, calculated using free 
species only, plotted against A) E2, B) B*, C) C*, D) D*, E) E*, and F) F*. In each case E1 = 0.   
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Activation ratios for the pathway endpoints E and F following activation by both 
E1 and E2 are shown in Figure 3.5.  The sets of lines observed in Figures 3.5A-B are 
typical of converging pathways, indicating that both C and D can independently activate 
E.  However, it is apparent from Figures 3.5C-D that D alone activates F, since all 
contours of C* collapse together.  This final information, combined with the results 
following analysis downstream of E1 and E2 individually, allows a complete and accurate 
reconstruction of the network structure in Figure 3.2. 
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Figure 3.5. Activation ratios for E (A and B) or F (C and D), plotted as contours against C* (constant D*, A 
and C) or D* (constant C*, B and D). 
As described in Chapter 2, the activation factors for direct interactions can be 
estimated through simple and multidimensional linear regression techniques.  Each linear 
plot in Figures 3.3-3.4, as well as the contour plots of Figure 3.5, were therefore fit by 
linear least squares using the MATLAB “regress” function, which allows for estimation 
of 95% parameter confidence intervals [3].  Regression results are shown in Table 3.3, 
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along with the expected values calculated using Equation 2.51, which accounts for 
variation in the amount of free inactivating enzyme for each reaction.  Further data used 
for calculating these activation ratios is included in Appendix 3.  In most cases, there is 
excellent agreement between the predicted and observed values for the activation factors.  
One notable exception is for αCE, which is somewhat lower than expected.  This is likely 
due to the curvature seen for low values of C* in Figure 3.5A; while it may appear slight, 
it is enough to decrease the slope for the overall fit.  If regression is performed using only 
data for values of C* greater than 0.05, then an accurate estimate of αCE is found (0.80 ± 
0.01).  Nevertheless, the calculated activation factors vary generally as expected based 
upon the kinetic constants for each reaction.  For example, the Km value for activation of 
E by D* is twice as high as for C*, so we would expect αCE ≈ 2 αDE.  For the same reason, 
we expect αAC ≈ 2 αBC, while αAG ≈ 1.3 αAH since the kcat for activation of G by A* (2) is 
1.3 times higher than for H (1.5).   
Table 3.3.  Regression results for simple network, using free activation ratios.  
Reaction 
No. αJI Linear fit 
Regressed αJI  
(95% C.I.) Theoretical αJ
I 
1 α1A ARA vs. E1 0.937 ± 0.001 0.938 
2 α2B ARB vs. E2 0.315 ± 0.001 0.316 
3 αAC ARC vs. A* 0.799 ± 0.006 0.805 
4 αBC ARC vs. B* 0.373 ± 0.003 0.378 
5 αBD ARD vs. B* 0.290 ± 0.004 0.296 
6 αCE ARE vs. C* (E1 and E2) 0.770 ± 0.002 0.800 
7 αDE ARE vs. D* (E1 and E2) 0.399 ± 0.005 0.400 
8 αDF ARF vs. D* 0.1878 ± 0.0004 0.1904 
9 αAG ARG vs. A* 0.336 ± 0.006 0.343 
10 αAH ARH vs. A* 0.230 ± 0.003 0.234 
6  ARE vs. C* (E1 only) 0.76 ± 0.01 0.76 
6  ARE vs. C* (E2 only) 0.98 ± 0.01 0.76 
7  ARE vs. D* (E2 only) 1.58 ± 0.03 0.38 
 
 It should be noted that the slopes for ARE in Figures 3.5A-B, which truly 
represent the activation of E by C and D, are different than the slopes seen in Figures 
3.4C-D, arising when only E2 is varied.  This can also be seen by the difference in 
activation factors shown at the bottom of Table 3.3.  The activation of E is the result of 
two distinct pathways downstream of B, and ARE shown in Figure 3.4 arises from the 
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activities of both C* and D*.  By varying E2 only we cannot deconvolute these two 
pathways, and would calculate incorrect activation factors—in fact, incorrectly predicting 
that activation is stronger by D.  Fortunately, by adding E1 to modulate C independent of 
D these two paths can the separated and the accurate activation factors αCE and αDE can 
be calculated.   Since E1 does not activate D, then αCE can also be estimated using the 
data for E1 in the absence of E2; the fact that this value (0.76) is different than using E2 
alone (0.98) hints that another component besides C is involved in the activation of E.   
3.2.3. Network analysis using total activation ratios 
As described in Section 2.4, the presence of enzyme-substrate complexes in 
measurements of active and inactive species can complicate network reconstruction by 
activation ratio analysis.  These “total activation ratios” behave nonideally in showing 
dependence upon other intermediates aside from direct activators, and may not be able to 
distinguish between direct and indirect downstream effects.  It is useful to observe how 
total activation ratios appear in the case of the simple model network, to demonstrate that 
it is still possible to determine the network structure, although quantitative analysis 
(through calculation of activation factors) is unavailable. 
Total activation ratios for the model network are shown in Figures 3.6-3.8.  The 
same simulation results were used for these plots as for analysis with free species only 
(Figures 3.3-3.5).  However, all enzyme-substrate complexes are included in calculation 
of total active and inactive forms for each intermediate.  As expected, the simple lines for 
direct effects seen in Figures 3.3-3.5 are replaced by hyperbolae, making network 
reconstruction somewhat more difficult, as direct and indirect effects cannot be 
distinguished.  Since total activation ratios plotted against upstream activators still appear 
as an inverse hyperbola, cascades must be deduced by observing which species are above 
or below a particular intermediate.  In this case, no quantitative factors can be calculated, 
and only a structural analysis is possible. 
All total activation ratios are hyperbolic when plotted against A* in Figure 3.4B, 
thus A appears at the top of the network activated by E1.  Similarly, E must be at the 
bottom of a cascade since all activation ratios appear inverse hyperbolic.  The remainder 
of the system is more confusing: although C, G, and H all lie in between A and E, it 
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cannot be easily determined which actually activates E.  Furthermore, while TARG and 
TARH are both inverse hyperbolic with respect to C*, TARC is slightly hyperbolic with 
respect to both G* and H*, indicating that G and H come before C in a cascade, and may 
even activate C.  TARG appears slightly inverse hyperbolic (almost linear) with respect to 
H*, and vice versa (TARH plotted against G*), which would seem to suggest that G and H 
are parallel branches downstream of A.   
In a similar fashion the results in Figure 3.7 for activation by E2 alone can be used 
to conclude that B is the start of the cascade, E is an endpoint, and C and D are parallel 
branches lying in between, activating E and F with some unknown crosstalk possible.  
Since TARE is slightly hyperbolic relative to F*, at first it might be assumed that F 
activates E.  Unfortunately, not much further detail on either side of the network can be 
deduced the results from each effector E1 and E2 alone.   
The network can be further clarified by examination of the overlap between E1 
and E2, and simultaneous modulation of both.  Since E2 activates C and E, but not G or H, 
we may conclude that C is parallel to G and H (not downstream of either), and likely 
activates E.  Similarly, F is not required for activation of E downstream of E1, so it is 
unlikely that F activates E.  Contour plots of TARE and TARF against C* and D* again 
show that D alone activates F, while both activate E.  And by plotting contours of TARE 
against F*, which appear as inverse hyperbola, we can again reject the notion that F 
activates E (data not shown).   
We can see that the use of total activation ratios makes structural reconstruction 
significantly more confusing, even for this relatively simple sample network.  Divergence 
of pathways to form parallel branches can be more difficult to detect, since total 
activation for each branch may be affected by binding of other components.  Similarly, 
selection between different possible activator candidates may require additional 
information such as observation of where overlaps appear.   For more expansive and 
interconnected networks, it may be necessary to incorporate knowledge arising from 
additional sources including in vitro reactions, knockouts, or homology to known 
cascades to help resolve the structure.  If free activation ratios can be calculated, 
however, then the analysis should still be straightforward, as described in Section 3.2.2. 
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Figure 3.6. Total activation ratios for intermediates in model network of Figure 3.2, plotted against A) E1, 
B) A*, C) C*, D) E*, E) G*, and F) H*. In each case E2 = 0.   
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Figure 3.7. Total activation ratios for intermediates in model network of Figure 3.2, plotted against A) E2, 
B) B*, C) C*, D) D*, E) E*, and F) F*. In each case E1 = 0.   
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Figure 3.8.  Total activation ratios for E (A and B) or F (C and D), plotted as contours against C* (constant 
D*, A and C) or D* (constant C*, B and D). 
A note should be made about network observability.  In these examples, it was 
possible to fully reconstruct the network, and it is also possible to calculate the activation 
factors when free concentrations are available.  This would not have been so simple if 
data for one or more intermediates were missing.  For example, without data on the 
activation profile for A or B then it would only be possible to say that E1 and E2 activate 
the remaining intermediates indirectly, through some undetermined components. 
Similarly, without data for C it would not have been possible to determine whether both 
C and D, or only D, activates F; and whether both C and D activate E.  Also, it was 
critical to examine the activation of E using data obtained from variation of both E1 and 
E2 simultaneously, to rule out activation by F, G, or H and separate effects from C and D.  
If data were obtained only by varying E2 it would be possible to determine that B 
indirectly activates E, but not that there were multiple mechanisms for this activation.  
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Only by differentially activating the two branches, by the addition of E1 to further 
activate C, could the presence of both pathways be discovered. 
3.3 Automated regression of data and pattern assignment 
3.3.1. Methodology 
Although it is certainly possible to personally examine each plot of activation 
ratios and develop a network structure by hand, it is quite useful to have a more 
automatic method, in particular as the number of components and possible interactions 
increases.   Furthermore, an automated procedure would necessarily include some 
measure of the statistical fit, which can be used in evaluating the accuracy of the 
assignment.  These results could be paired later with a decision-making algorithm to 
translate a matrix of assignments into one or more putative network structures.  This first 
step involving automated regression and pattern selection steps has been achieved using 
several functions written in MATLAB. 
The pattern assignment methodology has been implemented in three steps.  First, 
matrices X and Y are generated, where the columns of X are vectors containing the 
activator concentrations (E1, A*, B*, etc.) and the columns of Y contain the corresponding 
activation ratios for targets (ARA, ARB, etc.).  Second, each column of Y is regressed 
against each column of X using a linear, hyperbolic, and inverse hyperbolic model, as 
shown in Figure 3.9.  In each case the regression is performed to minimize the total least-
squares error between the model fit ( ) and data values (yiyˆ i).  Finally, the “best-fitting” 
model is determined by whichever yields the lowest error, as determined by the Akaike 
Information Criteria (AIC), as will be described in Section 3.3.2 [4].   
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Figure 3.9. Models used automated regression of activation ratio data, with graphical significance of 
parameters and half-saturation points shown. 
Regression for the linear model parameters is performed by standard linear least 
squares, using the MATLAB “regress” function [3].  The hyperbolic and inverse 
hyperbolic fits are achieved by utilizing the “constr” function, which performs 
constrained optimization of a nonlinear function by Sequential Quadratic Programming 
(SQP) [5].  These can be written as solution of the optimization problem: 
  (3.1) ublb
p
pppp ≤≤∑= ,2]y-),x(yˆ[min
i
iii
]c,b,a[
Where the model  is defined as shown in Figure 3.9.  Thus the objective function for 
optimization shown in Equation 3.1 is the total sum-of-squares error (SSE, also known as 
residual sum of squares RSS).  Note that in each case the regression is unweighted, with 
equal importance placed on the fit at each value of x.  An inherent assumption is that the 
standard deviation σ
yˆ
y,i is approximately equal at each data point xi.  This procedure may 
be readily modified to accommodate different weighting for each point, should additional 
information about the individual errors become available.   
Furthermore, the current regression procedure necessarily assumes no error in the 
x-values themselves, or at least that the error is small relative to that of y (σx2<σy2) [6].  
Considering that for activation ratio analysis, the x-values would represent measured 
concentrations of free activator, this assumption is unlikely to be strictly valid.  (And, 
since the activation ratios y are calculated from the free active and inactive 
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concentrations, the error in y is likely to be correlated to the error in x)  The error in y is 
likely to be greater than that in x, since it involves a ratio.  If we express the activation 
ratio y as the concentration of an active amount z divided by inactive zi, then the error in 
y can be approximated as [7]: 
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 (3.2) 
Assuming that the variance of measurements for x, z, and zi are all similar, then 
the variance in y will be approximately twice that of x.  Regression in the presence of 
errors for both x and y is possible, aided significantly by the presence of repeats, but is 
considerably more complicated [8].  Since the purpose of this work was to demonstrate 
one potential strategy to automate regression and model selection, however, this 
extension was not attempted.   
The constraints and initial estimates for parameter values when using the 
hyperbolic and inverse hyperbolic models are shown in Table 3.4.  The constraints 
require that the focal point of curvature (point of half-saturation, as shown in Figure 
3.9B-C) occur approximately within the data set.  For the hyperbolic model, this point 
occurs where y is half-maximal and x equals b.  If this point occurs at the extreme of the 
data, then at x=xmax=b, y=ymax=(a+c)/2.  Therefore b is constrained to be less than the 
maximum value observed for x, and a must be no more than twice the range in y.  If the 
data actually appears linear (or is almost indistinguishable from linearity), then the 
regression solution using the hyperbolic and inverse hyperbolic models will most likely 
contain some overlap with the parameter constraints.   
Table 3.4. Models and parameter bounds for automated regression of activation ratio data.  Here ∆y = 
ymax–ymin, ∆x = xmax–xmin, yavg=(ymax+ymin)/2, and xavg=(xmax+ xmax)/2. x(y=yavg) signifies the value of x 
nearest to where y equals yavg, and vice versa for y(x=xavg). 
Model Functional Form 
Parameter 
(p) 
Initial 
Estimate 
Lower 
Bound (plb) 
Upper 
Bound (pub)
Hyperbolic c
xb
axyˆ ++=  
a 
b 
c 
∆y 
x(y=yavg) 
ymin 
10-4 
10-4 
10-4 
2 ∆y 
xmax 
ymax 
Inverse 
Hyperbolic cxb
axyˆ +−=  
a 
b 
c 
y(x=xavg) 
1.2 xmax 
ymin 
10-4 
10-4 
10-4 
ymax 
2 xmax 
ymax 
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Initial estimates for the parameter values are calculated assuming that the data 
fully describes the model.  In that case, the estimate of the saturation extreme (a for 
hyperbolic, b for inverse hyperbolic) is approximately equal to the spread in values for y 
(∆y) or maximum value observed for x, respectively.  Note that a value slightly higher 
than xmax is used for the estimate of b for the inverse hyperbolic model, to avoid a 
singularity occurring when x=b.  The focal point of curvature for the hyperbolic model 
(b) is estimated as occurring at the x-value nearest to where y is approximately halfway 
maximal; and a is determined in an analogous fashion for the inverse hyperbolic model.   
3.3.2. Model selection and evaluation 
The details of different regression models and the general procedures to obtain 
best-fit parameters were described in the previous section.  Once regression has been 
performed using all three model equations, it becomes necessary to have a criterion that 
can be used to select which model best represents the data.  In general we should not 
assume any prior knowledge over which of the three models is most likely, and therefore 
need some sort of quantitative estimate of the likelihood of one the models, given the 
data, or L(model|data).  One option is to simply use the model with smallest residual 
error, as estimated by the SSE.  This approach has two drawbacks.  First, for data sets 
with considerable noise, then all three models may yield high SSE, and small 
discrepancies between them could incorrectly cause one model to be selected over 
another.  Second, use of SSE alone may bias the selection towards overfitting slightly by 
preference of the hyperbolic or inverse hyperbolic models over the linear model, in spite 
of little experimental support for the additional model complexity.  One alternative 
measure is the Akaike Information Criteria (AIC), which is defined as [4]: 
 ( )
1Kn
)1K(K2K2n
SSElnnAIC −−
+++=  (3.3) 
Where n is the number of data points and K is the number of parameters.  Equation 3.3 
contains a bias-adjustment term, which accounts for relatively low sample sizes (n/K < 
40), as is likely to occur in signaling experiments.  The AIC as defined in Equation 3.3 
therefore addresses both issues with using SSE alone: first, the logarithmic 
transformation helps to compress small differences in large error values, and second, it 
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contains a penalty for increasing the number of model parameters.  Other similar 
estimators, such as the Mallows Cp statistic or Bayes Information Criteria (BIC), may 
also be used, provided that they address these same issues [6].  For the purposes of this 
work, the AIC was found to be generally satisfactory as a measure of the fit for different 
models.  Selection of the “optimal” model, best representing the data, is achieved by 
determining which results in the lowest AIC after accounting for variation in number of 
points and parameters.   
One advantage of AIC is that the relative values for the three models can be used 
to provide an estimate of the relative likelihood of the optimal model compared against 
the other two.  First, the difference between the optimal model and remaining models is 
calculated [9]: 
  (3.4) AICminAICii −=∆
If we assume that the optimal model represents the “truth”, then the likelihood 
that another model also represents the data can be approximated roughly as: 
 )5.0exp()datael(modL i∆−∝  (3.5) 
Comparison between the three models can then be achieved by comparing the likelihood 
of each, normalized by the total: 
 ∑ ∆−
∆−=
)5.0exp(
)5.0exp(
w
i
i
i  (3.6) 
The Akaike weights wi, calculated in Equation 3.6, range from 0 to 1 and thus provide a 
readily recognizable value for how each model represents the data.  If the weight for the 
optimal model is greater than 0.9, then the next model can be at most ten times less likely 
to explain the data.  Models with similar weights may be, in essence, nearly 
indistinguishable in terms of these statistics.  In that case additional knowledge may be 
required to help select between the possible options.  This may involve a priori 
information about the interaction between the source and target or application of 
consistency rules.  In any case, the weights can be reviewed after the regression is 
completed as a measure of confidence in the assignment at each point. 
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3.3.3. Example:  cascade analysis in the presence of experimental noise 
The algorithms for automated regression and pattern assignment were tested using 
a model for an extended cascade without feedback, as shown in Figure 3.10A.  Each step 
is saturated and free activation ratios are used for the analysis.  Model details can be 
found in Appendix 4.  Initially no error was assumed in any of the variables, therefore the 
analysis represents the “true” system data.  A table with regression and assignment results 
for the cascade data is shown in Figure 3.10B. Each entry in the table Rji represents the 
model selected with the lowest AIC value as calculated using Equation 3.3 following 
regression of ARI against effector concentration J*; 0, 1 and –1 correspond to the linear, 
hyperbolic, and inverse hyperbolic models, respectively.  For this network arrangement 
and ordering in the table, the contents Rji are expected to be 0 along the main diagonal 
(linear for direct targets), 1 above the diagonal (for downstream targets) and –1 below 
(self-regression and upstream components).  This was indeed observed, and in each case 
the Akaike weights wi, calculated using Equation 3.6, for the optimal model was greater 
than 0.99, indicating that model to be at least 100 times more likely than the next-best fit.  
Plots of the activation ratio data and best-fit curves using the parameters obtained during 
the regression are shown in Figure 3.11, exhibiting excellent agreement in all cases. 
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Figure 3.10. A) Cascade structure and color scheme and B) Expected (and observed) output matrix Rji 
following automated regression analysis. 
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Figure 3.11. Activation ratios (symbols) and best-fit model curves (solid lines) for cascade of Figure 3.10A 
following automated regression.  Activation ratios for A: squares, B: circles, C: triangles, D: diamonds, E: 
x’s 
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The robustness of the regression algorithm was tested by addition of noise in two 
stages.  First, error was added only to the y-values, namely the activation ratios 
themselves.  Second, error was added to the individual concentrations of free active and 
free inactive species, therefore introducing error into both the activation ratios (y) and the 
predictor values (x).  In each case the noise added was normally distributed around the 
“true” value, with a standard deviation equal to some fraction of the “true” value at each 
individual point.  The modified matrices X' and Y' resulting from addition of error were 
then used for analysis.  This procedure was repeated 10 times for each error type, and the 
results of each individual regression were compiled.  The average regression assignment 
jiR  for the ten replicates for each error method is shown in Table 3.5.    
Table 3.5. Results of automated regression/decision analysis for extended cascade in Figure 3.9A.  Results 
shown are mean value from 10 replicate calculations in selecting an optimal model.  0 represents linear fit, 
1 is hyperbolic fit, and –1 is inverse hyperbolic fit. See Figures 3.12-13 for example data.   
 1) σ = 40%, only in ARI  2) σ = 20%, I* and I 
 ARA ARB ARC ARD ARE  ARA ARB ARC ARD ARE 
S -0.3 1.0 1.0 1.0 1.0  -0.1 1.0 0.9 0.9 0.8 
A* -1.0 -0.3 1.0 1.0 0.9  -0.3 -0.5 1.0 1.0 1.0 
B* -1.0 -1.0 -0.2 0.8 1.0  -0.1 -0.7 0.4 0.9 1.0 
C* -1.0 -1.0 -0.9 0.0 1.0  0.0 0.0 -0.3 0.6 1.0 
D* -1.0 -1.0 -1.0 -1.0 0.0  -0.1 0.0 0.0 -0.4 0.6 
E* -1.0 -1.0 -1.0 -1.0 -0.3  -0.4 -0.1 0.0 0.0 -0.1 
 
The procedure works well even in the presence of 40% error in the activation 
ratios ARI, selecting the correct model at least 70% of the time (compare against Figure 
3.10B).  In general, any incorrect assignments are for inverse hyperbola in preference 
over linear fits (e.g. ARB vs. A*), or vice versa (ARE against E*).  Addition of small error 
(5%) to the predicting activator concentrations J* also had relatively little detrimental 
effect on the analysis, but larger error values resulted in a significant deviation from 
expectations.  In particular, the error in x-values consistently resulted in a linear fit 
improperly being selected over an inverse hyperbola.   
This problem, which arises because of the incorrect assumption for regression that 
the x-values contain no error, seems to be compounded by the nature of the objective 
function in Equation 3.1.  The optimization during regression attempts to minimize the 
error between model-predicted  and observed yiyˆ i.  A significant penalty is introduced 
 91
when fitting an inverse hyperbola to sets of data with scattered x-values but similar y 
values (as observed in the asymptotic region of the inverse hyperbola), since the 
deviation from the model is actually observed more in the x-direction than in y.    
For each error type, the data set that resulted in the worst collection of 
assignments, as determined by deviation from expectations of Figure 3.10B, was selected 
for more thorough investigation.  The data and best-fit curves (for each optimized model) 
are shown in Figures 3.12 (for 40% error to ARI) and 3.13 (20% to both I* and I, and 
therefore also to J*).  Although the total variance in the activation ratios is higher in 
Figure 3.12, the data can still be relatively readily visualized as lines, hyperbolae and 
inverse hyperbolae.  On the other hand, the scatter for active fractions I* makes even 
visual inspection of Figure 3.13 difficult, and unsurprisingly also causes failures during 
assignment.  As described in Section 3.3.2, the Akaike weights can be used as an 
estimator of the relative probability for different models.  The assignment matrices R and 
weights wi for the two worst-case sample sets are shown in Tables 3.6-3.7.   
Two types of classification errors appear in Table 3.6, when error is added only to 
activation ratios.  The first is when a linear fit is selected over an inverse hyperbola as the 
activation ratio for a species is plotted against its own active concentration (ARC vs. C* 
and ARE vs. E*).  In both cases, the weight for the linear model (wlin) is only slightly 
higher than for the inverse hyperbolic model (winv), indicating a near-equal probability 
for the two models.  Recall that the activation ratio for a species should always appear 
inverse hyperbolic when plotted against itself, since ARI ~ I*/(IT-I*).  Therefore this error 
is easy to detect and correct.  The second error observed in Table 3.6 is when an inverse 
hyperbola is a better fit than the line expected for a direct interaction (ARA vs. S, ARB vs. 
A*).  The first of these can be remedied easily, since the external activator S can never be 
upstream of any target.  Since the activation ratio for A is also inverse hyperbolic with 
respect to B*, the analysis appears to suggest that these two molecules lie in parallel 
downstream of S.  Unfortunately, this error cannot be corrected by examination of the 
weights alone, although it would be detected if repeated experiments were performed, as 
indicated by the lower value for ABR  in Table 3.6. 
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Figure 3.12. Activation ratios (symbols) and best-fit model curves (solid lines) for cascade with noise 
added to activation ratios.  The noise has a standard deviation of 40% of the true value.   Symbols as in 
Figure 3.11. 
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Figure 3.13. Activation ratios (symbols) and best-fit model curves (lines) for cascade with noise added in 
active and inactive species.  The noise has a standard deviation of 20% of the true value.  Symbols as in 
Figure 3.11. 
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Table 3.6.  Worst-case results of automated regression/decision analysis for extended cascade in Figure 
3.10A, where activation ratios have an added noise term of 40% of true value.  Data is shown in Figure 
3.12.  Tables represent model with lowest AIC and weights for each model.  
 Model with lowest AIC  w  lin
 ARA ARB ARC ARD ARE  ARA ARB ARC ARD ARE 
S -1 1 1 1 1  0 0 0 0 0 
A* -1 -1 1 1 1  0 0 0 0 0 
B* -1 -1 0 1 1  0 0 0.76 0.46 0 
C* -1 -1 0 0 1  0 0 0.51 0.74 0.04 
D* -1 -1 -1 -1 0  0 0 0 0.06 0.82 
E* -1 -1 -1 -1 0  0.01 0 0 0 0.55 
            
 whyp  winv 
 ARA ARB ARC ARD ARE  ARA ARB ARC ARD ARE 
S 0 1 1 1 1  1 0 0 0 0 
A* 0 0 1 1 1  1 1 0 0 0 
B* 0 0 0.22 0.52 1  1 1 0.02 0.02 0 
C* 0 0 0.01 0.12 0.96  1 1 0.48 0.14 0 
D* 0 0 0 0.01 0.06  1 1 1 0.93 0.12 
E* 0 0 0 0 0  0.99 1 1 1 0.45 
 
 
Table 3.7.  Worst-case results of automated regression/decision analysis for extended cascade in Figure 
3.10A, where active and inactive concentrations have an added noise term of 20% of true value.  Data is 
shown in Figure 3.13.  Tables represent model with lowest AIC and weights for each model.  
 Model with lowest AIC  wlin 
 ARA ARB ARC ARD ARE  ARA ARB ARC ARD ARE 
S 1 1 1 1 0  0.09 0 0 0 0.57 
A* 0 0 1 1 1  0.68 0.59 0 0.35 0 
B* 0 0 1 1 1  0.66 0.67 0.48 0.08 0 
C* 0 0 0 1 1  0.63 0.78 0.80 0.41 0 
D* 0 0 0 0 1  0.73 0.76 0.77 0.74 0.17 
E* 0 0 0 0 0  0.64 0.67 0.79 0.70 0.98 
            
 whyp  winv 
 ARA ARB ARC ARD ARE  ARA ARB ARC ARD ARE 
S 0.91 1 1 1 0.28  0 0 0 0 0.15 
A* 0.21 0.41 1 0.64 1  0.11 0 0 0.01 0 
B* 0.22 0.01 0.51 0.92 1  0.12 0.32 0.01 0 0 
C* 0.25 0.06 0 0.58 1  0.12 0.16 0.20 0.01 0 
D* 0.09 0.02 0.14 0 0.83  0.18 0.22 0.09 0.26 0 
E* 0.20 0.24 0.14 0.24 0  0.16 0.09 0.07 0.06 0.02 
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If statistical error is added to both inactive and active concentrations of each 
species, thus affecting both the observed (activation ratios y) and predictor (active 
concentrations x) variables, then different problems in assignment appear.  Most of the 
direct interactions, which should yield linear relationships, are instead classified as 
hyperbolae.  In two cases (RCD and RDE), the weight for the hyperbolic model is not much 
greater than for the linear fit, but in the other two the discrepancy is indeed significant.  
The introduction of error in this case therefore causes direct interactions to be 
misinterpreted as indirect effects, but they remain oriented properly in sequence.  The 
misidentification of ARE as linear with respect to S can be recognized partly by the 
significance of the other weights, and also through a visual inspection of the graph or 
inspection of the regression parameters, which indicates that the linear fit is nearly flat 
(slope = 0.08), thus more likely a sharp hyperbola.  All upstream interactions and self-
regressions should yield inverse hyperbolae, resulting in Rji=-1 underneath the main 
diagonal.  In each case the data is mislabeled as linear.  This problem can be recognized 
by visual inspection of the data.  It should also be obvious from application of 
consistency rules of Section 3.1.3, since examination of any two-way interaction should 
yield at least one inverse hyperbola.  If winv values across the main diagonal are 
compared, then in each case the entry below the main diagonal (corresponding to the 
inverted sequence, e.g. RCB) is lower than its corresponding value above the diagonal 
(RBC), which can be used to correctly place the two components relative to each other.   
The relatively simple approach of model fitting, calculation of AIC and 
verification using consistency rules and Akaike weights can therefore provide a powerful 
method for performing automated pattern assignment.   Introduction of reasonable values 
for potential experimental error can still be handled, although the algorithm is more 
susceptible to misclassify interactions.  Addition of data replicates, and expansion of the 
regression procedures to account for errors in predictor variables, may overcome these 
limitations. 
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3.4. Conclusions 
The characteristics of activation ratios, developed and observed in the previous 
chapter, were exploited here for the development of a network reconstruction algorithm.  
A set of experimental measurements for active and inactive concentrations of signaling 
components can be used to generate activation ratios, which can then be either visually or 
computationally assigned a functional form.  The procedure is subject to similar 
observability issues seen in examination of other types of networks, such as its incapacity 
to describe interactions for unmeasured components or to visualize parallel pathways that 
cannot be independently modulated.   
The number and quality of measurements can critically influence pattern 
assignment.  The span of experimental conditions must result in sufficient variation in the 
measured activation ratios that visible signs of curvature appear.  Otherwise, differences 
between the three model types will not be significant enough to yield high confidence in 
a particular assignment.  Furthermore, excessive scatter in the data can lead to 
misclassifications as automated regression tools are used.  In some cases, application of 
consistency rules and “common sense” can indicate inaccuracies in assignment.  
Comparison of Akaike weights to evaluate the relative likelihood of different models can 
also be effective in proofreading a set of assignments for potential errors. 
The algorithms for network reconstruction and automated pattern assignment 
were applied to two model systems.  A small interconnected network was analyzed using 
both free and total activation ratios.  Use of free activation ratios enabled accurate 
structural determination of the network, and estimates of activation factors that reflected 
variation of kinetic parameters.  Total activation ratios could also be used for 
reconstruction, but it was significantly more complicated to resolve between several 
possible structures.  In either case, it became critical to combine knowledge resulting 
from activation by both inputs to properly identify the parallel pathways connecting 
intermediates B and E.  A simple extended cascade was used to demonstrate the pattern 
assignment algorithm, and demonstrate potential problems arising from several types of 
experimental error.  Although the procedure is relatively robust with respect to variation 
in activation ratios, scatter in activator concentrations can lead to significant 
confounding.  This may be corrected through manual editing following visual inspection 
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of the data, or through improvements in the regression and selection methods.  Of course, 
efforts to minimize experimental error will also be powerful in reducing the probability 
of misclassification.  Application of consistency rules will help to resolve these issues, 
since the regression results are not used independently but rather in the development of a 
network structure that must yield certain expected pattern sets.   
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4 ACTIVATION RATIO ANALYSIS OF ERK 
PHOSPHORYLATION 
The framework of activation ratio analysis was developed with the goal of 
application to a real experimental system in mind.  The hope was to yield an analytical 
method that could both indicate how experimental data should be obtained and how best 
to utilize that data.  The results described in Chapters 2 and 3 indicate in particular the 
need to measure amounts of both active and inactive forms of each intermediate, and to 
separate enzyme-bound from free substrate to enable calculation of free activation ratios.  
Sufficient activating enzyme must be introduced to drive the cycle forward enough to 
visualize any curvature in the activation ratios, whether hyperbolic, inverse hyperbolic, or 
power-law (quadratic or more).  Similarly, overall experimental uncertainty for activation 
ratios must be kept as low as possible, to improve confidence in the assignment of a 
particular pattern.   
The impact of these issues, developed using mathematical analysis and computer 
model simulations, was therefore addressed using a controlled experimental system.   
Considering the novelty of the activation ratio framework, it seemed best to investigate 
its application in as simple and easily controlled system as possible.  The experiments 
would therefore focus in detail on in vitro activation of a single species, rather than jump 
directly into studies using a cascade or larger network.   
The covalent modification cycles of the protein kinase Erk2 (mitogen-activated 
protein (MAP) Kinase 1) were selected as the basis for experimental studies.  This 
enzyme is one of the most highly investigated signaling intermediates, by in vivo 
mutation, expression and characterization experiments as well as detailed in vitro 
mechanistic studies [1-7].  The extensive body of prior research ensured access to 
materials and information that would be necessary in preparing the experimental system.  
Additional complexity, to evaluate network-oriented predictions from activation ratios, 
could later be examined by stepwise addition of other components to the reactive system.   
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Details regarding the conceptual development of the experimental system are 
described below in Section 4.1.  Each of the system components was evaluated 
separately, as discussed in Section 4.2, before combining them together for studies of Erk 
phosphorylation cycles as shown in Section 4.4.  Particular limitations in the materials 
and methods available for quantitation of different Erk phosphorylation forms were 
addressed by application of a model for the ELISA technique, as described in Section 4.3. 
4.1. Experimental system selection and design 
Two key assumptions were made in the development of activation ratio analysis.  
The first is that signaling systems achieve a steady state.  All reactions therefore must be 
allowed to progress until that steady state is achieved.  Second and more critical is that 
free species can be separated from enzyme-substrate complexes, which inherently 
requires that the complexes are relatively stable.  This must be accomplished without 
disrupting those complexes, since doing so would yield inaccurate estimates for the 
activation ratio and potentially lead to incorrect conclusions regarding either the structure 
or calculation of the activation factor α.  The general argument to assume that this is 
possible is that often substrates of enzymes can be identified via “pull-down” type co-
immunoprecipitation techniques [8, 9].  If the complexes were not stable, these methods 
would never be able to identify protein-protein interactions in a reproducible manner.  
Numerous efforts to separate antibody-antigen complexes, as a proxy for enzyme-
substrate complexes, by size-exclusion chromatography, nondenaturing polyacrylamide 
gel electrophoresis (ND-PAGE), or filtration showed extremely poor results.  It is likely 
that these separation techniques all failed because the time required to achieve separation 
was excessively long compared to the stable lifetime of the complexes.  A faster 
separation method was therefore required to improve the chances of successfully 
resolving free species from enzyme-substrate complexes. 
A simple reaction scheme that addresses these concerns is shown schematically in 
Figure 4.1.  The setup is illustrated for a phosphorylation cycle involving a substrate (S) 
that is converted to its phosphorylated form (S-P) by a kinase, and back again using a 
phosphatase.  The enzymes are immobilized upon a surface, for example the sides of a 
well or coated upon a bead.  This immobilization does not necessarily need to be covalent 
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in nature, so long as the enzymes remain bound during the reaction.  Substrates and other 
reagents are incubated with the enzymes until steady state is reached, both in terms of 
complex formation and net reaction.  The liquid supernatant can then be sampled to 
determine the amounts of the phosphorylated and nonphosphorylated forms, and more 
importantly, their ratio.  The portion of substrate that is abstracted in enzyme-substrate 
complexes is essentially also immobilized, and therefore readily separated from the free 
species. 
Enzyme-substrate complexes 
remain bound in wells 
Free species in solution 
Sample to assay
Kinase P’ase
S S-P
SS-P
 
Figure 4.1. Immobilization of enzymes enables separation of free species from enzyme-substrate 
complexes. 
The next key issue was selection of a detection method that could be used to 
independently measure active and inactive forms of a species.  Assays that are based 
upon either enzymatic activity or detection of active-specific label (e.g. radioactive 32P) 
would only enable estimation of the relative or total amount of active form of a species.  
But in neither case could they be used to determine the inactive fraction that remains 
inactive.  A separate measurement method could be used to determine the total, and the 
fractions inactive calculated as the difference.  However, it is preferable that the same 
method can be used to measure both inactive and active species, since the potential 
sources of error such as differences in sample handling, sensitivity, and operating 
conditions would be identical.  In the case of covalent modification cycles such as 
phosphorylation, it is possible to quantify the amount of nonphosphorylated as well as 
one or more phosphorylated forms of a protein using isotopic labeling and mass 
spectrometry (MS) [10, 11].  This discrimination is possible because the modified form 
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of the protein will have a different mass than the original form, and both can be 
visualized with the same instrument.  Unfortunately, this method was deemed infeasible 
due to a lack of an available MS and the expertise to perform such measurements.   
A more tractable alternative was the use of an enzyme-linked immunoassay 
(ELISA), since antibodies specific for phosphorylated forms of many proteins are readily 
available.  In the case of Erk1/2 isoforms, monoclonal antibodies specific for the different 
monophosphorylated and the nonphosphorylated forms have also been developed and are 
commercially available from Sigma [12].   Erk itself can be purchased readily in purified 
form from various sources, facilitating development of the reaction system. This helps to 
make Erk a good choice as the substrate for the reaction system.   
The reactions involved in modification of Erk are shown in Figure 4.2.  Erk is 
phosphorylated on two residues (Thr185 and Tyr187 for human Erk2) specifically by 
Mek1/2 isoforms in a distributed, nonprocessive manner [6, 13, 14].  The tyrosine residue 
is phosphorylated first in most cases, although threonine-monophosphorylated Erk has 
been observed during in vitro activation experiments.  Mek is itself activated by 
phosphorylation on two serine residues (Ser218 and Ser222 in human Mek1), and can be 
constitutively activated by site-directed mutagenesis of these residues to aspartate or 
glutamate [15-19].  Several different phosphatases have been shown to act upon 
phosphorylated Erk, in particular the dual-specificity phosphatase MKP-3, the tyrosine 
phosphatase HePTP, and the serine/threonine phosphatase PP2A [20-25].  Since MKP-3 
and HePTP are relatively difficult to obtain, the alternate tyrosine phosphatase PTP1B 
was used together with PP2A to regulate Erk phosphorylation, as illustrated in Figure 4.2. 
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Figure 4.2. Erk covalent modification cycles under action of Mek, PTP1B and PP2A.   
4.2. Development and Operation 
4.2.1. Materials and Methods 
Reagents were obtained at the highest grade available from Sigma-Aldrich (St. 
Louis, MO) unless described otherwise.  ATP and the Mek inhibitor U0126 were 
purchased from Cell Signaling Technologies (CST, Beverly, MA).  Luria-Bertani broth 
(LB) was obtained from Becton-Dickinson (Sparks, MD).  SuperSignal Pico 
chemiluminescent detection reagent, Micro BCA and Coomassie Plus protein assay kits, 
ImmunoPure Normal Rabbit and Goat serum, Reacti-Bind Protein A, Protein G, and Goat 
anti-Rabbit antibody coated plates were purchased from Pierce (Rockford, IL).  Ni2+-
NTA agarose was obtained from Qiagen (Valencia, CA).  Assay kits for 
Serine/Threonine and Tyrosine phosphatases were purchased from Promega (Madison, 
WI).  Immulon 4HBX high-binding plates were obtained from ThermoLabsystems 
(Franklin, MA).  Costar round-bottom, nonbinding and flat-bottom, high-binding plates 
were obtained from Corning Life Sciences (Acton, MA).  Nunc-Immuno MaxiSorp 
protein binding plates were purchased from Nalge Nunc International (Rochester, NY). 
Monoclonal antibodies against specific Erk phosphorylation forms (aDP: 
#M8159, aTP: #M3557, aYP: #M3682, aNP: #M3807) were obtained from Sigma.  A 
monoclonal antibody that cross-reacts with all Erk forms (#9107) and a polyclonal anti-
Mek antibody (#9122) were obtained from CST.  Antibodies against PP2A (#05-421) and 
PTP1B (#07-088) were obtained from Upstate Biotechnology (Lake Placid, NY).  Goat 
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polyclonal anti-mouse and anti-rabbit antibodies conjugated with horseradish peroxidase 
were obtained from Pierce.  
Purified kinase-deficient mouse Erk2 (hereafter designated as Erk) was obtained 
from CST.  Purified, partially phosphorylated “active” mouse Erk2 (#14-173, ErkPP) was 
obtained from Upstate and used as a control and in generation of standards for ELISAs.  
Active human Mek1 (#14-429, designated US-Mek) was also purchased from Upstate as 
a positive control for Mek purification and activity studies.  Human PTP1B produced in 
E. coli and partially purified was obtained from Calbiochem (La Jolla, CA).  PP2A 
purified from human erythrocytes was purchased from Promega. 
A sample of E. coli transfected with a plasmid encoding a constitutively active 
form of human Mek1 (hereafter designated N4-Mek) was a generous gift from Natalie 
Ahn, UC Boulder.  This gene product contains a 5kDa addition at the N-terminus 
including a 6-His sequence useful for purification, deletion of residues 44-51 of the 
original sequence, and two point mutations (S218E and S222D) that induce activation 
[16].  This strain was successfully grown, enzyme produced and partially purified in a 
manner similar to previously described procedures [26].   Briefly, bacteria were grown at 
30°C in two 500 mL batches in LB containing 50 µg/mL ampicillin and 34 µg/mL 
chloramphenicol until an OD600 of 0.6 was reached. Protein production was induced by 
addition of IPTG to a final concentration of 100 µM.  After 6 hours of growth and protein 
production, the cells were spun down (2,500g, 25 minutes, 4°C).  The cells were 
resuspended by gentle vortexing in 20 mL water, spun down again and frozen at –80°C.  
Cells were thawed, resuspended in extraction buffer (EB, see Table 4.1 for composition 
of buffers) and lysed with two cycles of a French press.  Lysates were cleared by 
centrifugation (15,000g, 30 minutes, 4°C) and adjusted to 1% Tween-20 and 1 M KCl. 
Ni2+-NTA-agarose was added and the mixture rotated end-over-end for 2 hr at 4°C.  The 
resin was loaded into a Poly-Prep gravity-flow column (Bio-Rad, Hercules, CA) and 
washed with two column volumes of wash buffer (WB).  Bound protein was eluted with 
elution buffer (WB containing 250 mM imidazole) and aliquots stored frozen at –80°C.  
Final purity was estimated at approximately 50% as judged by SDS-PAGE stained with 
Coomassie blue.  
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ELISAs were performed by first adsorbing protein samples to Costar high-binding 
plates in 50 mM carbonate buffer, pH 9.6, overnight at 4°C.  Plates were blocked with 
1% BSA in PBS for 2 hours at 25°C and washed once with PBST (PBS with 0.5% 
Tween-20).  Primary antibodies were added at approximately 1:1000 dilution in PBST 
containing 1% BSA, incubated for 4 hours, and washed three times with PBST.  
Secondary antibodies were added to 1:2000 dilution in PBST with 1% BSA for 2 hours, 
the plates were washed three times with PBST, and chemiluminescent reagent was added 
for 1 minute. Luminescence was read using a Fusion plate reader (Packard Instruments, 
Meriden, CT). 
Table 4.1. Buffers used in experimental studies (final values). 
Name Composition 
Extraction Buffer 
(EB) 
50 mM sodium phosphate, pH 8.0, 10% glycerol, 1 mM DTT, 0.25% Tween-20, 
1mM PMSF, 1 µg/mL pepstatin A, 2.5 µg/mL leupeptin, and 1 µg/mL aprotinin 
Wash Buffer (WB) 50 mM Tris, pH 8.0, 10% glycerol, 0.01% Triton X-100, 1 mM DTT, 20 mM 
imidazole, 300 mM NaCl 
Reaction Buffer (RB) 25 mM Tris, pH 7.5, 2 mM DTT, 15 mM MgCl2, 200 µM ATP 
RIPA buffer 50 mM Tris, pH 7.5, 150 mM NaCl, 0.1 mM EGTA, 0.1 mM EDTA, 0.1% β-
mercaptoethanol 
PP2A buffer 50 mM imidazole, pH 7.3, 0.2 mM EGTA, 0.1% BSA, 0.1% β-mercaptoethanol 
 
4.2.2. Reaction operating conditions 
Enzymes were tested first in liquid-phase reactions (in microtubes or non-binding 
plates) to verify individual activities and select reaction conditions.  Many previous 
experiments have been performed with Mek, PTP1B, or PP2A as enzymes and Erk as the 
substrate, in a variety of different buffers, but never with all components together in one 
single reaction [6, 7, 13, 14, 19, 21, 24, 27-30].  Almost all contained a buffer base and 
reducing agent (DTT or β-mercaptoethanol), but other additions varied with application.  
For example, in many cases phosphatase reactions are performed in the presence of 
EDTA, while kinase reactions necessarily included a source of Mg2+, ATP and on 
occasion, phosphatase inhibitors.  Very few trials have been performed previously with 
kinase, phosphatase and substrate all together, in these cases, turnover of ATP was 
enabled by further addition of phosphocreatine and creatine phosphokinase [31-34].  
Therefore one key step in system development was selection of buffer conditions that 
would promote activity of all enzymes together. 
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Initial trials for Erk phosphorylation using N4-Mek purchased from Sigma in a 
simple reaction buffer (50 mM Tris, pH 7.5, 1 mM DTT, 50 mM NaCl, 10 mM MgCl2, 
500 µM ATP) yielded extremely poor results, apparently due to lack of sufficient 
enzyme.  Other trials using activated native human Mek1 purchased from Upstate 
Biotechnology (US-Mek) under similar buffer conditions were much more successful.  
Unfortunately this enzyme could not be used for later experiments, since it would be 
inactivated by the phosphatases, so was useful only as a positive control.  Using E. coli to 
produce N4-Mek, it was possible to obtain sufficient constitutively active enzyme to 
continue further trials. 
Sample results using the partially purified N4-Mek are shown in Figure 4.3A.  In 
this early experiment, the N4-Mek was eluted in extraction buffer (EB) containing 250 
mM imidazole.  Interestingly, less activity is seen when more enzyme is used (N4/EB5 
contains 5 µL, N4/EB10 contains 10 µL).  These puzzling results appeared to be partially 
explained by interference of the phosphate contained in the extraction buffer, since 
simple addition of extra EB to the reaction also reduced Mek activity (N4/EB5+5).  
Dialysis of the enzyme into wash buffer (WB), which is based on Tris, showed improved 
activity (N4/WB).  This improvement was increased further by directly eluting into WB, 
thereby avoiding loss of sample during the extra dialysis step.  Activity of US-Mek was 
also poor in EB, better in WB, and better still in reaction buffer (RB: 50 mM Tris, pH 
7.5, 1 mM DTT, 15 mM MgCl2, 100 µM ATP).  It may be that the either salt or 
detergent, present in the wash buffer but not reaction buffer, inhibits kinase activity by 
discouraging protein-protein interactions.   
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Figure 4.3. Sample results for in vitro reactions using Erk as a substrate.  A) Phosphorylation by N4-Mek 
(5-10µL) or US-Mek (2µL) in different buffers (see text for composition).  For N4-Mek in EB, numbers 
signify µL Mek added (5+5 is 5µL N4-Mek+5µL EB).  B) ErkPP dephosphorylation by 1µL phosphatases 
in RB with or without addition of inhibitors. OA: 100 nM Okadaic Acid, NaVO4: 1 mM sodium vanadate. 
As shown in Figure 4.3B, both PTP1B and PP2A also showed activity towards 
Erk in RB, that could be disrupted using specific inhibitors such okadaic acid (for PP2A) 
or sodium vanadate (for PTP1B).  Addition of up to 150 mM NaCl, 0.05% Tween-20, 1 
mM EGTA or 1 mg/mL BSA to base RB had little effect on phosphatase activity towards 
phosphorylated peptide substrates (data not shown).  Therefore, no further modifications 
were made to the reaction buffer composition, although concentrations of some 
components were later increased to yield final values of 25 mM Tris, 2 mM DTT, 15 mM 
MgCl2, and 200 µM ATP.   
With each of the enzymes working well in isolation, the next step was to combine 
them together to form a complete system.  A time course for Erk phosphorylation at 30°C 
with 0.1 µL of each enzyme is shown in Figure 4.4A.  The system appears to stabilize 
within one hour using these conditions, with the Erk distribution unchanging for three 
additional hours.  Formation of tyrosine-monophosphorylated Erk (YP-Erk) peaks within 
5 minutes, while subsequent phosphorylation to yield diphosphorylated Erk (DP-Erk) 
lags behind.  Consistent with previously published reports, little threonine-
monophosphorylated Erk (TP-Erk) is observed [6, 14].  In fact, the TP-Erk shown in 
Figure 4.4 may actually be an artifact of cross-reactivity of the aTP antibody with 
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nonphosphorylated Erk (NP-Erk), since the signal decreases initially.  Estimation of each 
Erk form was accomplished under the assumption of no cross-reactivity of the antibodies, 
which is unlikely to be valid.  Nevertheless, each antibody is reported to have preference 
for the specific Erk form against which it was raised, and so the trends shown in Figure 
4.4 should still reflect the actual system [12].  A more detailed discussion of antibody 
cross-reactivity, and a model used to account for this effect, is described in Section 4.3. 
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Figure 4.4. Phosphorylation of Erk in presence of N4-Mek, PTP1B, and PP2A.  A) Dynamic time course 
of Erk phosphorylation using 0.1 µL of each enzyme. B) Distribution of Erk forms after reaction for 2 hr.   
According to Figure 4.4A, two hours reaction should be sufficient to reach steady 
state.  Variation of the total amount of N4-Mek, keeping the phosphatase concentrations 
constant at 0.1 µL stock in 50 µL reaction, yielded the activation profiles shown in Figure 
4.4B.  Again, the primary intermediate observed was YP-Erk, with little if any TP-Erk 
being formed.  Further addition of N4-Mek beyond 0.5 µL did little to change the Erk 
distribution, perhaps because of competition for the substrate, product inhibition, or 
interference from washing buffer used to store the enzyme.  Several groups have noted an 
inability to completely phosphorylate Erk to DP-Erk during in vitro reactions with Mek, 
in the absence of phosphatases [6, 13, 35].   The activation profiles shown above are 
consistent with these previous reports, which suggested substrate competition as the most 
likely source of the deficiency.  In any case, the three enzymes appear to work well in 
concert, and what remained was to obtain a similar activation profile using immobilized 
enzymes. 
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4.2.3. Enzyme immobilization 
As described in Section 4.1, a key component of the experimental design involves 
immobilization of the enzymes, to facilitate separation of free substrate from enzyme-
substrate complexes.  Ideally, as few distinct handling steps and reagents would be 
involved in the immobilization procedure, since a variety of washes and reactive agents 
could lead to enzyme inactivation.  Immobilization by chemical means, while certainly 
the most common method, did not appear suitable for this system, since each enzyme 
contains a different reactive center.  A lysine residue is critical for kinase activity in Mek, 
while tyrosine phosphatases such as PTP1B depend upon a cysteine, and PP2A may 
utilize a key histidine for phosphate removal [36-38].  Reagents therefore reactive against 
amine or sulfhydryl groups could potentially inactivate one or more of the enzymes.   
Two other options for straightforward immobilization were either direct adsorption onto a 
protein-binding surface or capture by antibodies (immunocapture). 
Initial experiments were performed by directly adsorbing enzymes onto treated 
polystyrene plates (Nunc MaxiSorp), as this would be the simplest procedure.  As shown 
in Figure 4.5A, N4-Mek appeared robust to adsorption, since activity was only slightly 
decreased during immobilization.  Elevated concentrations of N4-Mek actually decreased 
the activity towards Erk, as described above, even when the enzyme was immobilized.  It 
may be that the washing buffer (WB, as above) composition inhibited adsorption to 
polystyrene. The plates were washed with PBST before reactions were performed, so any 
interference of the buffer, potentially the cause of decrease in the liquid-phase reactions, 
would not occur for immobilized enzyme.   
Unfortunately, both phosphatases showed low activity following adsorption, as 
shown in Figure 4.5B.  In fact, most of the depletion of ErkPP was due to nonspecific 
adsorption to the plate, as evidenced by a decrease of substrate in the absence of enzyme.  
This nonspecific adsorption was virtually eliminated by optimization of blocking 
conditions, including decreasing the concentration of BSA in the blocking buffer from 
5% to 1% and by using the smaller casein (approximately 24 kDa) rather than BSA (67 
kDa).  However, the phosphatases remained inactive regardless of adsorption buffer 
composition, pH, or time (data not shown).  It may be that the surface chemistry, which 
was designed for tight capture of proteins, was overly strong for enzyme adsorption.  The 
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phosphatases may therefore have unfolded and spread out upon the surface, disrupting 
the structure around the catalytic sites and inactivating the enzyme.   As repeated trials 
failed to exhibit enzymatic activity, it appeared best to switch to immunocapture for 
enzyme immobilization. 
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Figure 4.5. Enzymatic activities following direct adsorption to polystyrene.  A) Phosphorylation of Erk 
using N4-Mek. B) Dephosphorylation of ErkPP using PTP1B (closed symbols) or PP2A (open symbols).  
Diamonds represent immobilized reaction conditions, while squares represent data taken for liquid-phase 
reactions. 
Studies using capture antibodies showed improved results, although activity was 
low when compared against liquid-phase reactions.  Antibodies against each enzyme 
were either captured themselves using plates precoated with Protein A, Protein G, or goat 
anti-rabbit antibodies or adsorbed directly onto polystyrene plates.  The use of antibody-
binding surfaces such as Protein G was attempted to increase the efficiency of enzyme 
capture by ensuring that epitope-binding regions of the antibodies would be presented 
towards the enzymes.  N4-Mek immobilized to pretreated plates showed excellent 
activity (Figure 4.6A), as did PTP1B when using a phosphotyrosine-containing peptide as 
test substrate (Figure 4.6C).  However, neither phosphatase was active towards Erk; 
instead, any ErkPP depletion was due to nonspecific adsorption (Figure 4.6E), even 
though the plates are already blocked. Addition of an extra blocking step inhibited Erk 
adsorption (Figure 4.6F).  However, the phosphatases were still inactive towards ErkPP, 
and activity towards peptide substrates was diminished (Figure 4.6D).  Mek activity was 
also decreased slightly after blocking (Figure 4.6B). 
 110
Phosphatase Activity: ErkPP
0
10
20
30
40
50
0 0.1 0.2 0.3 0.4 0.5 0.6
uL enzyme/50 uL 
Phosphatase Activity: ErkPP
0
20
40
60
80
0 0.2 0.4 0.6 0.8 1 1.2
uL enzyme/50uL
0
0.5
1
1.5
2
0 0.1 0.2 0.3 0.4 0.5 0.6
uL enzyme/50 uL
0
0.5
1
1.5
0 0.2 0.4 0.6 0.8 1 1.2
uL enzyme/50 uL
N4-Mek Activity
0
10
20
30
40
50
0 1 2 3 4 5 6
uL N4-Mek/50uL 
N4-Mek Activity
0
20
40
60
80
100
0 1 2 3 4 5 6
uL N4-Mek/50 uL 
A. B.
C. D.
E. F.
Before Blocking After Blocking
aD
P 
Lu
m
in
es
ce
nc
e 
(1
0-
3
RL
U)
Ab
so
rb
an
ce
 a
t 6
00
nm
aD
P 
Lu
m
in
es
ce
nc
e 
(1
0-
3
RL
U)
im
liq
Phosphatase Activity: Peptide Phosphatase Activity: Peptide
im 1B
liq 1B
im 2A
liq 2A
im 1B
liq 1B
im 2A
liq 2A
aD
P 
Lu
m
in
es
ce
nc
e 
(1
0-
3
RL
U)
Ab
so
rb
an
ce
 a
t 6
00
nm
aD
P 
Lu
m
in
es
ce
nc
e 
(1
0-
3
RL
U)
 
Figure 4.6. Enzymatic activities following immobilization on Protein G-coated plates using capture 
antibodies without (A, C, E) or with (B, D, F) an extra blocking step.  A and B) Phosphorylation of Erk by 
N4-Mek.  C and D) Dephosphorylation of phosphotyrosine- (PTP1B) or phosphoserine-containing (PP2A) 
peptides.  E and F) Dephosphorylation of ErkPP by phosphatases.  
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A benefit of antibody-binding plates should be the ability to orient antibodies such 
as to utilize completely their capture potential.  The Protein G or similar molecules would 
potentially reduce any steric hindrance from the blocking proteins by providing extra 
space between the surface and the epitope-binding regions of the antibody.   However, it 
may be that these antibody-binding molecules were showing undesired cross-reactivity 
with ErkPP.  The additional blocking step, which inhibited Erk adsorption but also any 
enzymatic activity, essentially nullified the benefit of using pretreated plates.   
Therefore, the antibodies were next directly adsorbed onto polystyrene plates with 
various degrees of hydrophobicity (ThermoLabsystems Immulon 1B, 2HB, 4HBX, EB, 
and UB).  As PP2A was generally the least active of the three enzymes following 
immobilization, the high-binding 4HBX plates, which yielded the highest activity of 
PP2A, were selected for all further work.  Of course, in this case a blocking step was 
essential following antibody coating, and was optimized both for inhibition of Erk 
adsorption and promotion of enzyme binding.  The coating, blocking, binding, and 
washing conditions tested during optimization are summarized in Table 4.2 below. 
As shown in Figure 4.7, each enzyme was immobilized with low but observable 
activity.  In particular, the phosphatases were indeed active towards ErkPP. (No ErkPP 
was added to wells for without immobilized enzyme.)  In all cases, it appeared that 
immobilized enzyme activity was approximately 5-10% of that for corresponding 
concentrations in liquid-phase reactions.  Increasing the amount of enzyme added to the 
wells during capture yielded higher immobilized activity, but only up to a saturation point 
beyond which no further improvement was seen, as evidenced for PP2A in Figure 4.7C.  
The supernatant liquid following enzyme binding contained almost all the activity added 
to the wells (compare triangles and squares in Figure 4.7D).  This seems to suggest that 
the low activity of immobilized enzymes was due simply to poor efficiency during 
binding, and that what little enzyme was bound was active.  Changing the antibody 
concentration, buffer composition, wash stringency, or binding incubation time did little 
to increase the capture efficiency.  Therefore, the conditions that yielded the highest 
activity possible for all enzymes were utilized for final studies of Erk activation, and are 
listed in Table 4.2.  All steps were performed at 4°C except for reactions, run at 30°C.  
Plates were washed once before and after enzyme binding. 
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Figure 4.7. Enzymatic activities following immobilization using capture antibodies directly adsorbed to 
plates.  A) Phosphorylation of Erk by N4-Mek.  B) Dephosphorylation of ErkPP by phosphatases.  C) 
Saturation of immobilization of PP2A.  D) Phosphate release from phosphopeptides. Diamonds: 
immobilized enzymes, Squares: liquid-phase reactions, Triangles: enzymes remaining in supernatant liquid 
following immobilization. 
Table 4.2. Conditions tested during optimization of enzyme immobilization, and details of final procedure.  
Parameter Variations Tested Final 
Plate Immulon 1B, 2HB, 4HBX, EB, UB 4HBX 
Coating: 
Antibody conc.  
Coating buffer 
 
1, 2, 5, 10, 20, 50 µg/mL 
TBS, TBST, PBS or carbonate buffer, pH 5.0, 7.4, 9.0 
 
2 µg/mL 
PBS, pH 9.0 
Blocking: 
Agent 
Concentration 
Buffer 
 
BSA, casein, bovine, goat, or rabbit sera 
1%, 2.5%, 5% 
PBS, TBS, TBST, RB, pH 7.4 or 9.0 
 
casein 
1% 
PBS, pH 9.0 
Enzyme binding: 
Incubation time 
Buffer 
 
4 hr or overnight (~14 hr) 
TBS, RB, RIPA, PP2A 
 
Overnight 
RIPA 
Washing buffer TBS, TBST, RB, RIPA, PP2A PP2A 
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4.3. Model for Interpreting ELISA Data 
 4.3.1. Motivation and concepts 
The set of monoclonal antibodies available from Sigma (designated aDP, aTP, 
aYP, aNP) was selected for use in quantitation of Erk in its various forms by ELISA.  
Unfortunately, this quantitation was complicated by cross-reactivity of the antibodies.   
The antibody raised against TP-Erk (aTP) also recognizes NP-Erk, as shown in Figure 
4.8A.   Additionally, aNP showed significant reactivity with TP-Erk and YP-Erk as well 
as NP-Erk (as reported by Sigma). The remaining antibodies almost complete selectivity 
for their intended targets.  Nevertheless, the failure of a simple one-to-one 
correspondence required a deconvolution procedure to translate ELISA data (in relative 
luminescence units, or RLU) into amounts of each form.  Furthermore, like many 
experimental methods ELISA rarely shows a purely linear response to the amount of 
sample, but may exhibit regions of linear behavior as seen in Figure 4.8B.  This 
nonlinearity arises from the numerous steps involved in ELISAs: equilibrium binding of 
sample to a solid substrate, primary antibody to sample, secondary antibody to primary 
antibody, and reaction of a luminescent substrate with secondary antibody-conjugated 
enzyme.  Each of these binding steps may saturate, leading to an overall saturation point 
of the assay, while sensitivity issues may induce curvature at low sample concentrations.   
A. B.
a-DP
a-TP
a-YP
DPYPTPNP
a
b baxmˆ +=
linear region
Erk peptides conjugated to BSA:
 
Figure 4.8. Expectations for ELISA results with potential issues. A) Cross-reactivity of anti-Erk antibodies 
(taken from Yao et al [12]), B) Sigmoidal overall response containing an intermediate linear region. 
For the sake of simplicity, we may focus our attention upon the linear response of 
the assay, with the realization that later this may introduce error if we attempt to 
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extrapolate beyond this region.  If we further assume that the cross-reactivity can be 
modeled as a simple additive effect of each species, then the following model for the 
measurements can be generated: 
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In Equation 4.1, the vector x contains amounts of each Erk species (DP-Erk, TP-
Erk, YP-Erk, and NP-Erk).  The model parameters a11-a44 reflect the affinities of each 
antibody for each substrate.  Note that the intercepts b1-b4 will likely be less than zero, so 
do not represent a physical characteristic of the system such as background signal alone.  
These parameter values may vary from one experiment to another, since they would 
depend upon the concentrations and activities of the antibodies and detection reagent. 
Within one experiment, however, once the parameters are known this same model can be 
used as a set of calibration curves to estimate the composition in other samples from a 
known set of measurements m, by solving for a now unknown .   xˆ
Unfortunately, pure samples of DP-, TP-, YP-, and NP-Erk were not 
commercially available, nor could they be readily prepared, making parameter estimation 
and model verification more difficult.  Upstate Biotechnology sells “active” Erk, which is 
phorphorylated and purified by a proprietary method.  It is almost certainly not 100% 
DP-Erk, and likely contains some monophosphorylated (YP and/or TP) as well as NP.  
We can assume that it contains some unknown composition d, t, and y representing the 
fraction of DP-, TP-, and YP-Erk, respectively.  (The fraction of NP-Erk would 
necessarily equal 1-d-t-y). By reacting the “active” Erk with PTP1B, PP2A, or both the 
distribution between Erk forms changes as follows, assuming complete reaction: 
    DP TP YP NP  
 Original ErkPP (“D”): fD =  [ d t y 1-d-t-y ]T 
 Add PTP1B (“T”): fT =  [ 0 d+t 0 1-d-t ]T (4.2) 
 Add PP2A (“Y”): fY =  [ 0 0 d+y 1-d-y ]T  
 Add both (“N”): fN =  [ 0 0 0 1 ]T 
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ELISAs performed on the ErkPP in its original state and after reaction with the 
phosphatases should yield different results, since although the total amount of Erk 
remains the same, the amount of each form will change, as indicated in Equation 4.2.  
Combining the model for ELISAs with the fractional distributions gives a set of 
equations for the expected data: 
 aDPD = a11·d·xT + b1 (4.3) 
 aTPD = [a22·t + a24·(1-d-t-y)]·xT + b2 (4.4) 
 aYPD = a33·y·xT + b3 (4.5) 
 aNPD = [a42·t + a43·y + a44·(1-d-t-y)]·xT + b4 (4.6) 
 aDPT = b1 (4.7) 
 aTPT = [a22·(d+t) + a24·(1-d-t)]·xT + b2 (4.8) 
 aYPT = b3 (4.9) 
 aNPT = [a42·(d+t) + a44·(1-d-t)]·xT + b4 (4.10) 
 aDPY = b1 (4.11) 
 aTPY = a24·(1-d-y)·xT + b2 (4.12) 
 aYPY = a33·(d+y)·xT + b3 (4.13) 
 aNPY = [a43·(d+y) + a44·(1-d-y)]·xT + b4 (4.14) 
 aDPN = b1 (4.15) 
 aTPN = a24·xT + b2 (4.16) 
 aYPN = b3 (4.17) 
 aNPN = a44·xT + b4 (4.18) 
This system contains 16 equations in 14 unknowns: the ELISA parameters a11-a44, 
b1-b4 as well as the composition d, t, and y.   Further, the system can be written for each 
of a set of values for total Erk xT.  The samples of original Erk (D) and following reaction 
with phosphatases were diluted to yield a total of 25, 20, 15, 10, 5, 2.5, 1, or 0 ng total 
Erk in each ELISA measurement.  The constrained optimization function (“constr”) of 
MATLAB was then used to find the values for the 14 unknowns that minimize the least-
squared error between model and measured values for each antibody.  This can be written 
as the solution of the following optimization problem: 
 
( )∑∑ σ−= i
2
j
2
j,i
]y,t,d,b,A[
ˆ ji,ji,
p
mm
min  (4.19) 
subject to: d + t + y ≤ 1, a22 ≥ a24 , a44 ≥ a43  , a44 ≥ a42, 
and   (Eq. 4.3-4.18 above)  bxAfm jT,iji, +=ˆ
where 
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i  represents the sample i , }N,Y,T,D{∈
j designates the particular total amount of Erk xT,j, 
mi,j  is the set of ELISA measurements (aDP, aTP, aYP, aNP) observed for sample i at 
total Erk xT,j, and 
2
j,iσ  is the variance for the measurements mi,j (not necessarily constant across j). 
One way to help understand the regression procedure is to consider the ELISA 
model as occurring in two interrelated stages.  First, the compositional parameters d, t, 
and y are selected so as to create the fractional distribution for each Erk species as shown 
in Equation 4.2.  This step acts to rescale the data, written in terms of total Erk xT, into 
amounts of each form DP, TP, YP and NP in the sample.  If appropriate parameters are 
selected, then data for each antibody using all samples should compress together to form 
a single curve, representing the “real” response towards the Erk form found in all 
samples.  A best-fit line passing through all the compressed data points gives the 
parameters a and b, as in Equation 4.1.  These two steps must be performed together, 
since the scaling by composition can only be considered “appropriate” if they are able to 
yield a reasonable linear fit during the second stage. 
As an example, consider the response of the antibody aYP, which is assumed to 
be selective for YP-Erk.  Sample data for different Erk samples using aYP is shown in 
Figure 4.9A.  As expected from Equation 4.2, samples “D” (blue circles) and “Y” (orange 
triangles) contain YP-Erk, but at different amounts, so data shown in terms of total Erk 
appear as two curves.  By selecting appropriate values for d and y, the two data sets can 
be collapsed together, as shown in Figure 4.9B.  The best-fit line through the data (Figure 
4.9C) then yields values for a33 and b3, which can be used later to estimate YP-Erk in an 
unknown sample.  Note that different values for d and y would not consolidate the data in 
the same way, and the best-fit line would show significantly more scatter than is observed 
in Figure 4.9B-C.  The regression model can also be drawn using Equations 4.3-4.18 (i.e. 
with unscaled data), to compare the fits for individual samples, as shown in Figure 4.9D. 
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Figure 4.9. ELISA data modeling and regression as two steps: first, rescaling of data using composition 
parameters, second, linear fit of resulting rescaled data.  Circles: “D” (original ErkPP), squares: “T” (ErkPP 
+ PTP1B), diamonds: “Y” (ErkPP + PP2A), triangles: “N” (ErkPP + both phosphatases).   
Also visible in the figure is curvature for low sample amounts, as described 
previously and shown schematically in Figure 4.8B.  Above 1.5ng YP-Erk, the aYP 
antibody yields a linear response with increasing Erk, but below this value the signal-
response curve is shallow.  This helps to justify omission of particular data points as 
being outside the linear range and to provide an estimate for the lower limit of detection 
for the assay.  When the model parameters are later used to invert a set of measurements 
to estimate the composition of an unknown sample, calculated values of YP-Erk below 
1.5 ng should not be attributed much confidence. 
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An example set of results for ELISA measurements and regression for standards 
samples is shown in Figure 4.10-4.11.  In Figure 4.10, the data is plotted using total Erk 
concentrations, whereas in Figure 4.11 the amounts are scaled for particular Erk forms as 
in Figure 4.9.  Open symbols represent the observed values, while solid lines show best-
fit model estimates following constrained optimization.  This includes the effects of 
compositional parameters d, t, and y, so the lines are realizations of Equations 4.3-4.18.  
In most cases model predictions show excellent agreement with measured values. 
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Figure 4.10. Sample results from ELISA standards regression.  Symbols as in Figure 4.9.  Solid lines 
represent model predictions using best-fit parameters.   
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Figure 4.11. Collection of data points from different samples and best-fit regression results.  Data is the 
same as used in generation of Figure 4.10, with xT rescaled using model parameters.     
The ability to analyze standards, even with unknown initial sample composition, 
is not the ultimate goal of the ELISA model.  Instead, the regression procedure is 
necessary to separate the parameters A and b, which correspond to the response of the 
ELISA measurements to a particular sample, from the standards composition, defined by 
parameters d, t, and y.  With the response parameters A and b known, the same model of 
Equation 4.1 may be used with ELISA measurements for a new test sample to estimate 
the Erk composition.    
In this case, for each sample the model yields a linear system of four equations in 
four unknowns  = [DP TP YP NP]xˆ T.  There is one constraint that prevents simply 
inverting Equation 4.1 and choosing , namely that the unknowns must all 
be greater than zero to be physically reasonable.  Therefore, analysis of data samples is 
accomplished using the MATLAB function “nnls”, to solve the optimization problem: 
b)(mAx 1 −= −ˆ
 120
 2
x
b)(mAx −−min  (4.20) 
subject to  ≥ 0. xˆ
It is extremely important to be able to estimate the expected error in the model 
predictions for , in particular because these estimates will be used later in calculation of 
activation ratios.  Samples that upon analysis yield concentrations of Erk forms with high 
relative error should necessarily be considered suspect, as they may distort the shape of 
activation ratio plots.   With an estimate for a reasonable confidence interval for the 
calculated Erk composition, particular trouble points may be identified and discarded if 
necessary.  This estimation procedure is descried in Section 4.3.3. 
xˆ
4.3.2. Selection of data  
In practice, there was a (small) positive slope seen in the data for aDP for samples 
T, Y and N, and aYP for T and N, as seen in Figures 4.9-4.11.  This arose even in 
samples reacted with phosphatases for eight hours at 30°C.  Either the reactions failed to 
reach completion, or there existed some nonspecific binding or low cross-reactivity of the 
antibodies for other Erk forms not incorporated into the model given in Equation 4.1.  For 
the sake of simplicity it appeared easier to ignore this discrepancy, and admit some likely 
error in the parameter estimates.  Therefore the optimization was performed neglecting 
this data, i.e. omitting the measurements and expressions 4.7, 4.9, 4.11, 4.15 and 4.17 
above.  This left at best 11 equations * 8 samples = 88 expressions for 14 unknowns.   
In fact, not all measurement points were used, since some appeared to fall outside 
the linear range for a particular antibody, as shown in Figure 4.9B.  Generally this linear 
range was determined visually, but as a matter of course any signal less than 2000 RLU 
was discarded.  This was justified by observations that often the standard deviation of 
ELISA measurements was greater than 10% of the mean value for signals less than 2000 
RLU, as shown in Figure 4.12.  In some cases, measurements above 45,000 RLU 
appeared to be saturating the detector or assay reagents and were again ignored.   
Typically, this process excluded one-third of the data points, often in the low signal range 
(for no or low values of total Erk).  In any case more than 30 data points remained, 
leaving more than enough redundancy to solve the system for the unknown parameters.  
The omission of data points from consideration in the objective function (Equation 4.19) 
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was achieved by setting the variance σ equal to infinity, or equivalently, its reciprocal 
equal to zero.  The variance was observed experimentally to increase with the magnitude 
of the measurement signal, but decrease as a proportion of the signal.  To avoid bias 
towards samples with lower absolute variance (and lower signal), the standard deviation 
was set equal for all remaining points at a value of 2200 RLU.  This was the largest value 
observed during repeated trials with aNP on different samples, used in generation of 
Figure 4.12.   
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Figure 4.12. Sample ELISA data, showing dependence of experimental variance on absolute signal.  
Diamonds: average signal (triplicate measurements).  Squares: ratio of standard deviation to average value 
at each point. 
Another justification for excluding particular data points arises through 
consistency analysis for gross errors in measurements, when redundant measurements are 
available [39, 40].  The objective function in Equation 4.19, representing the total 
weighted least-squares error at the optimum solution, is also known as the consistency 
index, h.  Since the consistency index takes the form of a sum of squared values of 
random variables (the measured ELISA signals m), it is expected to follow a χ2-
distribution with the same number of degrees of freedom, f, as redundant measurements 
(in this case, total number of data points remaining, n, minus 14 parameters, p).  At a 
specified probability α, if h ≥ χ21-α(f) then it is likely that there are gross errors in the 
measurements, since the variance from the model cannot be explained by variance in the 
measurements alone.    Individual measurement points may therefore be removed if their 
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individual contribution, hi, to the consistency index is significantly large.  Of course, 
following removal of one measurement point, the regression needs to be redone to 
determine new best-fit model parameters, and a new consistency index calculated.  This 
process is repeated until the consistency index is less than the χ2-value for the degrees of 
freedom remaining.  For example, during regression for the data shown in Figures 4.10-
4.11, 38 data points were omitted, leaving 50 points (n) and therefore 36 degrees of 
freedom (f).  The consistency index following regression was 45.7, less than 
χ2(0.9,36)=47.2, so it is unlikely that the remaining set contains gross inconsistencies.  
Thus the linear model, accounting for measurement error, does have sufficient support to 
be considered statistically reasonable.   
4.3.2. Error analysis and model validation 
The calculation of an Erk composition using the ELISA model, through solution 
of the optimization problem in Equation 4.20, is an example of inverse regression.  In 
other words, an initial set of known composition x was used to generate model estimates 
, and so the model involves regression of m onto x.  In Equation 4.20 the opposite is 
occurring, and x is being regressed onto a known measurement m.  For a simple one-to-
one linear model between m and x (m = ax + b), the confidence intervals for inverse 
regression are relatively straightforward to determine [41].  Essentially, the model is 
solved to estimate some  at a known m
mˆ
0xˆ 0.  The confidence intervals for  are 
determined by solution at the bounds of the confidence interval for m
0xˆ
0, which is obtained 
from estimates in the error in the parameters a and b. 
For the current arrangement, however, error analysis is complicated by the 
constraints provided in the inverse regression (Equation 4.20) as well as the inherent 
nonlinearity in the original regression, caused by cross-multiplication of parameters 
(Equation 4.19).  For such a problem, no simple closed-form relationship exists between 
the standard error in the parameters, se(p), and the confidence band for x .  Therefore one 
way to estimate a reasonable range for x  is to obtain a confidence interval for the 
parameters p, then solve Equation 4.20 at the bounds of the parameter values.  What 
remains is an estimation of se(p) for the nonlinear regression problem, by combining a 
sensitivity analysis of the model with an estimate for the data variance σ
ˆ
ˆ
2. 
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The optimization function in Equation 4.19 is the weighted sum-of-squares error 
S(p), which can also be written as a matrix product: 
 
( ) ( ) ( mmVmmmmp ji,ji, −−=σ
−= −∑∑ ˆˆˆ)(S 1T
i
2
j
2
j,i
)  (4.21) 
where   
mˆ  is a (128x1) matrix of estimates calculated using Equations 4.3-4.18 at each xT, 
m is a (128x1) matrix of corresponding observed measurements, and 
V-1  is the inverse of the variance-covariance between the measurements.  Assuming 
independence in the measurements then V-1 is a (128x128) matrix with 1/ σ  along the 
diagonal, and zeros elsewhere. 
2
j,i
To investigate the variation of the parameters, embedded within the modelm , a 
Taylor expansion is performed around a particular solution p
ˆ
0 [42, 43]: 
 ( ) (4.22) 0jj
j j
0 pp
p
)(ˆ)(ˆ)(ˆ
0
−∂
∂+≈ ∑
p
i
ii
pmpmpm
Or equivalently,  
  ( )00 )(ˆ)(ˆ ppGpmpm −+≈  (4.23) 
The sensitivity matrix G in Equation 4.23 reflects how each parameter pj may 
influence the estimate for a particular measurement mi. The contents Gij can be readily 
determined from partial differentiation of Equations 4.3-4.18 as appropriate.  The results 
of differentiation are shown in Appendix 5.  Note that the total amount of Erk xT appears 
in Equations 4.3-4.18 (and thus the entries Gij), and therefore will appear as part of G.  
Thus the true matrix G will contain 16 (expressions) * 8 (concentrations xT) or 128 rows, 
and 14 (parameter) columns. 
Combining Equations 4.21 and 4.23 leads to the following approximation: 
 ( )[ ] ( )[ ]001T00 )(ˆ)(ˆ)(S ppGpmmVppGpmmp −−−−−−≈ −  (4.24) 
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Equation 4.24 is of the same form as the classic linear regression problem, and by 
analogy is minimized when 
 ( ) [ ] [ ])(ˆ 01T11T0 pmmVGGVGpp −=− −−−  (4.25) 
By analogy with the linear problem, it can be shown that around the solution p0 
the parameters approximately follow a normal distribution, with variance [GTV-1G]-1, i.e. 
that (p-p0), and therefore p ~ N(p0,σ2[GTV-1G]-1) [43].  By the properties of the normal 
distribution, multiplication of the p by a factor a yields aTp ~ N(aTp0,σ2aT [GTV-1G]-1a), 
and that: 
 [ ] f11T
0
t~
s aGVGa
papa
T
TT
−−
−  (4.26) 
Recall that f is the number of degrees of freedom of the system, while s is the 
estimate of the standard deviation of the system, calculated from s2 = S(p)/f.  Rearranging 
Equation 4.26, an approximate 100(1-α)% confidence interval for the parameters around 
the solution can be written as 
 [ ] aGVGapa TT 11T2/,f0 st −−α±  (4.27) 
The confidence interval for a particular parameter pi is found by setting a(i) = 1 
and all other elements 0, i.e. a = [0 0 … 0 1 0 … 0]T. In that case the vector product in 
Equation 4.27 will leave only the ith diagonal element of the matrix [GTV-1G]-1, denoted 
.  Therefore the confidence interval for pii
11T }]{[ −− GVG i is: 
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± −−α GVG  (4.28) 
An example set of parameter values and confidence intervals, for the data shown 
in Figures 4.9-4.11, is shown in Table 4.3.  The aDP antibody appears to show the 
highest affinity, based upon the high value of a11.  This should not be particularly 
surprising given that recognition of DP-Erk, containing two phosphorylated residues in 
close proximity, would necessarily involve several strong charge-based interactions with 
an antibody.  Other Erk forms, lacking such charged epitopes, would interact with an 
antibody using more hydrophobic or hydrogen-bonding interactions, which are relatively 
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weak by comparison.  The relative values of a22 and a24 indicate an approximately 3-fold 
higher affinity of aTP for TP-Erk over NP-Erk, somewhat lower than the 10-fold 
difference expected from previous in vitro characterizations [12].  However, these 
previous studies were based on competitive ELISAs using short peptide sequences, not 
parallel ELISAs using entire proteins.  It may be that conformational changes in protein 
structure due to phosphorylation state may change the availability of some residues to 
interact with the antibodies, and thus alter the affinities for different forms of Erk.  On the 
other hand, aNP was expected to cross-react weakly with TP- and YP-Erk, but the results 
from this study indicate no statistically significant affinity.  Here, the charge on tyrosine 
or threonine due to phosphorylation could impair interaction with aNP, which may 
recognize the phosphorylation site through hydrogen bonding to the unmodified residues.  
Table 4.3. Parameter values from ELISA standards regression (data shown in Figures 4.9-4.11) 
 Parameter  Value (95% CI) Parameter Value 
a11 16700 ± 4800 b1 -1500 ± 3100 
a22 4400 ± 1200 b2 -4600 ± 2100 
a24 1760 ± 160 b3 -6300 ± 3700 
a33 4390 ± 930 b4 -8000 ± 3100 
a42 0 ± 1000 d 0.164 ± 0.042 
a43 420 ± 500 t 0.191 ± 0.117 
a44 2000 ± 200 y 0.208 ± 0.049 
 
In many cases the uncertainty in a parameter can be as high as 30% of the 
optimized value, which will induce a high uncertainty later when estimating Erk 
composition in unknown samples.  Unfortunately, this error appears to be a characteristic 
of the system, likely a combination between variability in the measurements themselves 
and nonlinearity in the response.  This can be observed as scatter between the model 
predictions (lines) and observations (open symbols) in Figures 4.10-4.11.  For example, 
aTP exhibits significant scatter, particularly at 10 ng total Erk for all samples, and 
original ErkPP (D, circles) shows curvature for aYP.  Improvements in measurement 
accuracy, including better estimates of how the variance for each measurement varies 
with xT, would certainly help.  However, a much more powerful benefit would be 
realized by preparation of well-defined standards, to avoid assumptions necessary about 
the composition of samples D, T, Y, and N.    
 126
It is also interesting to note the estimates for the ErkPP composition, d, t, and y.  
The regression results predict that at most 20% of the “active” sample is in fact DP-Erk, 
and another 40-50% may be monophosphorylated on threonine or tyrosine.  The 
monophosphorylated species may arise during the proprietary procedure that Upstate 
Biotechnology uses to activate Erk, or may be an artifact of sample handling.  Separate 
experiments using MALDI and LC-MS of ErkPP after digestion with trypsin yielded an 
estimate of approximately 50% phosphorylated Erk (DP-, TP-, and YP-Erk) with 
monophosphorylated species certainly present (data not shown).  Unfortunately, it was 
not possible to separately resolve between TP- and YP-Erk using MS techniques, or to 
quantify the relative amounts of DP- and monophosphorylated Erk as a separate method 
to validate the regression estimates.   
Recall that ultimately the ELISA model is used to estimate  from a set of 
measurements m for an unknown sample.  The error in  is approximated by solving the 
optimization problem (Equation 4.20) with parameters p at the bounds of the confidence 
interval for each p
xˆ
xˆ
i, calculated from Equation 4.28.  Therefore, an alternative approach to 
investigating the accuracy of the model parameters was to perform a validation 
experiment using mixtures of the standards samples.  The predicted Erk composition 
could be determined from the compositions of the standards themselves, calculated from 
the parameters d, t, and y in accordance with Equation 4.2.  On the other hand, ELISA 
measurements of these same mixtures could be analyzed to give a model-predicted 
composition, by solving the regression problem in Equation 4.20.   
The results of the validation experiment are shown in Table 4.4.  Two standards 
samples (D, T, Y, or N) were combined together in equal parts (10 ng total Erk each) and 
applied to ELISA wells.  In general, very good agreement is seen between the predictions 
from the original sample composition (“Pred”) and estimates based upon ELISA 
measurements (“Meas”) for DP-, YP-, and NP-Erk forms, although significant ranges can 
be seen for the estimates.  However, the measured estimates for TP-Erk appear 
consistently lower than the predicted values based on the original ErkPP composition, 
and the confidence interval for TP-Erk does not contain the predicted value.  Most likely, 
this is the result of an overestimation for a24, perhaps because the N sample (assumed to 
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be 100% NP-Erk) actually contains some remaining TP-Erk.  Analysis of the 
measurement system may attribute too much of the aTP signal to NP- and not TP-Erk, 
lowering the overall estimation for TP-Erk.  Recall that previous experiments appear to 
indicate that in general, very little TP-Erk is formed during Erk phosphorylation in cycles 
(e.g. Figure 4.4 and [13, 14]).  Therefore, an error in the estimation for TP-Erk may not 
significantly alter the analysis of a sample from Erk cycles, which would be dominated 
by DP-, YP-, and NP-Erk forms.  Without a more characterized set of standards (ideally, 
pure in each Erk form), it is difficult to separate the potential sources of error associated 
with inaccuracies in sample composition as opposed to those related to describing the 
response of the antibodies.  
Table 4.4. Comparison of predicted (from standards composition) and observed (estimated from 
measurements) Erk amounts using mixtures of standards (D, T, Y, N) samples. 10 ng of each standard (20 
ng total) was added to wells, and ELISA measurements used with Equation 4.20 to calculate x.  Predictions 
were calculated according to Equation 4.2.  All entries are shown in ng Erk of each form. 
 DP-Erk Estimates  TP-Erk Estimates 
 Pred. Meas Low High  Pred. Meas Low High 
D+N 4.02 4.56 3.74 5.63  2.17 1.18 1.13 1.15 
D+T 4.02 4.74 3.90 5.84  8.36 6.36 5.72 7.12 
T+Y 0 0.10 0 0.49  6.19 5.22 4.82 5.63 
Y+N 0 0.10 0 0.48  0 0 0 0.17 
N+T 0 0 0 0.34  6.19 3.39 3.72 3.09 
D+Y 4.02 4.29 3.51 5.32  2.17 1.42 1.28 1.43 
          
 YP-Erk Estimates  NP-Erk Estimates 
 Pred. Meas Low High  Pred. Meas Low High 
D+N 1.20 1.88 1.19 2.78  12.61 11.85 8.95 15.70 
D+T 1.20 1.17 0.57 1.96  6.42 3.59 0.83 7.54 
T+Y 5.22 5.72 4.57 7.21  8.59 5.51 2.19 10.23 
Y+N 5.22 5.85 4.69 7.38  14.78 11.68 8.57 15.16 
N+T 0 0.45 0 1.13  13.81 13.19 9.98 17.48 
D+Y 6.42 5.67 4.53 7.16  7.39 2.65 0.18 6.12 
 
It has already been noted that the current model fails to account for signal 
observed using aDP for the samples T, Y, and N, and aYP for samples T and N, which 
may arise from nonspecific antibody cross-reaction or from incomplete 
dephosphorylation by phosphatases.  Additional modifications to the model, to account 
for these observations, and possibly to include the nonlinear regions as well, could 
perhaps provide a more successful representation in validation experiments.  However, it 
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was felt that this introduction would complicate the sample analysis (Equation 4.20) 
while introducing additional parameters that might not be determined with any higher 
accuracy than in the current model.   Thus the model, however imperfect, was maintained 
in its current form for analysis of immobilized and liquid-phase cycles.   
4.4. Activation Ratios in Erk Phosphorylation Cycles 
As described in Chapter 2, the activation ratios for a system should be dependent 
upon kinetic parameters as well as concentrations of each component, in particular when 
enzyme-substrate complexes cannot be separated from free species.  Several sets of 
experiments were performed to investigate whether Erk activation profiles and activation 
ratios were consistent with predicted patterns.  Liquid-phase and immobilized enzyme 
reactions were compared to examine the linear and nonlinear behavior of activation ratios 
under different conditions.  Variation of the total Erk and phosphatase concentrations 
allowed for investigation on how changes in these parameters would be reflected in the 
activation ratios.  Unfortunately, there was no method available for making modifications 
to the catalytic parameters for the individual enzymes.   
Results for these experiments are discussed in the sections below and shown in 
Figures 4.13-4.16, where both activation profiles (normalized by total Erk) and all 
possible activation ratios are included.  In most cases, the primary monophosphorylated 
intermediate was YP-Erk, with estimates for TP-Erk within the error of the 
measurements.  Therefore although activation ratios based on TP-Erk are calculated and 
shown in Figures 4.13-4.16, caution must be taken in interpreting the results.  Confidence 
intervals for Erk estimates and activation ratios are omitted for the sake of clarity, as in 
most cases excessive overlap between different series would cause confounding.  Hence 
there was little statistically significant differences observed between series, but 
observable variations in patterns did appear and are noteworthy.   
4.4.1. Comparison of liquid-phase and immobilized reactions 
A critical design feature of the immobilized reaction system was to allow 
resolution of freely soluble substrate from that bound by enzyme.  As described in 
Section 2.4, the activation ratio for a system may appear linear when calculated using free 
substrate concentrations, but appear hyperbolic for a system if enzyme-substrate 
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complexes are included in calculations.  A test both for the immobilized reaction system 
and activation ratio analysis itself was to experimentally observe this prediction.  
Activation ratios calculated for samples taken from immobilized reactions should appear 
linear, since enzyme-bound substrate would remain within the wells of the reaction plate.  
Samples from liquid-phase reactions would contain enzyme and substrate, and would 
therefore expected to yield hyperbolic activation ratios, provided that sufficient enzyme is 
added to the system.  At low enzyme concentrations, activation ratios should appear 
linear regardless of which system is utilized. 
 Comparison of results between liquid-phase and immobilized enzyme systems 
are shown in Figure 4.13, where the amount of N4-Mek applied to the wells ranges from 
0-0.1 µL (“low”, circles), 0-1 µL (“normal”, squares), or 0-10 µL (“high”, triangles).  
Liquid-phase reactions are indicated by closed symbols, and immobilized enzyme 
reactions by open symbols.  The experiment was conducted in this manner to account for 
differences in enzymatic activity between the two systems.  Recall from Section 4.2.3 
that immobilized antibodies were observed to retain approximately 5-10% of the enzyme 
during the binding step.  Thus direct comparisons should be made between liquid-phase 
reactions and immobilized reactions with 10-fold higher N4-Mek concentrations (i.e. red 
squares vs. green circles, or blue squares vs. red circles).  In general, the results for “low” 
concentrations of N4-Mek (< 0.1 µL) were indistinguishable from those containing no 
enzyme at all. 
However, for “normal” and “high” amounts of N4-Mek added, liquid reactions 
yield very similar results to corresponding immobilized reactions, both in terms of 
activation profiles and activation ratios.  At higher N4-Mek concentration ranges, 
formation of DP-Erk saturates quickly, whereas a peak is observed for YP-Erk that 
disappears more quickly for the liquid-phase reaction.  Lower ranges of N4-Mek show 
wider peaks for YP-Erk formation, as well as more shallow curves for appearance of DP-
Erk.  Together, this suggests that the enzymatic system continues to operate essentially 
unchanged in the immobilized phase, except for an overall lower activity. 
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Figure 4.13. A) Activation profiles and B) Activation Ratios for Erk cycles vs. normalized volume of N4-
Mek added, in liquid phase (closed symbols) or immobilized using capture antibodies (open symbols).  
“Low” (circles) signifies a maximum of 0.1 µL N4-Mek added, “Norm” (squares): 1 µL, “High” 
(triangles): 10 µL Mek. 
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In general, it should slightly surprising that the Erk distribution from immobilized 
enzymes appears similar to freely soluble enzymes.  Both systems use the same enzymes 
in similar proportions, and all other parameters are kept constant.  However, the amount 
of substrate bound to different enzymes changes with each Erk form, and thus the amount 
remaining in free solution should also change.  Furthermore, a small decrease is expected 
in recovery of all Erk forms, but as shown in Figure 4.13A samples from immobilized 
reactions contain the same amount of each Erk species as those arising from liquid-phase 
reactions.  Separate ELISA data using an antibody that reacts with all Erk forms also 
indicated that Erk recovery from the two systems was equal (data not shown).  Therefore, 
the activation profile data appears to suggest that enzyme-substrate complexes are not 
being separated from free substrate in immobilized reactions.   
This conclusion is made more apparent by the hyperbolic shape for activation 
ratios for high concentrations of immobilized N4-Mek.  As described in Chapter 2, 
activation ratios appear hyperbolic if total concentrations are utilized and the system is 
operating under saturating conditions.  If the enzymes are in fact far from saturation, then 
activation ratios should appear linear regardless of whether total or free substrate 
concentrations are measured.  Since activation ratios for liquid-phase reactions are 
hyperbolic, the system must indeed be operating with saturated enzymes.  That 
immobilized reactions follow the same behavior indicates that the immobilized system is 
not operating as intended in separating enzyme-bound substrate. 
The most obvious explanation for this observation is that the enzyme-substrate 
complexes are in fact not stable under current conditions.  This conclusion would be 
consistent with prior difficulties in separating protein-protein complexes by filtration or 
electrophoresis.  Interactions between Mek and Erk have been observed experimentally 
by co-immunoprecipitation [44].  However, these studies may have been performed 
under experimental conditions more conducive to protein-protein complex formation than 
for enzymatic reaction, and perhaps more importantly, within a cellular context where a 
scaffolding protein like MP-1 could assist in bringing the enzyme and substrate together 
[45, 46].  Whereas immunoprecipitation is performed using high salt concentrations that 
help bring proteins together, the reaction buffer for this system had no salt.  The presence 
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of the reducing agent DTT in the reaction buffer, necessary for maintaining PTP1B 
activity, may have had adverse affects upon the Mek-Erk interaction as well.   
Although less likely, it may also be that the enzyme-substrate complexes account 
for only a small fraction of the total substrate pool.  The fraction of substrate bound by 
enzyme is dependent upon the ratio between the concentrations of enzyme the Michaelis 
constant defined for their interaction ([E·A]/AT ~ ET/Km).  Thus, for complexes to be 
negligibly small it would require that the Michaelis constants for each enzymatic step be 
significantly greater than the enzyme concentrations.  The Michaelis constants for 
dephosphorylation of DP-, YP- and TP-Erk by PTP1B and PP2A could not be determined 
during in vitro reactions, but were estimated to be much greater than 1 µM [25].  On the 
other hand, the interaction between Mek and Erk is more specific, with the Km estimated 
at approximately 300-460 nM for NP-Erk phosphorylation and 30-50 nM for the second 
phosphorylation step [13, 47].  Therefore, some fraction of Erk (in particular, of YP-Erk, 
the likely monophosphorylated intermediate) should be abstracted by interaction with 
Mek if the complexes are stable.  Since no change in total Erk recovery was observed in 
immobilized reactions, it appears more reasonable to conclude that enzyme-substrate 
complexes were unstable using the immobilized reaction system. 
If the reaction is assumed to proceed only through a YP-Erk intermediate (thus, 
only one path) then the system is identical to that described in Section 2.3.4.  
Unfortunately, the failure to separate free species prevents the calculation of individual 
activation factors for each step or even verification of the linear responses expected for 
each intermediate step (YP/NP and DP/YP) and quadratic response expected for the 
overall dual activation ratio (DP/NP).  Instead, the data shown in Figure 4.13B represents 
total activation ratios, as described in Section 2.4.  After accounting for enzyme-substrate 
complexes in balances for total enzyme and substrate concentrations, the free activation 
ratios in Equations 2.35-2.36 can be converted into expressions for the total activation 
ratios as follows: 
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For the Erk experimental system, E1, E2 and E4 correspond to N4-Mek, PTP1B, 
and PP2A respectively, while A, A*, and A** would correspond to the free amounts of 
NP-, YP-, and DP-Erk (a closed-form expression for TAR using only total substrate 
concentrations such as A*T is not feasible). Assuming that the phosphatases operate far 
from saturation, as described above, then Km2 and Km4 will dominate adjacent terms in 
Equations 4.29-4.30, which thus can be simplified to yield: 
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Since enzyme and substrate concentrations appear in Equations 4.29-4.32, the 
magnitude of total activation ratios does not reflect the kinetic parameters alone.  
Nevertheless, the fact that DP/YP activation ratios appear greater than YP/NP ratios 
seems to suggest that the second phosphorylation step is overall faster than the formation 
of YP-Erk.  This may be due to differences in the catalytic constants and phosphatase 
concentrations (k3/k4E4T > k1/k2E2T), but perhaps also because of differences in the 
Michaelis constants.  With Km1 > Km3 and all other parameters equal it is likely that 
TARA2 > TARA1, or in terms of Erk activation, DP/YP > YP/NP.  
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Without better estimates for concentrations of the enzymes, it is difficult to 
resolve between these possibilities.  Both cases appear to require that the second 
phosphorylation step proceed more quickly than the first (in terms of higher net kcat or 
lower Km).  Should the first step be faster, an accumulation of YP-Erk would be observed 
that would lead to an overall increase in YP/NP activation ratios, and a decrease in the 
magnitude of DP/YP across all Mek concentrations.  With the first step limiting overall 
reaction, then the concentration of intermediate YP-Erk would be expected to decrease 
relative to the other forms, and DP/YP activation ratios would increase beyond YP/NP.   
4.4.2. Variation of total Erk concentration 
This issue was investigated further through modulation of the amount of Erk 
substrate.  The experiments described in Section 4.4.1 were performed using a total Erk 
concentration of 125 nM, in between the approximate Michaelis constants for Mek, Km1 
and Km3, but less than those for the phosphatases.  By varying the amount of Erk 
involved in liquid-phase reactions from 25-250 nM, the extent of saturation for each 
phosphorylation step should also change.  According to Equations 4.29-4.32, the amount 
of Erk in each form influences the total activation ratios, and of particular interest is the 
distribution between YP-Erk and NP-Erk (A* and A, respectively).  Results for this case 
are shown in Figure 4.14.  Note that the activation profiles in Figure 4.14A are 
normalized by the total Erk estimated for each sample, thus demonstrating how the 
fractional distribution of Erk forms varies with total Erk concentration.  
Interestingly, the fractions of NP and DP increase with total Erk, while 
intermediate YP decreases relative to the others.  Accordingly, the activation ratios for 
DP/YP increase with Erk but YP/NP decreases (DP/NP increases very slightly).  These 
results might appear nonintuitive, since one would expect that increasing the total Erk 
concentration would drive both reactions forward and thus all activation ratios should 
increase.   However, if we consider that Mek has a 10-fold higher affinity for YP, then as 
more total Erk is present, more of the available Mek will be devoted to conversion of YP 
to DP, with less available to form YP from NP, and the balance of the system tips 
towards the DP/YP cycle.  Since the phosphatases are far from saturation, free YP will be 
readily dephosphorylated to NP and thus the YP/NP ratio decreases.  Use of activation 
ratios make these results more apparent than examining the activation profiles alone. 
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Figure 4.14. A) Activation profiles (fraction Erk in each form) and B) Activation Ratios vs. volume Mek 
added, for Erk cycles in liquid phase, varying total concentration of Erk.   
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4.4.3. Modulation of phosphatases  
Although examination of the Erk phosphorylation system can be complicated 
when interactions between Erk and Mek are considered, the analysis is much more 
straightforward when considering the affects of each phosphatase.  This is because each 
phosphatase will primarily encounter only one Erk species, whereas Mek binds both NP- 
and YP-Erk.  From physical grounds it might be expected that increasing both 
phosphatase concentrations will tend to decrease all phosphorylated forms.  The same 
conclusion arises from examination of Equations 4.31-4.32.  Moreover, activation ratios 
suggest that if only one phosphatase is modulated, the activation ratio for the step 
regulated by the other phosphatase should not change significantly.   
To verify these predictions, experiments involving liquid-phase reactions using 
125 nM Erk were performed, but in this case varying from the base value of 0.2 µL 
phosphatase per 50 µL reaction.  As shown in Figure 4.15, increasing both phosphatases 
together generally resulted in decreases in DP-Erk and increases in YP- and NP-Erk, but 
furthermore, decreases in the YP/NP activation ratio as well as DP/YP.  This again 
suggests that the second phosphorylation step tends to be faster, since a fast initial 
phosphorylation would help to maintain levels of YP even in the presence of additional 
phosphatase, and so the YP/NP ratio would be expected to increase.  
Each phosphatase was also added independently, to examine the effects of either 
enzyme.  With only one phosphatase, the system is expected to center primarily around 
the second phosphorylation step, i.e. formation of DP-Erk either from YP-Erk or (if only 
PTP1B is present) TP-Erk.  The activation profiles, shown in Figure 4.16A, indicate as 
expected that high PTP1B concentrations tend to increase the amount of TP-Erk and 
decrease YP-Erk, while PP2A promotes formation of YP-Erk.  Curiously, YP-Erk is still 
formed when only PTP1B is present, suggesting perhaps that most of the PTP1B is 
dedicated to dephosphorylation of DP-Erk.  The impact of each phosphatase is strikingly 
apparent when attention is placed on the activation ratios DP/YP and DP/TP.  The ratio 
DP/YP appears to depend only upon the amount of PP2A (compare squares vs. circles), 
whereas DP/TP is almost entirely dependent upon PTP1B (open vs. closed symbols).  
Therefore even with total activation ratios, the influence of each phosphatase on Erk 
phosphorylation can be separated. 
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Figure 4.15. A) Activation profiles and B) Activation Ratios vs. volume Mek added, for Erk cycles in 
liquid phase, varying total amounts of both phosphatases.   
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Figure 4.16. A) Activation profiles and B) Activation Ratios vs. volume Mek added, for Erk cycles in 
liquid phase, varying total amounts of each phosphatase independently.   
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4.5. Conclusions 
The cycles produced by phosphorylation of Erk2 by the protein kinase Mek and 
dephosphorylation by phosphatases PP2A and PTP1B were selected as a model system 
for the validation of the theoretical framework described in Chapter 2.   A regression 
scheme was coupled with measurements of Erk standards (originating from an unknown 
mixture obtained from Upstate Biotechnology) to prepare a model for the response of 
ELISAs to each form of Erk.  The resulting parameters were used to estimate Erk 
composition in test samples.  A sensitivity analysis on the ELISA model was used to 
estimate uncertainty in the model parameters, which could then be used to approximate 
the uncertainty in measured Erk composition.   
Enzymes were immobilized using capture antibodies so as to facilitating the 
separation of free substrate from enzyme-substrate complexes following reactions.  This 
procedure enabled immobilization of all three enzymes while maintaining activity and 
inhibiting nonspecific adsorption of substrate.  However, immobilized enzymes exhibited 
only 5-10% activity when compared against their liquid form, apparently due to poor 
capture efficiency by the antibodies.  After accounting for the differences in activity, the 
immobilized system behaves identically to liquid-phase reactions.   
Activation ratios for Erk phosphorylation cycles were hyperbolic for both reaction 
systems, suggesting that enzyme-bound substrate was not separated from freely soluble 
species.  It appears likely that the enzyme-substrate complexes were not stable under 
current reaction conditions, perhaps because of a lack of appropriate buffer composition 
or scaffold protein.   This prevented examination of some of the features of activation 
ratio analysis, such as the predicted linear and quadratic responses and calculation of the 
activation factors, as described in Section 2.3.4.   
Nevertheless, several qualitative characteristics including the effects of Erk and 
phosphatase concentrations were still realized, by analyzing the data using total activation 
ratios (Equations 4.29-4.32).  In particular, the relative affinities of Mek for 
nonphosphorylated and monophosphorylated Erk forms (Km for each phosphorylation 
step) could be readily established by the behavior of activation ratios in response to 
variation in total Erk concentration.  As expected, increasing both phosphatase 
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concentrations decreased all activation ratios, while independent modulation of each 
enzyme primarily regulated only one of the two steps.  The overlap of activation ratios 
for constant phosphatase concentrations (Figure 4.16) is a particularly striking example of 
how this method can isolate activation steps even when there may be additional 
interactions with other components. 
The difficulties in performing these experiments highlight key issues regarding 
investigation into signaling systems, notably a lack of effective measurement techniques, 
standards for quantitation of samples, and well-defined methods for handling of enzymes.  
Certainly, these issues will need to be addressed for further detailed studies into kinetics 
of enzymes, in particular when calculating activation ratios where more demands are 
placed upon the measurements.  However, they should not detract from understanding the 
utility of activation ratios themselves, as a different way to investigate individual 
signaling interactions and to interpret the data.  Furthermore, activation ratio analysis 
should be considered in the context of analyzing larger signaling networks, where 
detection of interactions in the whole system is more important than precise examination 
of the individual steps.  In that case verification of the qualitative characteristics of 
activation ratio analysis is more pertinent, and the ability to perform network 
reconstruction with “total” species measurements should be recognized.     
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5 CONCLUSIONS – FUTURE WORK 
The field of biology has changed dramatically within the last fifty years, since the 
discovery of the structure of DNA and the birth of molecular biology.  The capabilities to 
sequence genomes and computational tools to identify gene products and splice variants 
have given researchers a veritable “parts list” for the cell.  This is only a first step (albeit 
a necessary one) in describing cellular behavior.  Simply knowing the components of a 
system is not enough.  Understanding the way these molecules react together, forming a 
responsive network, by determining the reactions that occur is also important.  However, 
a critical final step in the study of cellular operation is determination of the in vivo 
engagement of each of these reactions, as this provides information not just on what the 
cell is capable of but what is actually occurring under a particular set of conditions. 
This thesis represents an approach to perform both the second and third steps, 
namely, network structure identification and in vivo quantitative characterization, for the 
analysis of signal transduction processes.  The former has traditionally been achieved 
using a variety of experimental techniques, normally focused on individual steps: 
reactions involving completely isolated species in vitro, heterologous expression of 
proteins in novel hosts, genetic and functional knockouts, etc.  The latter has been 
attempted using a mathematical sensitivity analysis approach originally developed for 
study in metabolic reactions, but never applied experimentally.   
Use of activation ratios as described here enables both steps to be performed 
simultaneously in vivo, without resorting to detailed mechanistic models or requiring 
extensive molecular perturbations even to analyze simple systems.  The nature of the 
connection between two signaling species is reflected in the shape of activation ratio 
plots, thus enabling the inversion of data for activation ratios to determine the structure of 
their interaction.  Activation factors, found from simple linear regression of data for 
direct interactions, yield simple quantitative measures of signal transfer.   
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The procedure is simple enough to perform visually, although has also been 
partially automated via a computational regression and evaluation protocol, which can be 
used to assign confidence in assignment in the face of experimental errors or insufficient 
data.  Although generally robust to errors in estimates for the activation ratios, the pattern 
assignment algorithm performs more poorly when fitting sharp inverse hyperbolae with 
errors in the predictor (activating enzyme) concentrations.   
One difficult but important extension of this work would therefore be to modify 
the regression procedure to allow for errors in the x-data.  Essentially, this amounts to 
solving the standard regression problem (for a linear, hyperbolic, inverse hyperbolic 
model) but with additional parameters being the “true” values of the x data.  In general 
solution of this problem requires replicate measurements at each value of x, and is 
facilitated if separate information about the potential variance in each x (σx) is available 
[1].  Although this adds additional experimental requirements and analytical complexity 
to the procedure, it should provide more stability to the process of pattern assignment.   
Somewhat more straightforward should be the development of an automated 
network reconstruction algorithm, used to connect the results of pattern assignment (a 
matrix R as described in Section 3.3.3) to a graphical structure.   This would simplify 
assignment for simple signaling systems, and be essential for the study of larger 
networks.  In effect, this would a computational implementation of the algorithm 
described in Section 3.1, and the consistency rules in Section 3.1.3 would play an 
important role in error-checking, as would the Akaike weights as measures in confidence.  
One option would be to simply enumerate all possible networks for a particular number 
of components, and eliminate those that would not result in the observed R.  However, 
considering the combinatorial permutations that arise as the number of species increases, 
a much more tractable alternative appears to be to assemble a structure starting from a 
known input and working down.     
The process involved in development of the ELISA model, as well as the 
difficulties encountered in its application, illustrate a key limitation preventing 
quantitative analysis of signaling systems.  Namely, the lack of highly accurate 
measurement techniques for signaling intermediates, and of well-defined standards to 
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help translate measured values into estimates of species concentrations.  The sensitivity 
and selectivity of antibodies varies widely, and is rarely characterized or optimized for 
quantitative purposes.  Although individual peptides also vary in their recovery during 
MS, use of an internal standard still enables quantitation of proteins with less than 10% 
variance [2, 3].  Use of mass spectrometry would certainly both improve the accuracy and 
expand the variety of proteins that could be investigated, since it would not depend upon 
the availability of antibodies.  Nevertheless, pure standards would be required for 
absolute quantitation of proteins in different states.  (Only relative quantitation is possible 
if a consistent, but unknown, sample is used as an internal control) 
In the end, the most important, and most useful, continuation of this work will be 
continued application in a variety of experimental settings.  Small, well-controlled in 
vitro studies, similar to the examination of Erk phosphorylation discussed in Chapter 4, 
could be used to illustrate further the capacity of activation ratios to reflect the kinetics of 
signaling systems.  The issue of separating enzyme-bound from free substrate still 
remains, and may be addressed by further experiments with immobilized enzymes.  
Considering the problems encountered using antibody capture, it appears that a different 
strategy for enzyme immobilization is required.  A promising option is to utilize a RNA-
protein fusion, which simplifies immobilization through simple DNA-RNA base pairing, 
while maintaining catalytic function [4].   
However, cascades and other signaling network arrangements should also be 
examined, to demonstrate the capacity of activation ratios to examine signaling structure. 
Controlled in vivo experiments could first be performed using mammalian signaling 
intermediates expressed in bacteria or insect cells to construct cascades in a novel setting 
[5, 6].  As methods for separation and analysis of intermediates improve, more 
complicated systems including yeast and higher-order eukaryotic cells could be studied, 
to characterize known signaling networks as well as previously undetermined systems, 
including a variety of multifaceted diseases such as diabetes.    
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6 APPENDICES 
Appendix 1. Single cycle model  
A1.1. Simulation details 
All models of signaling systems were constructed as a set of coupled first-order 
differential equations for the time-dependent change in concentration of each species, 
including enzyme-substrate complexes.  For the single cycle described in Section 2.2, this 
constitutes Equations 2.8-2.13.  As not all equations are independent, only the 
expressions for the signaling intermediate itself (2.8-2.11) were explicitly coded.  
Conservation relationships (Equations 2.14-2.16) were used to find the concentrations of 
free enzymes (E1, E2) and free unmodified intermediate (A).  At the initial conditions, all 
species = 0 except for A = AT, E1 = E1T, E2 = E2T.   
The stiff ODE solver function “ode15s” was then used to integrate the set of 
differential equations from t0 = 0 to tfinal = 5000 to ensure steady state.  The solver 
internally sets the integration step size; through the parameter “tspan” results at specific 
time points can be returned.  Default solver options were used; this includes relative 
tolerance (10-6) and absolute tolerance (10-3) requirements for each species at each 
integration step time.   
The models were constructed as two files.  A script file is used to create variables 
and assign values, create matrices to store output data, and iteratively call the ODE solver 
ode15s to simulate the cycle activation at each value of input stimulus (or pair of input 
stimuli).  The equations for reaction rates are included in a separate file as a function, that 
returns f(t,x,p) = dx/dt.    Kinetic parameters and total concentrations of species are 
passed as matrices p to the function, as well as to the ODE solver.   
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A1.2. MATLAB files 
Shown below are the two files used for examination of a single cycling 
intermediate, as described above and in Section 2.2.  Extension to other signaling 
arrangements was achieved by changing the script file (to add kinetic parameters, total 
concentrations, and handle additional species) and the function of rate equations (to add 
expressions for additional species or change reactions steps) as appropriate.  Copies of all 
files, including those containing output data, are available from the author by request. 
 
% Script file to prepare data for single cycle, single activation step  
% Calculates steady-state distribution of forms (free active, free 
% inactive, bound to each enzyme) at a range of activating enzyme  
% concentrations and also varies a1 so as to modify Km1 
% 
% F. Javier Femenia, MIT Chemical Engineering Department 
% 8/29/00 
 
 
% Assignment of kinetic parameters 
a = 20*ones(1,2); 
d = 10*ones(1,2); 
k = 10*ones(1,2); 
 
Param = [a;d;k]'; 
 
% Total concentrations for each species 
Atot = 10;  
E1tot = 1; 
E2tot = 1; 
 
Totals = [Atot; E1tot; E2tot];  
 
% Varying the concentration of input stimulus (E1tot), and the  
%  association constant for first reaction (a1) 
 
npts = 27; 
E1vals = logspace(-3,1,npts); 
Avals = [1 2 5 10 20 50 100];  
npts2=length(Avals); 
[X,Y] =meshgrid(E1vals,Avals); 
 
% Setting up necessary variables for the ode solver 
% See 'help odeset' for information regarding options. 
% tspan sets the integration from 0 to tfinal, such that the output 
%  matrix 'Res' will only have 3 rows--easier for later. 
 
tfinal = 5000;    % Length of integration—until system at ss. 
options = [];     % Default options, can make modifications later 
tspan = [0 10 tfinal]; % Output of odesolver will give rows at  
        % t=0, 10, 5000 
 
Results = zeros(npts2,npts,4); % Matrix to store output 
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% At each value of E1tot and a1, integrates to steady state and 
% assigns the output to the matrix Results. 
% The ode solver calls the file "singlefile.m" which contains the 
% differential equations governing each species (form of A) 
 
for i = 1:npts    % Outer (E1tot) loop 
   for j = 1:npts2  % Inner (a1) loop 
 E1tot = X(j,i) 
   a(1) = Y(j,i); 
  vars0 = [Atot;0;0;0];  
   Param = [a;d;k]'; 
   Totals = [Atot; E1tot; E2tot]; 
 [t,Res] = ode15s('singlefile',tspan,vars0,options,Param,Totals); 
 Results(j,i,:) = Res(3,:); 
 end 
end 
 
% Calculate fractions of enzymes in active form (including those in  
% complexes with other proteins). 
 
A=Results(:,:,1); 
AP=Results(:,:,2); 
AE=Results(:,:,3); 
APE=Results(:,:,4); 
 
% If desired, create plots of activation profiles and activation ratios 
 
figure(1) 
plot(E1vals,AP./Atot) 
title('Fraction A Activated for Different Values of a_1') 
xlabel('E1_t_o_t') 
legend('1','2','5','10','20','50','100') 
 
figure(2) 
plot(E1vals,AP./A) 
title('Activation Ratios for Different Values of a_1') 
xlabel('E1_t_o_t') 
legend('1','2','5','10','20','50','100') 
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function varargout = singlefile(t,vars,flag,Param,Totals) 
 
% Function used to calculate distribution of forms in signaling cycles. 
% Based on using deterministic model for each chemical reaction  
%  between species as a set of first-order differential equations 
%  that describes the time-dependent behavior of each species. 
% 
% The flag is needed for the odesolver.  Thus there are subfunctions to 
%  allow evaluation at different flags. 
% Param is a matrix containing all the kinetic rate parameters, and 
% Totals is a vector containing the total concentrations of all  
% species. 
% vars represents the variables y for which we are integrating; in this  
%  case is A, AP, E1_A and E2_AP 
 
switch flag 
case ''                             % Return dy/dt = f(t,y). 
  varargout{1} = f(t,vars,Param,Totals); 
case 'init'                         % Return initial conditions y(0). 
  [varargout{1:3}] = initval(Param,Totals); 
 
%case 'jacobian'                    % Return Jacobian matrix df/dy. 
%  varargout{1} = jacobian(t,y,p1,p2); 
%case 'jpattern'                    % Return sparsity pattern matrix S. 
%  varargout{1} = jpattern(t,y,p1,p2); 
%case 'mass    '                    % Return mass matrix M(t) or M. 
%  varargout{1} = mass(t,y,p1,p2); 
%case 'events'                   % Return [value,isterminal,direction]. 
%  [varargout{1:3}] = events(t,y,p1,p2); 
 
otherwise 
  error(['Unknown flag ''' flag '''.']); 
end 
 
 
 
 
% -------------------------------------------------------------------- 
% Normal case:  Evaluates df/dt at given t and parameter values 
 
function eqneval = f(t,vars,Param,Totals) 
 
% Relation of local variables to input values 
 
a = Param(:,1);  % Column 1 in Param is ai 
d = Param(:,2);  % Column 2 is di 
k = Param(:,3);  % Column 3 is ki 
 
Atot = Totals(1); 
E1tot = Totals(2); 
E2tot = Totals(3); 
 
AP = vars(2); 
A_E1 = vars(3); 
AP_E2 = vars(4); 
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% Application of conservation relationships 
 
A = Atot - (AP + A_E1 + AP_E2); 
E1 = E1tot - A_E1; 
E2 = E2tot - AP_E2; 
 
% Actual system of equations (evaluation of differential equations) 
 
eqns(1) = -a(1)*A*E1 + d(1)*A_E1 + k(2)*AP_E2;  % dA/dt 
eqns(2) = -a(2)*AP*E2 + d(2)*AP_E2 + k(1)*A_E1;  % dAP/dt 
eqns(3) = a(1)*A*E1 - (d(1)+k(1))*A_E1;    % dA_E1/dt 
eqns(4) = a(2)*AP*E2 - (d(2)+k(2))*AP_E2;    % dAP_E2/dt 
 
eqneval=eqns'; 
 
 
% -------------------------------------------------------------------- 
 
function [tspan,y0,options] = initval(Param,Totals) 
tspan = [0 10 5000]; 
y0 = [Totals(1);0;0;0]; 
options = []; 
 
disp(‘Go Bears!!’); 
 
%% ------------------------------------------------------------------- 
% 
%function dfdy = jacobian(t,y,p1,p2) 
%dfdy = < Insert Jacobian matrix here. >; 
% 
%% ------------------------------------------------------------------- 
% 
%function S = jpattern(t,y,p1,p2) 
%S = < Insert Jacobian matrix sparsity pattern here. >; 
% 
%% ------------------------------------------------------------------- 
% 
%function M = mass(t,y,p1,p2) 
%M = < Insert mass matrix here. >; 
% 
%% ------------------------------------------------------------------- 
% 
%function [value,isterminal,direction] = events(t,y,p1,p2) 
%value = < Insert event function vector here. > 
%isterminal = < Insert logical ISTERMINAL vector here.>; 
%direction = < Insert DIRECTION vector here.>; 
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Appendix 2. Parameter values for simple signaling models 
A2.1. Linear Cascade 
Total Concentrations (µM) 
A 10 
B 10 
C 10 
E1 10-6 – 100 
EIA 10 
EIB 10 
EIC 10 
Kinetic Rate Constants (s-1 or µM-1s-1) 
Reaction a d k Km 
E1 → A 2 1 1 1 
EIA → A* 0.5 1 1 4 
A* → B 4 1 1 0.5 
EIB → B* 0.67 1 1 3 
B* → C 2.5 1 1.5 1 
EIC → C* 0.85 1 0.7 2 
 
A2.2. Converging Cycles 
Total Concentrations (µM) 
A 0.1 
E1 0 – 0.1 
E2 0 – 0.1 
EIA 0.01 
Kinetic Rate Constants (s-1 or µM-1s-1) 
Reaction a d k Km 
E1 → A 200 100 100 1 
E2 → A 200 150 50 1 
EIA → A* 200 100 100 1 
 
A2.3. Diverging Pathways 
Total Concentrations (µM) 
A 10 
B 10 
E1 0 – 20 
EIA 1 
EIB 1 
Kinetic Rate Constants (s-1 or µM-1s-1) 
Reaction a d k Km 
E1 → A 20 10 10 1 
EIA → A* 20 10 10 1 
E1 → B 20 15 5 1 
EIB → B* 20 10 10 1 
 
A2.4. Cascades with Feedback 
(†Note: kFB was varied from 0-104, aFB adjusted to maintain KFB=100)
Total Concentrations (µM) 
A 10 
B 10 
C 10 
D 10 
E 10 
E1 10-5 – 10 
EIA 0.1 
EIB 0.1 
EIC 0.1 
EID 0.1 
EIE 0.1 
Kinetic Rate Constants (s-1 or µM-1s-1) 
Reaction a d k Km 
E1 → A 101 1 100 1 
EIA → A* 25.25 1 100 4 
A* → B 4 1 1 0.5 
EIB → B* 33.67 1 100 3 
B* → C 2.5 1 1.5 1 
EIC → C* 35.5 1 0.7 2 
C* → D 3 1 2 1 
EID → D* 25.25 1 100 4 
D* → E 5 1 1 0.4 
EIE → E* 51 1 50 1 
E* → A or A* 0.11† 1 10† 100 
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Appendix 3. Model signaling network 
Total Concentrations (µM) 
A 10 
B 10 
C 10 
D 10 
E 10 
F 10 
G 10 
H 10 
E1 10-6 – 10 
E2 10-6 – 10 
EIA 10 
EIB 10 
EIC 10 
EID 10 
EIE 10 
EIF 10 
EIG 10 
EIH 10 
Kinetic Rate Constants (s-1 or µM-1s-1) 
Reaction a d k Km 
E1 → A 12 10 2 1 
EIA → A* 2.75 10 1 4 
E2 → B 12 10 2 1 
EIB → B* 11 10 1 1 
A* → C 22 10 1 0.5 
B* → C 11 10 1 1 
EIC → C* 3.67 10 1 3 
B* → D 12 10 2 1 
EID → D* 11 10 1 1 
C* → E 11.5 10 1.5 1 
D* → E 5.75 10 1.5 2 
EIE → E* 5.35 10 0.7 2 
D* → F 5.75 10 1.5 2 
EIF → F* 5.5 10 1 2 
A* → G 12 10 2 1 
EIG → G* 11 10 1 1 
A* → H 11.5 10 1.5 1 
EIH → H* 11 10 1 1 
 
Calculations for predicted αMN based on Equation 2.51: 
*N
M
mN
*
mIN
INTIN
*
N
*
M
K
NK
Ek
Mk
N
N α+=  so 
mN
*
mIN
INTIN
NN
M K
NK
Ek
k +=α  
Reaction # Reaction maximum N* αMN predicted αMN observed 
1 E1 → A 0.6905 0.9381 0.937 ± 0.001 
2 E2 → B 0.5818 0.3164 0.315 ± 0.001 
3 A* → C 1.0234 0.8047 0.799 ± 0.006 
4 B* → C 0.7779 0.3780 0.373 ± 0.003 
5 B* → D 0.4777 0.2956 0.290 ± 0.004 
6 C* → E 1.7317 0.7997 0.770 ± 0.002 
7 D* → E 1.7317 0.3998 0.399 ± 0.005 
8 D* → F 0.5388 0.1904 0.1878 ± 0.0004 
9 A* → G 0.7165 0.3433 0.336 ± 0.006 
10 A* → H 0.5593 0.2339 0.230 ± 0.003 
     
6 (E1 only) C* → E 1.5637 0.7637 0.76 ± 0.01 
6 (E2 only) C* → E 1.5604 0.7629 0.98 ± 0.01 
7 (E2 only) D* → E 1.5604 0.3815 1.58 ± 0.03 
Appendix 4. Extended cascade with noise 
Parameter values and model were identical to the extended cascade with feedback 
(See A2.4 for values).  However, feedback was eliminated by setting the rate constants 
for the feedback step (a, d, and k) equal to zero.  The resulting model was integrated to 
yield “true” values of active and inactive species (e.g. A, A*, etc). 
The MATLAB function “randn” was used to help simulate experimental error in 
measurements.  This function produces as an output a randomly selected number x from a 
Normal distribution centered around zero with a variance of one (x ~ N(0,1)).  
Multiplying this number by any factor a will make the standard deviation equal to a.  
Therefore, multiplying the true value of a measurement (say, A*) by 0.05*randn will 
produce a number that is normally distributed about the true A*, with a standard deviation 
equal to 5% of the true value.  This value (which may be positive or negative) can be 
added to the “true” value as the error, yielding an error-adjusted estimate for the 
measured value.  This process was performed either on the activation ratios ARI or on all 
individual values I and I*, from which activation ratios were then calculated.  The 
automated regression and pattern assignment procedure was applied to the adjusted data, 
producing an output matrix as shown in Figure 3.10B.  This approach was repeated ten 
times (to produce ten sets of adjusted data) and the average results are shown in Table 
3.5. 
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Appendix 5. Sensitivity matrix for ELISA measurement model  
 
Results of differentiation of ELISA model (Equations 4.3-4.18) as a matrix Gij = ∂mi/∂pj..  
Columns represent parameters pj, and rows correspond to measurements mi. 
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